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    Synthetic organic chemistry creates ways important organic compounds, such as 
physiologically active substances and functionalized molecules.  Carbon–carbon 
bond formation is the most meaningful strategy in synthetic organic chemistry.  
    Catalytic reactions using transition metals, such as Suzuki-Miyaura cross 
coupling reaction1 and Negishi cross coupling reaction2, are the most powerful tools 
for the efficient and selective carbon–carbon bond formations.  Transition-metal 
catalyzed organic reactions have been developed for the efficient synthesis of useful 
compounds in many practical ways3.  
    Especially, nickelacycles and heteronickelacycles made from unsaturated 
hydrocarbons and Ni-complex are attractive and convenient intermediates for C–C 





    Metalacycles are well-known as a important active intermediate for synthetic 
organic chemistry5.  However, oxametalacycles, in which carbon atom replaced by 
the oxygen atom, have not been used as active intermediates.   






























active intermediate for the catalytic reactions.  In 1997, Montgomery and 
co-workers have found a reductive coupling reaction of alkyne and aldehyde via 
oxanickelacycle to provide allylalcohols 1 (eq. 1)6.  Kimura, Tamaru and 
co-workers have reported that the reductive coupling reaction of conjugated diene 
and aldehyde via oxanickelacycle to provide bishomoallylalcohols 2 in 1998 (eq. 2)7.  
Furthermore, Kimura and Tamaru developed multicomponent coupling reaction of 
unsaturated hydrocarbon and carbonyl compounds via oxanickelacycle as active 
intermediates8.  The first example of the isolation oxanickelacycle has been reported 
by Ogoshi and Kurosawa in 2004 (eq. 3, Figure 1)9.  Since then, many reports on 
the catalytic reaction via oxanickelacycles have been appeared.  And the related 


























































Figure 1. ORTEP Drawing of Oxanickelacycle 3 
 
 
    This thesis is composed of three chapters.   
Chapter 1: Multicomponent coupling reaction of alkyne, Me2Zn and vinylic cyclic 
compounds via oxanickelacycle is described.   
Chapter 2: Multicomponent coupling reaction of alkyne, Et3B and N,O-acetals 
prepared from cyclic hemiacetals and primary amines via azanickelacycle is 
developed.   
Chapter 3: Selective formation of unsaturated carboxylic acid and phenyl acetic acid 
from diketene via nickelacycles as active intermediates is demonstrated. 
 
    Chapter 1 deals with Ni-catalyzed three-component coupling reaction of alkynes, 
Me2Zn, and vinyloxacyclopropane or vinylcyclopropane through oxanickelacycle 
intermediates to provide dienyl homoallylalcohols and α-dienyl malonates (Scheme 2)10.  
The reaction is readily conducted by exposing of Me2Zn to a mixture of 
vinyloxacyclopropane and alkynes at room temperature under nitrogen atmosphere.  
Alkynes tends to attack on the terminal carbon atom of the vinylic group to afford 
heptadienyl alcohols with mixture of E and Z isomers.  Furthermore, the coupling 
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reactions of alkynes, Me2Zn, and vinylcyclopropane derived from dimethyl malonate 
and 1,4-dichloro-2-butene under similar catalytic conditions are also investigated.  The 
reaction proceeds smoothly at room temperature within several hours and the coupling 






    Chapter 2 descibes that Ni-catalyzed homoallylation of N,O-acetals prepared from 
cyclic hemiacetals and primary amines to provide ω-hydroxybishomoallylamines in 
high regio- and stereoselectivity (Scheme 3)11.  In similar catalytic reaction systems, 
N,O-acetals from carbohydrates with primary amines give rise to the polyhydroxy- 
bishomoallylamines as physiologically active molecules for development of medicinal 
and synthetic chemistry. 

















































    Chapter 3 deals with selective formation of unsaturated carboxylic acids and 
phenyl acetic acids from diketene (Scheme 4).  It’s shown that Ni-catalyzed 
multicomponent coupling reaction of alkyne, dimethylzinc, and diketene (as butenoic 
acid equivalent) to provide 3-methylene-4-hexenoic acids in a single manipulation 
(path A)12.  On the other hand, in the presence of Ni catalyst, a formal [2+2+2] 
cycloaddition reaction with diketene and two equivalents of alkynes proceeds to give 
phenylacetic acid derivatives by use of Et2Al(OEt) instead of Me2Zn (path B).  
Furthermore, in the presence of Ni catalyst and PPh3 under the similar catalytic 
conditions, the regioselectivity was changed dramatically to provide the symmetrical 
substituted phenylacetic acid as a single product via C–C double bond cleavage of 
diketene (path C, D). 
    Ni-catalyzed oxidative cyclization of alkyne and diketene seems to form 
nickelacyclopentene intermediate.  In the absence of phosphine ligand, the ring 
expansion reaction undergoes to form oxanickelacycle intermediate, whereas, in the 
presence of phosphine ligand, the active nickelacycle bearing PPh3 ligand invokes C–
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Multicomponent Coupling Reaction via Oxanickelacycle:  












Summary: Ni-catalyzed three-component coupling reaction of Me2Zn, alkynes, and 
vinyloxacyclopropanes and vinylcyclopropanes to afford dienyl alcohols and α-hep- 


























     Multicomponent coupling reaction is among the most efficient and 
straightforward synthetic strategies for C–C bond transformation1.  Especially, 
Ni-catalyzed coupling reactions, which have involving unsaturated hydrocarbons, are 
widely utilized for the synthesis of physiologically active compounds and complicated 
molecules2.  We previously reported the Ni(0) catalyst accelerated oxidative 
cyclization of aldehydes and conjugated dienes in the presence of Et3B3 and Et2Zn4, with 
subsequent reductive coupling, to provide bis-homoallyl alcohols with excellent regio- 
and stereoselectivities through key oxanickelacycle intermediates.  Furthermore, we 
demonstrated that similar catalytic systems promoted the four-component coupling of 
1,3-butadiene, alkynes, aldehydes, and dimethylzinc to provide 3,6-octadienyl alcohols 
with excellent regio- and stereoselectivities (Scheme 1)5. 
    Ikeda et al. repored the Ni-catalyzed three-component coupling reaction of allyl 
chloride, an alkyne, and Me2Zn in the presence of Ni catalyst via the syn stereoselective 
addition manner of π-allylnickel species followed by methyl group transfer to the 








Scheme 2.  Ni-Catalyzed Coupling of Allylhalides, Alkyne, and Me2Zn 
 
     Furthermore, the Ni(0) metal-catalyzed coupling reaction of alkyne-tethered 
vinylcyclopropanes with allyl chloride has been reported7.  In this case, the addition of 
the π-allylnickel species to the alkyne moiety proceeds with β-syn elimination of the 



































stereoselectivities.  Encouraged by these multicomponent coupling reactions involving 
π-allylnickel species by Ikeda’s protocols and our previous strategies utilizing 
oxanickelacycles with alkynes and organozinc reagents, we were prompted to develop 
stereodefined functionalizations using allylating agents and alkynes based on the 
structural variety of oxanickelacycles. 
     Herein, we would like to report highly regio- and stereocontrolled three- 
component coupling reaction of alkynes, dimethylzinc, and vinyloxacyclopropane, 
vinylcyclopropanes involving the addition of π-allylnickel species toward the alkynes to 




Results and Discussion 
 
    The reaction was readily conducted by exposing Me2Zn to a mixture of 
vinyloxacyclopropane and alkynes at room temperature under nitrogen atmosphere.  
The results using various kinds of ligands and solvents are shown in Table 1.  The 
initial investigation using vinyloxacyclopropane and 3-hexyne made it clear that THF 
was the most effective solvent (entries 1-8, Table 1).  In all cases, the alkynes tended 
to attack on the terminal carbon atom of the vinylic group to afford heptadienyl alcohol 
3aa via methyl group transfer from Me2Zn in a 3:1 ratio of E and Z isomers with respect 
to the C-2 olefin geometry.  Among these results with various kinds of ligands using 
monodentate, bidentate phosphine ligands, and NHC ligands, no ligands at room 
temperature provided the best result in the formation of the desired product (entries 9-13, 
Table 1).  
    Next, we conducted the multicomponent coupling reaction of substituted 
vinyloxacyclopropane, various alkynes, and Me2Zn under the optimized conditions of 
Table 1.  Although diphenylacetylene participated in the coupling reaction in good 
yield to afford a mixture of E and Z isomers (entry 1, Table 2), bis(trimethylsilyl)acety- 
lene and an electron-deficient alkyne did not provide the desired results (entries 2 and 3, 
Table 2).  An unsymmetrical alkyne took part in the coupling reaction in excellent 
yields to give 3ae as four inseparable regio- and stereoisomers and 3af as two 
stereoisomers (entries 4 and 5, Table 2).   
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Table 1.  Optimization of Reaction Conditions for the Nickel-Catalyzed 
Three-Component Coupling Reaction of Alkyne, Vinyloxacyclopropane and 
Me2Zna 
 
entry ligand solvent condition yield of 3aa (%) [E/Z] 
1 none THF r.t., 24 h 92 [3:1] 
2b none THF r.t., 24 h 90 [3:1] 
3 none THF 50 ˚C, 24 h 89 [3:1] 
4 none toluene 80 ˚C, 24 h 81 [3:1] 
5 none toluene 110 ˚C, 24 h 82 [3:1] 
6 none ether r.t., 24 h 84 [3:1] 
7 none CH2Cl2 r.t., 24 h 59 [3:1] 
8 none dioxane r.t., 24 h 20 [3:1] 
9 Ph3P THF r.t., 48 h 71 [3:1] 
10 n-Bu3P THF r.t., 48 h no reaction 
11c dppf THF r.t., 48 h no reaction 














(Table 1, continued)    
     
13e NHC THF r.t., 24 h 81 [1:1] 
 
a The reaction was conducted in the presence of vinyloxacyclopropane (1 mmol), Ni(acac)2 (0.1 mmol), 
ligand (0.2 mmol), 3-hexyne (1 mmol), and dimethylzinc (1.2 mmol; 1 M hexane) in solvent (3 mL) 
under nitrogen atmosphere. 
b Ni(cod)2 (0.1 mmol) was used instead of Ni(acac)2. 
c dppf: diphenylphosphinoferrocene (0.1 mmol) was used. 
d dppbz: diphenylphosphinobenzene (0.1 mmol) was used. 
e NHC ligand was prepared from 1,3-bis(2,6-diisopropylphenyl)- imidazolium chloride with 0.2 mmol of 
t-BuOK. 
     
    Two equivalents of terminal alkynes were required to afford the products 3ag and 
3ah in modest yields along with the branched regioisomers 4ag and 4ah, which were 
produced by attack of the terminal alkynes on the internal allylic position of 
vinyloxacyclopropane (entries 6 and 7, Table 2).  2-Methyl-2-vinyloxacyclopropane 
underwent a similar coupling reaction in good to excellent yields, and employment of 
3-hexyne and diphenylacetylene led to the formation of the desired product 3ba and 
3bb in high yields in a 1:2 to 1:3 ratios of E and Z stereoisomers (entries 8 and 9, Table 
2).  Bis(trimethylsilyl)acetylene showed the modest yield and selectivity as well as the 





Table 2.  Scope of the Nickel-Catalyzed Three-Component Coupling Reaction 
of Vinyloxacyclopropane 1 with Alkyne 2a 
 
entry epoxide R alkyne R1 R2 yield of 3 and 4 (%) [E/Z] 
1 H (1a) Ph Ph  (2b) 3ab: 84 [2:1] 
2 H (1a) TMS TMS  (2c) 3ac: 35 [2:1] 
3 H (1a) CO2Me CO2Me  (2d) no reaction 
4 H (1a) Et Ph  (2e) 3ae: 93 [4 isomers] 
5 H (1a) Me TMS  (2f) 3af: 97 [2:1] 
6b H (1a) H Ph  (2g) 3ag: 81 [2:1], 4ag: 15 
7b H (1a) H TMS  (2h) 3ah: 64 [2:1], 4ah: 33 
8 Me (1b) Et Et  (2a) 3ba: >99 [1:2] 
9 Me (1b) Ph Ph  (2b) 3bb: 73 [1:3] 
10 Me (1b) TMS TMS  (2c) 3bc: 61 [1:1] 
 
a The reaction was undertaken in the presence of vinyloxacyclopropane (1 mmol), Ni(acac)2 (0.1 mmol), 
alkyne (1 mmol), and dimethylzinc (1.2 mmol; 1 M hexane) in THF (3 mL) under nitrogen atmosphere. 























    Based on the optimized catalytic systems, we examined the multicomponent 
coupling reaction of vinyloxacyclopropane and substituted alkynes, and dimethylzinc in 
the multi-grams scale to give the corresponding dienyl alcohols 3 and 4 in good to 
reasonable yields.  In that case, even if it reduces catalyst quantity to 1 mol%, it is 
satisfactory (Table 3). 
 
Table 3.  Scope of the Nickel-Catalyzed Three-Component Coupling Reaction 
of Vinyloxacyclopropane 1 with Alkyne 2 on a 15-mmol Scalea 
 
entry epoxide R alkyne R1 R2 yield of 3 and 4 (%) [E/Z] 
1 H (1a) Et Et  (2a) 3aa: 99 [3:1] 
2 H (1a) Ph Ph  (2b) 3ab: 99 [2:1] 
3 H (1a) TMS TMS  (2c) 3ac: 41 [2:1] 
4 H (1a) Et Ph  (2e) 3ae: 95 [4 isomers] 























(Table 3, continued)    
     
6b H (1a) H Ph  (2g) 3ag: 37 [2:1], 4ag: 18 
7b H (1a) H TMS  (2h) 3ah: 27 [2:1], 4ah: 10 
8 Me (1b) Et Et  (2a) 3ba: 93 [1:2] 
9 Me (1b) Ph Ph  (2b) 3bb: 84 [1:3] 
10 Me (1b) TMS TMS  (2c) 3bc: 41 [1:1] 
 
a The reaction was undertaken in the presence of vinyloxacyclopropane (18 mmol), Ni(acac)2 (0.15 
mmol), alkyne (15 mmol), and dimethylzinc (15 mmol; 1 M hexane) in THF (30 mL) under nitrogen 
atmosphere. 
b Alkyne (45 mmol) was used. 
 
 




    A plausible reaction mechanism for the multicomponent coupling reaction of 
vinyloxacyclopropane, alkyne, and dimethylzinc is displayed in Scheme 3.  Low 
stereoselectivities for the coupling reactions using vinyloxacyclopropane might 
originate from the formation of the π-allyloxanickelacycle intermediate I in equilibrium 
with the 6-membered oxanickelacycle II.  It is known that vinyloxacyclopropane 
readily undergoes oxidative addition toward Ni(0) metal species coordinated by alkynes 
to form four- or six-membered oxanickelacycles.  This is followed by methyl group 
transfer from the Zn atom to the Ni metal center, leading to C–C bond formation and a 
mixture of E and Z isomers.  Terminal carbons of phenylacetylene and trimethylsilyla- 
cetylene attack on the allylic position of vinyloxacyclopropane to afford the branched 
regiosomers 4 owing to less steric repulsion between the H atom of the terminal alkyne 





Scheme 3.  Reaction Mechanism for Three-Component Coupling Reaction of 
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    The coupling reaction with various alkynes, dimethylzinc, and vinylcyclopropane, 
which is prepared from dimethyl malonate with 1,4-dichloro-2-butene, are summarized 
in Table 4.  In most cases, the reaction proceeded smoothly at room temperature within 
several hours and the coupling products were obtained with excellent E-stereoselectiv- 
ities (entries 1 and 2, Table 4).  The trimethylsilyl group also took part in efficient 
coupling to give the corresponding desired product 5cc in moderate yield with E-stereo- 
selectivity (entry 3, Table 4).  And an electron-deficient alkyne did not provide the 
desired result (entry 4, Table 4).  Unsymmetrical internal alkynes participated in the 
coupling reaction giving rise to a mixture of regioisomers with exclusive E-stereosele- 
ctivities (entries 5 and 6, Table 4).  In all cases, the stereochemistry with respect to the 
Me group and the olefinic main chain is the Z-form, as in the reaction of vinylcyclopro- 
pane.  The reaction feature using terminal alkyne such as phenylacetylene and trimet- 
hylsilylacetylene were changed dramatically and the desired product 5 was not obtained 
at all.  Instead, the dienynes 7cg and 7ch, involving dimerization of the terminal 
alkynes, were produced as major products by the stereoselective coupling reaction with 







Table 4.  Scope of the Nickel-Catalyzed Three-Component Coupling Reaction 
of Vinylcyclopropane 1c with Alkyne 2a 
 
entry alkyne R1 R2 time (h) yield of 5, 6 and 7 (%) [E/Z] 
1 Et Et  (2a) 1 5ca: 84 [E only] 
2 Ph Ph  (2b) 3 5cb: 73 [E only] 
3 TMS TMS  (2c) 3 5cc: 63 [E only] 
4 CO2Me CO2Me  (2d) 24 no reaction 
5 Et Ph  (2e) 6 5ce: 92 [E only]b 
6 Me TMS  (2f) 1 5cf: 83 [E only] 
7c H Ph  (2g) 24 7cg: 71 [E only] 
8c H TMS  (2h) 6 7ch: 56 [E only], 6ch: 24 
 
a The reaction was undertaken in the presence of vinylcyclopropane (1 mmol), Ni(acac)2 (0.1 mmol), 
alkyne (1 mmol), and dimethylzinc (1.2 mmol; 1 M hexane) in THF (3 mL) under nitrogen atmosphere. 
b Product 5ce was obtained as a mixture of regioisomer in a 3:1 ratio. 





























    Moreover, Also in a multi-gram scale, a reaction advances equal, and this reaction 
gives the same products. In that case, even if it reduces catalyst quantity to 1 mol%, it is 
satisfactory (Table 5). 
Table 5.  Scope of the Nickel-Catalyzed Three-Component Coupling Reaction 
of Vinylcyclopropane 1c with Alkyne 2 on a 15-mmol Scalea 
 
entry alkyne R1 R2 time (h) yield of 5, 6 and 7 (%) [E/Z] 
1 Et Et  (2a) 24 5ca: 80 [E only] 
2 Ph Ph  (2b) 24 5cb: 68 [E only] 
3 TMS TMS  (2c) 24 5cc: 59 [E only] 
4 Et Ph  (2e) 24 5ce: 83 [E only]b 
5 Me TMS  (2f) 24 5cf: 91 [E only] 
6c H Ph  (2g) 24 7cg: 65 [E only] 
 
a The reaction was undertaken in the presence of vinylcyclopropane (1 mmol), Ni(acac)2 (0.1 mmol), 
alkyne (1 mmol), and dimethylzinc (1.2 mmol; 1 M hexane) in THF (3 mL) under nitrogen atmosphere. 
b Product 5ce was obtained as a mixture of regioisomer in a 3:1 ratio. 





























    The stereochemistry of the products was unequivocally determined on the basis of 
NOE experiments.  The results of irradiation at the bold protons are illustrated in 
Figure 1.  According to the NOE results, irrespective of the kinds of regioisomers 
derived from the symmetrical and unsymmetrical alkynes, it was apparent that methyl 
group transfer from Me2Zn to the acetylenic triple bond proceeded in a syn manner to 
deliver Z-stereochemistry with respect to the C5 olefinic geometry and E-stereo- 
chemistry with respect to the C2 position by the ring expanding reaction processes of 


























5cf: E = CO2Me
5ce (major isomer) 5ce (minor isomer)
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    A reaction mechanism for the coupling reaction of alkyne, vinylcyclopropane, and 
Me2Zn is displayed in Scheme 4.  The exclusive E-stereochemistry might stem from 
the stability of the produced nickelacycles.  Formation of allylnickel species IV would 
predominate over that of 8-membered ring species V owing to the entropy effect for the 
ring-closing reaction.  This is followed by insertion of the alkyne to the allylic termi- 
nus of the allylnickel species to provide (E)-5 isomer exclusively.  As in the case of 
using terminal alkyne, zinc acetylide derived from dimethylzinc and terminal alkyne 
might preferentially participate in the coupling reaction via transmetalation with allyl- 
nickel species VI to give rise to diene-yne 7 as the major products.  Since Ni(0) 
catalysts tend to promote a head-to-tail dimerization of terminal alkynes in the presence 
of organozinc reagents to give the enyne framework, the aleternative coupling reaction 
involving dimerization of terminal alkyne followed by carbonickelation toward vinyl- 




Scheme 4.  Reaction Mechanism for Three-Component Coupling Reaction of 






























































    In summary, we have demonstrated Ni-catalyzed multicomponent coupling 
reaction of vinyloxacyclopropane, alkyne, and dimethylzinc to provide 2,5-heptadienyl 
alcohols as a mixture of E and Z isomers in high yields.  Furthermore, vinylcyclopro- 
pane participated in highly regio- and stereoselective multicomponent coupling reac- 
tion to afford dimethyl(α-2,5-heptadienyl)malonates with excellent E-stereoselectivity.  
And we have succeeded to extend these reactions in multi-grams scale for the efficient 
synthesis of dienyl alcohols and sterodefined dienyl esters9.  These reactions could be 
performed with standard laboratories glassware and equipment and did no require the 











    Reactions employed oven-dried glassware unless otherwise noted.  Thin layer 
chromatography (TLC) employed glass 0.25 mm silica gel plates with UV indicator 
(Merck, Silica gel 60F
254
).  Flash chromatography columns were packed with 230-400 
mesh silica gel as a slurry in hexane.  Gradient flash chromatography was conducted 
eluting with a continuous gradient from hexane to the indicated solvent.  Distillation 
were carried out in a Kugelrohr apparatus (SIBATA glass tube oven GTO-350RG).  
Boiling points are meant to refer to the oven temperature (± 1 °C).  Microanalyses 
were performed by the Instrumental Analysis Center of Nagasaki University.  Analysis 
agreed with the calculated values within ± 0.4%.  Proton and carbon NMR data were 
obtained with a JEOL-GX400 with tetramethylsilane as an internal standard.  
Chemical shift values were given in ppm downfield from the internal standard.  
Infrared spectra were recorded with a JASCO A-100 FT-IR or SHIMAZU FTIR-8700 
spectrophotometer.  High resolution mass spectra (HRMS) were measured with a 
JEOL JMS-DX303. 
Solvents and Reagents 
    Tetrahydrofuran, diethyl ether, and 1,4-dioxane were dried and distilled from 
benzophenone and sodium immediately prior to use under nitrogen atmosphere. 
Anhydrous toluene and dichloromethane were purchased (Aldrich) and used without 
further purification.  Ni(acac)2, PPh3, n-Bu3P, dppf [1,1’-bis(diphenylphosphino)ferro- 
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cene], 1,3-bis(2,6-di-isopropylphenyl)imidazolium chloride, and Me2Zn (1.0 M hexane 
solution) (Kanto Kagaku) were purchased and used without further purification.  
3-Hexyne, dimethylacetylene, bis(methoxycarbonyl)ethyne, 1-phenyl-1-butyne, phenyl- 
acetylene, trimethylsilylacetylene, bistrimethylacetylene, and diphenylacetylene (Tokyo 
Kasei Kogyo Co., Ltd) were purchased and distilled prior to use.  Butadiene monoxide 
and isoprene oxide (Aldrich) were purchased and distilled prior to use.  Dimethyl 






General procedure 1: for the Nickel-catalyzed three-component coupling reaction 
of alkynes, vinyloxacyclopropane and Me2Zn (entry 1, Table 1)   
    An oven-dried, 25 mL, three-necked round-bottomed flask equipped with a dropp- 
ing funnel, a rubber septum cap, an air condenser (fitted with a three-way stopcock 
connected into nitrogen balloon), and a Teflon-coated magnetic stir bar was charged 
with Ni(acac)2 (25.7 mg, 0.1 mmol).  The apparatus was purged with nitrogen and the 
flask was charged successively via syringe with freshly dry THF (3 mL), vinyloxacy- 
clopropane (70.1 mg, 1 mmol), and 3-hexyne (82.1 mg, 1 mmol). Dimethylzinc (1.2 
mmol, 1.0 M hexane solution) was added slowly at room temperature via the dropping 
funnel over a period of 10 min (the reaction temperature should not be exceeded 50 ˚C).  
The mixture was stirred at room temperature for 24 h and monitored by TLC.  After 
the reaction was completed, the reaction mixture was cooled to 0 ˚C, and then poured 
into ice-water.  The resulting solution was diluted with 30 mL of EtOAc and carefully 
washed with 2 M HCl, with sat. NaHCO3, and brine.  The aqueous layer was extracted 
with 30 mL of EtOAc.  The combined organic phases were dried (MgSO4) and conce- 
ntrated in vacuo, and the residual oil was subjected to column chromatography over 
silica gel (eluent; hexane/EtOAc = 16/1 v/v) to afford 3aa as a colorless oil (155.6 mg, 




(2E,5E)-5-Ethyl-6-methylocta-2,5-dien-1-ol : (3aa) 
 
(2E,5E)-5-Ethyl-6-methylocta-2,5-dien-1-ol (3aa): (a mixture of E- and Z- isomers in 
a ratio of 3 : 1): IR (neat) 3319 (m), 2962 (s), 2931 (s), 2872 (s), 1655 (w), 1458 (m), 
1373 (m), 1070 (m), 1004 (m), 970 (m), 792 (w) cm-1; 1H NMR (400 MHz, CDCl3, 
(E)-) δ 0.94 (t, J = 7.6 Hz, 3 H), 0.97 (t, J = 7.6 Hz, 3 H), 1.62 (s, 3 H), 2.03 (q, J = 7.6 
Hz, 2 H), 2.04 (q, J = 7.6 Hz, 2 H), 2.75 (br m, 2 H), 4.09 (br m, 2 H), 5.62 (m, 2 H); 
13C NMR (100 MHz, CDCl3, (E)-) δ 13.3, 13.6, 17.5, 24.9, 27.0, 34.7, 63.8, 127.9, 
128.8, 131.2, 131.6; 1H-NMR (400 MHz, CDCl3, (Z)-): δ 0.94 (t, J = 7.6 Hz, 3 H), 0.97 
(t, J = 7.6 Hz, 3 H), 1.58 (s, 3 H), 2.03 (q, J = 7.6 Hz, 2 H), 2.04 (q, J = 7.6 Hz, 2 H), 
2.80 (d, J = 7.3 Hz, 2 H), 4.26 (br m, 2 H), 5.45 (dt, J = 11.0, 7.3 Hz, 1 H), 5.58 (dm, J 
= 11.0 Hz, 1 H); 13C-NMR (100 MHz, CDCl3, (Z)-) δ 13.2, 13.6, 17.5, 24.8, 27.1, 30.2, 
58.7, 127.9, 128.8, 131.0, 131.4; High-resolution MS, calcd for C11H20O: 168.1514. 
Found m/z (relative intensity): 169(M++1, 1), 168.1497 (M+, 8), 167 (20), 151 (27), 
150 (31), 139 (100). 
 
(2E,5Z)-5,6-Diphenylhepta-2,5-dien-1-ol : (3ab) 
Following General Procedure 1. Purification by flash chromatography (eluent; hexane/ 







(2E,5Z)-5,6-Diphenylhepta-2,5-dien-1-ol (3ab): (a mixture of E- and Z- isomers in a 
ratio of 2 : 1): IR (neat) 3350 (s), 3055 (s), 3020 (s), 2993 (s), 2928 (s), 2870 (m), 1717 
(s), 1682 (s), 1599 (m), 1489 (s), 1443 (s), 1026 (m), 970 (m), 912 (m), 764 (m) cm-1; 
1H NMR (400 MHz, CDCl3, (E)-) δ 2.17 (s, 3 H), 3.31 (br m, 2 H), 4.10 (br m, 2 H), 
5.72 (m, 2 H), 7.00 (m, 10 H); 13C NMR (100 MHz, CDCl3, (E)-) δ 21.1, 37.9, 63.6, 
125.6, 127.4, 127.5, 128.9, 129.0, 129.4, 129.5, 129.6, 134.7, 142.8, 143.1, 144.1; 1H 
NMR (400 MHz, CDCl3, (Z)-): δ 2.20 (s, 3 H), 3.34 (d, J = 6.6 Hz, 2 H), 4.00 (d, J = 
6.3 Hz, 2 H), 5.57 (dt, J = 10.2, 6.6 Hz, 1 H), 5.72 (dt, J = 10.2, 6.3 Hz, 1 H), 7.00 (m, 
10 H); 13C NMR (100 MHz, CDCl3, (Z)-) δ 20.9, 33.5, 58.4, 125.8, 127.4, 127.5, 128.9, 
129.3, 129.4, 129.5, 129.6, 135.4, 142.8, 143.1, 144.0; High-resolution MS, calcd for 
C19H20O: 264.1514. Found m/z (relative intensity): 264.1440 (M+, 42), 263 (100), 262 
(51), 246 (57). 
 
(2E,5Z)-5,6-Bis(trimethylsilyl)hepta-2,5-dien-1-ol : (3ac) 
Following General Procedure 1. Purification by flash chromatography (eluent; 
hexane/EtOAc = 12/1 v/v) afforded 3ac as a colorless oil. bp 110 °C/0.1 mmHg. 
 









isomers in a ratio of 2 : 1): IR (neat) 3329 (m), 2955 (s), 2899 (m), 2864 (m), 1456 (w), 
1248 (s), 1001 (m), 968 (m), 837 (s), 756 (m) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.12 
(s, 18 H), 1.26 (br, 1 H), 1.78 (s, 3 H), 2.89 (d, J = 7.6 Hz, 2 H), 4.26 (d, J = 6.3 Hz, 2 
H), 5.60-5.68 (m, 2 H); 13C NMR (100 MHz, CDCl3, (E)-) δ 0.4, 17.6, 33.4, 63.8, 
128.6, 130.3, 142.9; 13C NMR (100 MHz, CDCl3, (Z)-) δ 0.4, 17.6, 31.6, 60.3, 128.6, 
130.3, 143.3; High-resolution MS, calcd for C13H28OSi2: 256.1679. Found m/z (relative 
intensity): 257 (M++1, 24), 256.1679 (M+, 100), 225 (9). 
 
(2E,5E)-5-Ethyl-6-phenylhepta-2,5-dien-1-ol : (3ae) 
Following General Procedure 1. Purification by flash chromatography (eluent; 
hexane/EtOAc = 8/1 v/v) afforded 3ae as a colorless oil. bp 150 °C/0.1 mmHg. 
 
(2E,5E)-5-Ethyl-6-phenylhepta-2,5-dien-1-ol (3ae): (a mixture of 4 isomers, the ratio 
was not determined): IR (neat) 3350 (s), 3057 (m), 3020 (m), 2968 (s), 2933 (s), 2873 
(s), 1717 (s), 1682 (s), 1599 (m), 1491 (s), 1441 (s), 1026 (s), 972 (m), 766 (s) cm-1; 1H 
NMR (400 MHz, CDCl3, (2E)-) δ 0.89 (t, J = 7.6 Hz, 3 H), 1.58 (br s, 1 H), 1.89 (q, J 
= 7.6 Hz, 2 H), 1.93 (s, 3 H), 2.94 (br m, 2 H), 4.14 (br m, 2 H), 5.73 (m, 2 H), 7.10 (t, 
J = 7.6 Hz, 2 H), 7.21 (d, J = 7.6 Hz, 2 H), 7.30 (t, J = 7.6 Hz, 1 H); 13C NMR (100 
MHz, CDCl3, (2E)-) δ 13.4, 21.0, 26.2, 33.8, 63.7, 125.8, 127.8, 127.9, 128.5, 129.3, 






1.31 (br s, 1 H), 1.89 (q, J = 7.6 Hz, 2 H), 1.95 (s, 3 H), 2.98 (d, J = 7.3 Hz, 2 H), 4.31 
(d, J = 6.6 Hz, 2 H), 5.56 (dt, J = 10.7, 7.3 Hz, 1 H), 5.67 (dt, J = 10.7, 6.6 Hz, 1 H), 
7.10 (t, J = 7.6 Hz, 2 H), 7.21 (d, J = 7.6 Hz, 2 H), 7.29 (t, J = 7.6 Hz, 1 H); 13C NMR 
(100 MHz, CDCl3, (2Z)-) δ 13.3, 20.9, 26.1, 29.4, 58.7, 125.8, 127.9, 127.9, 128.6, 
129.2, 130.4, 130.9, 144.9; High-resolution MS, calcd for C15H20O: 216.1514. Found 
m/z (relative intensity): 217 (M++1, 16), 216.1496 (M+, 100), 214 (15), 199 (36). 
 
(2E,5E)-5-methyl-6-(trimethylsilyl)hepta-2,5-dien-1-ol: (3af) 
Following General Procedure 1, Purification by distillation afforded 3af as a color less 
oil. bp 115 °C/0.1mmHg.  
 
(2E,5E)-5-methyl-6-(trimethylsilyl)hepta-2,5-dien-1-ol (3af): (a mixture of 2E- and 
2Z- isomers in a ratio of 2 : 1): IR (neat): 3312 (s), 2953 (s), 2912 (s), 2860 (m), 1612 
(m), 1445 (m), 1247 (s), 1001 (m), 835 (s), 756 (s), 687 (m) cm-1; 1H NMR (400 MHz, 
CDCl3, (E)- ): δ 0.12 (s, 9 H), 1.26 (brs, 1 H), 1.70 (s, 3 H), 1.78 (s, 3 H), 2.84 (d, J = 
7.4 Hz, 2 H), 4.09 (d, J = 6.3 Hz, 2 H), 5.45-5.65 (m, 2 H); 13C NMR (100 MHz, 
CDCl3, (E)-): δ 0.4, 17.6, 21.1, 37.9, 63.7, 128.4, 129.2, 131.9, 142.9; 1H NMR (400 
MHz, CDCl3, (Z)- ): δ 0.13 (s, 9 H), 1.35 (brs, 1 H), 1.71 (s, 3 H), 1.85 (s, 3 H), 2.89 (d, 
J = 7.4 Hz, 2 H), 4.25 (d, J = 6.3 Hz, 2 H), 5.45-5.65 (m, 2 H); 13C NMR (100 MHz, 
CDCl3, (Z)-): δ 0.7, 17,6, 22.9, 34.3, 58.6, 128.6, 129.8, 130.3, 144.7; High-resolution 







198.1431 (M+, 60), 183 (20) 169 (16) 127 (100). 
General procedure 2: for the Nickel-catalyzed three-component coupling reaction 
of alkynes, vinyloxacyclopropane and Me2Zn (entry 6, Table 1)   
    An oven-dried, 25 mL, three-necked round-bottomed flask equipped with a dropp- 
ing funnel, a rubber septum cap, an air condenser (fitted with a three-way stopcock 
connected into nitrogen balloon), and a Teflon-coated magnetic stir bar was charged 
with Ni(acac)2 (25.7 mg, 0.1 mmol).  The apparatus was purged with nitrogen and the 
flask was charged successively via syringe with freshly dry THF (3 mL), vinyloxacy- 
clopropane (70.1 mg, 1 mmol), and phenylacetylene (409 mg, 4 mmol). Dimethylzinc 
(1.2 mmol, 1.0 M hexane solution) was added slowly at room temperature via the 
dropping funnel over a period of 10 min (the reaction temperature should not be 
exceeded 50 ˚C).  The mixture was stirred at room temperature for 24 h and monitored 
by TLC.  After the reaction was completed, the reaction mixture was cooled to 0 ˚C, 
and then poured into ice-water.  The resulting solution was diluted with 30 mL of 
EtOAc and carefully washed with 2 M HCl, with sat. NaHCO3, and brine.  The 
aqueous layer was extracted with 30 mL of EtOAc.  The combined organic phases 
were dried (MgSO4) and conce- ntrated in vacuo, and the residual oil was subjected to 
column chromatography over silica gel (eluent; hexane/EtOAc = 16/1 v/v) to afford 3ag 
as a colorless oil (152.4 mg, 81%; Rf = 0.40; hexane/EtOAc = 4/1 v/v). 





(2E,5E)-6-Phenylhepta-2,5-dien-1-ol (3ag): (a mixture of E- and Z- isomers in a ratio 
of 2 : 1): IR (neat) 3371 (br), 3024 (s), 2926 (s), 2872 (s), 1719 (m), 1647 (m), 1495 (s), 
1447 (s), 1028 (s), 927 (s), 760 (s), 698 (s) cm-1; 1H NMR (400 MHz, CDCl3, (E)-): δ 
1.55 (br, 1 H), 2.05 (t, J = 1.0 Hz, 3 H), 2.99 (t, J = 7.0 Hz, 2 H), 4.12 (d, J = 5.3 Hz, 1 
H), 4.27 (d, J = 5.3 Hz, 1 H), 5.60-5.80 (m, 3 H), 7.21 (tt, J = 7.0, 2.0 Hz, 1 H), 7.30 
(td, J = 7.0, 1.5 Hz, 2 H), 7.36 (dt, J = 7.0, 1.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3, 
(E)-) δ 15.8, 31.4, 63.6, 125.5, 126.6, 128.0, 128.2, 129.4, 130.7, 135.9, 143.5; 1H 
NMR (400 MHz, CDCl3, (Z)-): δ 1.55 (br, 1 H), 2.05 (t, J = 1.0 Hz, 3 H), 2.95 (t J = 
7.0 Hz, 2 H), 4.12 (d, J = 5.3 Hz, 1 H), 4.27 (d, J = 5.3 Hz, 1 H), 5.60-5.80 (m, 3 H), 
7.21 (tt, J = 7.0, 2.0 Hz, 1 H), 7.30 (td, J = 7.0, 1.5 Hz, 2 H), 7.36 (dt, J = 7.0, 1.3 Hz, 2 
H); 13C NMR (100 MHz, CDCl3, (Z)-) δ 15.8, 27.3, 58.6, 125.5, 126.6, 128.0, 128.2, 
128.8, 130.7, 135.6, 143.4; High-resolution MS, calcd for C13H16O: 188.1183. Found 
m/z (relative intensity): 189 (M++1, 8), 188.1183 (M+, 54), 171 (13), 157 (48). 
 
(E)-4-Phenyl-2-vinylpent-3-en-1-ol: (4ag) 
Following General Procedure 2, Purification by flash column chromatography afforded 
4ag as a color less oil.  
OH
Ph  
(E)-4-Phenyl-2-vinylpent-3-en-1-ol (4ag): IR (neat): 3362 (br), 3080 (s), 2928 (s), 





NMR (400 MHz, CDCl3): δ 1.54 (s, 1 H), 2.09 (d, J = 1.5 Hz, 3 H), 3.38 (ddt, J = 10.3, 
9.0, 7.4 Hz 1 H), 3.62 (d, J = 7.4 Hz, 2 H), 5.17 (dd, J = 7.6, 1.5 Hz, 1 H), 5.20 (dd, J = 
17.3, 1.5 Hz, 1 H), 5.63 (dq, J = 9.0, 1.5 Hz, 1 H), 5.78 (ddd, J = 17.3, 10.3, 7.6 Hz, 1 
H), 7.24 (tt, J = 7.9, 2.3 Hz, 1 H), 7.31 (td, J = 7.9, 1.5 Hz, 2 H), 7.39 (dt, J = 7.9, 1.3 
Hz, 2 H); 13C NMR (100 MHz, CDCl3): δ 16.4, 46.3, 65.5, 116.5, 125.6, 125.9, 126.9, 
128.1, 137.4, 138.0, 143.3; High-resolution MS, calcd for C13H16O: 188.1183. Found 
m/z (relative intensity): 189 (M++1, 7), 188.1183 (M+, 46), 157 (100), 142 (76). 
 
(2E,5E)-6-(Trimethylsilyl)hepta-2,5-dien-1-ol: (3ah) 
Following General Procedure 2, Purification by flash column chromatography afforded 




(2E,5E)-6-(Trimethylsilyl)hepta-2,5-dien-1-ol (3ah): (a mixture of E- and Z- isomers 
in a ratio of 2 : 1): IR (neat): 3317 (br), 3009 (s), 2955 (s), 2899 (s), 1614 (m), 1404 
(m), 1248 (s), 1013 (s), 970 (s), 837 (s), 750 (s), 689 (s) cm-1; 1H NMR (400 MHz, 
CDCl3, (E)-): δ 0.01 (s, 9 H), 1.28 (s, 1 H), 1.63 (d, J = 0.9 Hz, 3 H), 2.84 (t, J = 6.9 
Hz, 2 H), 4.06 (d, J = 5.6 Hz, 2 H), 5.62 (m, 3 H); 13C NMR (100 MHz, CDCl3, (E)-): 
δ -2.1, 14.4, 31.2, 63.7, 128.5, 129.1, 131.0, 135.9; 1H NMR (400 MHz, CDCl3, (Z)-): 
0.01 (s, 9 H), 1.28 (s, 1 H), 1.65 (d, J = 0.9 Hz, 3 H), 2.81 (t, J = 6.9 Hz, 2 H), 4.19 (d, 
J = 5.6 Hz, 2 H), 5.62 (m, 3 H); 13C NMR (100 MHz, CDCl3, (Z)-): δ -2.1, 14.4, 27.0, 
58.6, 128.5, 129.1, 131.0, 135.9; High-resolution MS, calcd for C10H20OSi: 184.1283. 
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Following General Procedure 2, Purification by flash column chromatography afforded 





(E)-4-(Trimethylsilyl)-2-vinylpent-3-en-1-ol (4ah): IR (neat): 3313 (br), 3080 (m), 
2955 (s), 2874 (m), 1618 (m), 1406 (m), 1248 (s), 1028 (s), 991 (m), 835 (s), 750 (s), 
689 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 0.07 (s, 9 H), 1.43 (s, 1 H), 1.73 (d, J = 
1.7 Hz, 3 H), 3.38 (tdd, J = 8.5, 7.8, 6.7 Hz, 1 H), 3.52 (d, J = 7.8 Hz, 2 H), 5.11 (dd, J 
= 17.6, 1.7 Hz, 1 H), 5.12 (dd, J = 9.8, 1.7 Hz, 1 H), 5.53 (dq, J = 8.5, 1.7 Hz, 1 H), 
5.72 (ddd, J = 17.6, 9.8, 6.7 Hz, 1 H); 13C NMR (100 MHz, CDCl3): δ 1.6, 15.4, 46.3, 
65.6, 116.7, 136.5, 137.9, 140.9; High-resolution MS, calcd for C10H20OSi: 184.1283. 




Following General Procedure 1, Purification by distillation afforded 3ba as a color less 







(2Z,5E)-5-Ethyl-2,6-dimethylocta-2,5-dien-1-ol (3ba): (a mixture of E- and Z- 
isomers in a ratio of 1 : 2): IR (neat): 3336 (m), 2964 (s), 2934 (s), 2872 (s), 1653 (m), 
1456 (s), 1375 (s), 1005 (s), 951 (w), 785 (w) cm-1; 1H NMR (400 MHz, CDCl3, (Z)-): 
δ 0.94 (t, J = 7.6 Hz, 3 H), 0.96 (t, J = 7.6 Hz, 3 H), 1.64 (s, 3 H), 1.80 (d, J = 1.2 Hz, 3 
H), 1.99 (q, J = 7.6 Hz, 2 H), 2.02 (q, J = 7.6 Hz, 2 H), 2.77 (d, J = 7.1 Hz, 2 H), 4.19 
(s, 2 H), 5.21 (tq, J = 7.1, 1.2 Hz, 1 H); 13C NMR (100 MHz, CDCl3, (Z)-): δ 13.2, 13.6, 
17.5, 21.3, 24.6, 27.1, 30.2, 61.7, 127.2, 130.5, 132.2, 133.7; 1H NMR (400 MHz, 
CDCl3, (E)-): δ 0.94 (t, J = 7.6 Hz, 3 H), 0.96 (t, J = 7.6 Hz, 3 H), 1.64 (s, 3 H), 1.72 (s, 
3 H), 1.99 (q, J = 7.6 Hz, 2 H), 2.02 (q, J = 7.6 Hz, 2 H), 2.75 (d, J = 6.6 Hz, 2 H), 4.00 
(s, 2 H), 5.31 (t, J = 6.6 Hz, 1 H); 13C NMR (100 MHz, CDCl3, (E)-): δ 13.2, 13.6, 13.8, 
17.6, 24.9, 27.1, 30.4, 69.1, 125.4, 130.5, 132.3, 134.2; High-resolution MS, calcd for 




Following General Procedure 1, Purification by distillation afforded 3bb as a color less 





(2Z,5Z)-2-Methyl-5,6-diphenylhepta-2,5-dien-1-ol (3bb): (a mixture of E- and Z- 
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isomers in a ratio of 1 : 3): IR (neat): 3350 (s), 3057 (m), 3024 (s), 2968 (s), 2933 (s), 
2876 (s), 1719 (s), 1701 (s), 1670 (m), 1599 (m), 1491 (s), 1437 (s), 1026 (m), 912 (m), 
760 (m) cm-1; 1H NMR (400 MHz, CDCl3, (Z)-): δ 1.55 (br s, 1 H), 1.74 (d, J = 1.2 Hz, 
3 H), 2.20 (s, 3 H), 3.30 (d, J = 7.6 Hz, 2 H), 3.91 (s, 2 H), 5.31 (tq, J = 7.6, 1.2 Hz, 1 
H), 6.92 - 7.08 (m, 10 H); 13C NMR (100 MHz, CDCl3, (Z)-): δ 20.9, 21.3, 33.8, 61.5, 
124.6, 125.7, 127.4, 127.5, 128.9, 129.6, 135.2, 136.0, 143.0, 144.1. 1H NMR (400 
MHz, CDCl3, (E)-): δ 1.55 (br s, 1 H), 1.63 (s, 3 H), 2.18 (s, 3 H), 3.30 (d, J = 7.6 Hz, 
2 H), 3.97 (s, 2 H), 5.41 (t, J = 7.6 Hz, 1 H), 6.92 - 7.08 (m, 10 H); 13C NMR (100 
MHz, CDCl3, (E)-): δ 13.8, 21.1, 33.8, 68.8, 123.5, 125.5, 127.4, 127.5, 129.0, 129.4, 
135.2, 136.0, 143.0, 144.1; High-resolution MS, calcd for C20H22O: 278.1671. Found 
m/z (relative intensity): 279 (M++1, 17), 278.1658 (M+, 73), 260 (100). 
 
(2Z,5Z)-2-methyl-5,6-bis(trimethylsilyl)hepta-2,5-dien-1-ol: (3bc) 
Following General Procedure 1, Purification by distillation afforded 3bc as a color less 




(2Z,5Z)-2-methyl-5,6-bis(trimethylsilyl)hepta-2,5-dien-1-ol (3bc): (a mixture of E- 
and Z- isomers in a ratio of 1 : 1): IR (neat): 3396 (br), 2955 (s), 2899 (s), 1717 (s), 
1699 (s), 1437 (m), 1248 (s), 1047 (s), 1009 (s), 839 (s), 756 (s), 689 (m) cm-1; 1H 
NMR (400 MHz, CDCl3, (Z)-): δ 0.14 (s, 9 H), 0.18 (s, 9 H), 1.72 (s, 3 H), 1.80 (brs, 1 
H), 1.83 (s, 3 H), 2.85 (d, J = 6.7 Hz, 2 H), 4.19 (d, J = 4.2 Hz, 2 H), 5.04 (t, J = 6.7 Hz, 
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1 H); 13C NMR (100 MHz, CDCl3, (Z)-): δ 0.81, 1.46, 13.9, 18.7, 25.4, 69.1, 124.3, 
133.4, 143.9, 149.8; 1H NMR (400 MHz, CDCl3, (E)-): δ 0.13 (s, 9 H), 0.17 (s, 9 H), 
1.72 (s, 3 H), 1.80 (brs, 1 H), 1.83 (s, 3 H), 2.83 (d, J = 6.8 Hz, 2 H), 4.19 (d, J = 4.2 
Hz, 2 H), 5.02 (t, J = 6.8 Hz, 1 H); 13C NMR (100 MHz, CDCl3, (E)-): δ 0.81, 1.93, 
18.7, 20.2, 25.4, 61.9, 125.9, 133.5, 143.9, 151.2; High-resolution MS, calcd for 
C14H30OSi2: 270.1835. Found m/z (relative intensity): 270.1812 (M+, 100), 269 (72), 
254 (94). 
 
General procedure 3: for the Nickel-catalyzed three-component coupling reaction 
of alkynes, vinylcyclopropane and Me2Zn (entry 1, Table 3)   
    An oven-dried, 25 mL, three-necked round-bottomed flask equipped with a 
dropp- ing funnel, a rubber septum cap, an air condenser (fitted with a three-way 
stopcock connected into nitrogen balloon), and a Teflon-coated magnetic stir bar was 
charged with Ni(acac)2 (25.7 mg, 0.1 mmol).  The apparatus was purged with 
nitrogen and the flask was charged successively via syringe with freshly dry THF (3 
mL), vinylcyclo- propane (184 mg, 1 mmol), and 3-hexyne (82.1 mg, 1 mmol). 
Dimethylzinc (1.2 mmol, 1.0 M hexane solution) was added slowly at room 
temperature via the dropping funnel over a period of 10 min (the reaction temperature 
should not be exceeded 50 ˚C).  The mixture was stirred at room temperature for 1 h 
and monitored by TLC.  After the reaction was completed, the reaction mixture was 
cooled to 0 ˚C, and then poured into ice-water.  The resulting solution was diluted 
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with 30 mL of EtOAc and carefully washed with 2 M HCl, with sat. NaHCO3, and 
brine.  The aqueous layer was extracted with 30 mL of EtOAc.  The combined 
organic phases were dried (MgSO4) and conce- ntrated in vacuo, and the residual oil 
was subjected to column chromatography over silica gel (eluent; hexane/EtOAc = 16/1 
v/v) to afford 5ca as a colorless oil (236.6 mg, 84%; Rf = 0.60; hexane/EtOAc = 4/1 








Dimethyl-2-((2E,5E)-5-ethyl-6-methylocta-2,5-dienyl)malonate (5ca): IR (neat): 
2959 (s), 2882 (m), 1738 (s), 1655 (w), 1437 (s), 1340 (m), 1269 (m), 1161 (m), 974 
(m), 698 (w) cm-1; 1H NMR (400 MHz, CDCl3, (E)-): δ 0.91 (t, J = 7.6 Hz, 3 H), 0.96 
(t, J = 7.6 Hz, 3 H), 1.54 (s, 3 H), 1.97 (q, J = 7.6 Hz, 2 H), 2.02 (q, J = 7.6 Hz, 2 H), 
2.58 (ddd, J = 7.8, 6.8, 1.2 Hz, 2 H), 2.67 (d, J = 6.1 Hz, 2 H), 3.40 (t, J = 7.8 Hz, 1 H), 
3.71 (s, 6 H), 5.32 (dt, J = 15.1, 6.8 Hz, 1 H), 5.46 (dtt, J = 15.1, 6.1, 1.2 Hz, 1 H); 13C 
NMR (100 MHz, CDCl3, (E)-): δ 13.3, 13.6, 17.5, 24.7, 27.0, 31.9, 35.0, 52.1, 52.3, 
52.7, 124.9, 127.7, 131.1, 131.8, 169.2, 172.4; High-resolution MS, calcd for 






Following General Procedure 3, Purification by distillation afforded 5cb as a color less 






Dimethyl-2-((2E,5Z)-5,6-diphenylhepta-2,5-dienyl)malonate (5cb): IR (neat): 3078 
(w), 3020 (s), 2999 (m), 2953 (s), 1732 (s), 1599 (w), 1491 (m), 1435 (s), 1339 (m), 
1267 (m), 1232 (m), 1198 (m), 1155 (s), 972 (w), 764 (s), 700 (s) cm-1; 1H NMR (400 
MHz, CDCl3): δ 2.13 (s, 3 H), 2.60 (ddd, J = 7.6, 6.8, 1.0 Hz, 2 H), 3.23 (d, J = 5.9 Hz, 
2 H), 3.38 (t, J = 7.6 Hz, 1 H), 3.69 (s, 6 H), 5.46 (dt, J = 15.1, 6.8 Hz, 1 H), 5.58 (dtt, J 
= 15.1, 5.9, 1.0 Hz, 1 H), 6.90-7.06 (m, 10 H); 13C NMR (100 MHz, CDCl3): δ 21.0, 
31.9, 38.2, 52.0, 52.3, 52.4, 125.5, 125.6, 127.3, 127.4, 128.6, 128.9, 129.4, 134.5, 
134.9, 138.9, 143.3, 144.2, 169.1; High-resolution MS, calcd for C24H26O4: 378.1831. 
Found m/z (relative intensity): 379 (M++1, 27), 378.1835 (M+, 100), 360 (3). 
 
Dimethyl-2-((2E,5Z)-5,6-bis(trimethylsilyl)hepta-2,5-dienyl)malonate: (5cc) 
Following General Procedure 3, Purification by distillation afforded 5cc as a color less 




Dimethyl-2-((2E,5Z)-5,6-bis(trimethylsilyl)hepta-2,5-dienyl)malonate (5cc): IR 
(neat): 2957 (s), 1736 (s), 1456 (m), 1437 (m), 1340 (m), 1248 (s), 1198 (s), 1155 (s), 
972 (m), 839 (m) cm-1; 1H NMR (400MHz, CDCl3): δ 0.15 (s, 18 H), 1.76 (s, 3 H), 
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2.62 (d, J = 6.4 Hz, 2 H), 2.62 (t, J = 7.5 Hz, 2 H), 3.42 (t, J = 7.5 Hz, 1 H), 3.75 (s, 6 
H), 5.64-5.46 (m, 2 H); 13C NMR (100MHz, CDCl3): δ -2.1, 22.8, 32.1, 52.3, 125.5, 
130.1, 143.2, 150.5, 169.3; High-resolution MS, calcd for C18H34O4Si2: 370.1996. 
Found m/z (relative intensity): 371 (M++1, 22), 370.2006 (M+, 78), 355 (100), 339 (6). 
 
Dimethyl-2-((2E,5E)-5-ethyl-6-phenylhepta-2,5-dienyl)malonate: (5ce) 
Following General Procedure 3, Purification by distillation afforded 5ce as a color less 
oil. bp 140 ˚C /0.1mmHg. 
Ph CO2Me
CO2Me




Dimethyl-2-((2E,5E)-5-ethyl-6-phenylhepta-2,5-dienyl)malonate (5ce): (a mixture 
of regioisomers in a ratio of 3 : 1): IR (neat): 3020 (m), 2959 (s), 2934 (s), 1738 (s), 
1491 (m), 1437 (s), 1232 (s), 1153 (s), 1026 (m), 970 (m), 768 (s), 704 (s) cm-1; 1H 
NMR (400 MHz, CDCl3, (major)-): δ 0.86 (t, J = 7.4 Hz, 3 H), 1.85 (q, J = 7.4 Hz, 2 
H), 1.90 (s, 3 H), 2.63 (td, J = 7.3, 1.2 Hz, 2 H), 2.85 (d, J = 6.2 Hz, 2 H), 3.44 (t, J = 
7.3 Hz, 1 H), 3.72 (s, 6 H), 5.46 (dtt, J = 15.4, 7.3, 1.5 Hz, 1 H), 5.57 (dtt, J = 15.4, 6.2, 
1.5 Hz, 1 H), 7.09 (dd, J = 7.5, 1.4 Hz, 2 H), 7.19 (tt, J = 7.5, 1.4 Hz, 1 H), 7.29 (td, J 
= 7.5, 1.4 Hz, 2 H); 13C NMR (100 MHz, CDCl3, (major)-): δ 13.4, 20.9, 26.1, 31.9, 
34.1, 52.0, 52.3, 125.5, 125.7, 127.7, 127.9, 128.5, 131.2, 134.5, 145.0, 169.2; 1H 
NMR (400 MHz, CDCl3, (minor)-): δ 0.90 (t, J = 7.4 Hz, 3 H), 1.75 (s, 3 H), 1.91 (q, J 
= 7.4 Hz, 2 H), 2.55 (td, J = 7.3, 1.2 Hz, 2 H), 2.98 (d, J = 6.2 Hz, 2 H), 3.35 (t, J = 7.3 
Hz, 1 H), 3.69 (s, 6 H), 5.32 (dtt, J = 15.4, 7.3, 1.5 Hz, 1 H), 5.45 (dtt, J = 15.4, 6.2, 
 
 49 
1.5 Hz, 1 H), 7.03 (dd, J = 7.5, 1.4 Hz, 2 H), 7.19 (tt, J = 7.5, 1.4 Hz, 1 H), 7.27 (td, J 
= 7.5, 1.4 Hz, 2 H); 13C NMR (100 MHz, CDCl3, (minor)-): δ 13.2, 17.0, 28.5, 31.8, 
37.9, 52.0, 52.3, 125.4, 125.7, 127.9, 128.5, 130.7, 131.9, 134.4, 143.8, 169.2; 
High-resolution MS, calcd for C20H26O4: 330.1831. Found m/z (relative intensity): 371 
(M++1, 23), 330.1832 (M+, 100), 315 (2), 301 (4), 299 (4). 
 
Dimethyl-2-((2E,5E)-5-methyl-6-(trimethylsilyl)hepta-2,5-dienyl)malonate: (5cf) 
Following General Procedure 3, Purification by distillation afforded 5cf as a color less 







IR (neat): 2955 (s), 1740 (s), 1612 (w), 1437 (m), 1340 (w), 1248 (m), 1155 (m), 972 
(w), 856 (m), 837 (m), 756 (w), 689 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 0.12 (s, 
9 H), 1.62 (d, J = 1.2 Hz, 3 H), 1.74 (q, J = 1.2 Hz, 3 H), 2.58 (ddd, J = 1.2, 6.8, 7.6 Hz, 
2 H), 2.76 (d, J = 6.3 Hz, 2 H), 3.41 (t, J = 7.6 Hz, 1 H), 3.71 (s, 6 H), 5.34 (dt, J = 
15.1, 6.8 Hz, 1 H), 5.46 (dtt, J = 15.1, 6.3, 1.2 Hz, 1 H); 13C NMR (100 MHz, CDCl3): 
δ 0.40, 17.4, 22.9, 26.8, 31.9, 38.1, 52.0, 52.3, 125.5, 127.6, 130.6, 143.2, 169.2; 
High-resolution MS, calcd for C16H28O4Si: 312.1757. Found m/z (relative intensity): 




General procedure 4: for the Nickel-catalyzed three-component coupling reaction 
of alkynes, vinylcyclopropane and Me2Zn (entry 7, Table 3)   
    An oven-dried, 25 mL, three-necked round-bottomed flask equipped with a 
dropp- ing funnel, a rubber septum cap, an air condenser (fitted with a three-way 
stopcock connected into nitrogen balloon), and a Teflon-coated magnetic stir bar was 
charged with Ni(acac)2 (25.7 mg, 0.1 mmol).  The apparatus was purged with 
nitrogen and the flask was charged successively via syringe with freshly dry THF (3 
mL), vinylcyclo- propane (184 mg, 1 mmol), and phenylacetylene (409 mg, 4 mmol).  
Dimethylzinc (1.2 mmol, 1.0 M hexane solution) was added slowly at room 
temperature via the dropping funnel over a period of 10 min (the reaction temperature 
should not be exceeded 50 ˚C).  The mixture was stirred at room temperature for 24 h 
and monitored by TLC.  After the reaction was completed, the reaction mixture was 
cooled to 0 ˚C, and then poured into ice-water.  The resulting solution was diluted 
with 30 mL of EtOAc and carefully washed with 2 M HCl, with sat. NaHCO3, and 
brine.  The aqueous layer was extracted with 30 mL of EtOAc.  The combined 
organic phases were dried (MgSO4) and conce- ntrated in vacuo, and the residual oil 
was subjected to column chromatography over silica gel (eluent; hexane/EtOAc = 16/1 










Dimethyl-2-[(2E,5Z)-6,8-diphenylocta-2,5-dien-7-ynyl]malonate (7cg): IR (neat): 
3028 (s), 2953 (s), 2843 (m), 1738 (s), 1597 (m), 1489 (s), 1435 (s), 1155 (s), 1028 (s), 
970 (m), 914 (m), 758 (s), 692 (s) cm-1; 1H NMR (400MHz, CDCl3): δ 2.63 (td, J = 7.6, 
1.0 Hz, 2 H), 3.25 (td, J = 6.9, 1.0 Hz, 2 H), 3.43 (t, J = 7.6 Hz, 1 H), 3.71 (s, 6 H), 
5.53 (dtt, J = 15.4, 6.9, 1.3 Hz, 1 H), 5.65 (dtt, J = 15.4, 7.6, 1.3 Hz, 1 H), 6.37 (t, J = 
7.6 Hz, 1 H), 7.27-7.37 (m, 6 H), 7.50-7.55 (m, 2 H), 7.62-7.65 (m, 2 H); 13C NMR 
(100MHz, CDCl3): δ 31.9, 34.4, 51.8, 52.4, 86.4, 95.5, 123.3, 124.1, 125.9, 126.8, 
127.5, 128.2, 130.4, 131.4, 135.2, 137.9, 169.1; High-resolution MS, calcd for 
C25H24O4: 388.1675. Found m/z (relative intensity): 389 (M++1, 28), 388.1689 (M+, 
100), 373 (6), 357 (92), 329 (22). 
 
Dimethyl 2-[(2E,5E)-6,8-bis(trimethylsilyl)octa-2,5-dien-7-ynyl]malonate: (7ch) 
Following General Procedure 4, Purification by flash column chromatography afforded 





Dimethyl 2-[(2E,5E)-6,8-bis(trimethylsilyl)octa-2,5-dien-7-ynyl]malonate (7ch): IR 
(neat) 3003 (m), 2957 (s), 2899 (s), 2847(m), 2127 (s), 1738 (s), 1582 (m), 1435 (s), 
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1250 (s), 1155 (s), 970 (m), 841 (s), 758 (m), 698 (m) cm-1; 1H NMR (400MHz, CDCl3) 
δ 0.13 (s, 9 H), 0.18 (s, 9 H), 2.60 (td, J = 7.6, 0.9 Hz, 2 H), 3.06 (td, J = 6.8, 1.0 Hz 2 
H), 3.42 (t, J = 7.6 Hz, 1 H), 3.72 (s, 6 H), 5.42 (dt, J = 15.3, 7.6 Hz, 1 H), 5.53 (dt, J = 
15.3, 6.8 Hz, 1 H), 6.00 (t, J = 6.8 Hz, 1 H); 13C NMR (100MHz, CDCl3) δ -2.0, 0.3, 
32.0, 35.8, 51.9, 52.4, 102.8, 104.1, 125.7, 126.7, 130.5, 148.7, 169.2; High-resolution 
MS, calcd for C19H32O4Si2: 380.1841. Found m/z (relative intensity): 381 (M++1, 31), 
380.1841 (M+, 100), 365 (44), 349 (8). 
 
Dimethyl 2-[(E)-4-(trimethylsilyl)-2-vinylpent-3-enyl]malonate: (6ch) 
Following General Procedure 4, Purification by flash column chromatography afforded 




Dimethyl 2-[(E)-4-(trimethylsilyl)-2-vinylpent-3-enyl]malonate (6ch): IR (neat) 
3074 (m), 3003 (m), 2955 (s), 2855 (s), 1740 (s), 1616 (m), 1437 (s), 1248 (s), 1157 (s), 
1024 (m), 837 (s), 752 (m), 691 (m) cm-1; 1H NMR (400MHz, CDCl3) δ 0.05 (s, 9 H), 
1.65 (d, J = 1.7 Hz, 3 H), 1.96 (t, J = 7.4 Hz 1 H), 2.02 (t, J = 7.4 Hz, 1 H), 3.14 (dtd, J 
= 8.7, 7.4, 7.2 Hz, 1 H), 3.38 (t, J = 7.4 Hz, 1 H), 3.72 (s, 3 H), 3.73 (s, 3 H), 4.99 (dd, J 
= 17.3, 1.3 Hz, 1 H), 5.00 (dd, J = 10.0, 1.3 Hz, 1 H), 5.45 (dq, J = 8.7, 1.7 Hz, 2 H), 
5.64 (ddd, J = 17.3, 10.0, 7.2 Hz, 1 H); 13C NMR (100MHz, CDCl3) δ -2.1, 14.6, 33.6, 
40.5, 49.5, 52.4, 114.5, 138.3, 138.8, 139.5, 169.7, 169.7; High-resolution MS, calcd for 
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C15H26O4Si: 298.1600. Found m/z (relative intensity): 299 (M++1, 18), 298.1591 (M+, 
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Multicomponent Coupling Reaction via Azanickelacycle:  
Ni-Catalyzed Homoallylation of Polyhydroxy N,O-Acetals with 









Summary: In the presence of Ni-catalyst and triethylborane, N,O-acetals prepared from 
glycolaldehyde and glyceraldehyde with primary amines in situ underwent homo- 
allylation with conjugated dienes to provide 2-amino-5-hexenols in high regio- and 
stereoselectivity.  Under similar reaction conditions, N,O-acetals from carbohydrates 
with primary amines provided the corresponding polyhydroxy-bishomoallylamines in 






























    Ni-catalyzed C–C bond formation is a useful strategy for organic syntheses1. 
Cross-coupling of organometallic compounds with aromatic halides, as well as 
allylation and vinylation of carbonyls, is widely utilized for the synthesis of 
physiologically active molecules and fine chemicals2.  Compared to catalytically C–C 
bond transformations involving allylation and vinylation, homoallylation of carbonyls 
providing bis-homoallyl alcohols have serious limitations, which may be due to the 
unavailability and low stability of homoallyl anion species that can react with 
electrophiles3. 
    Recently, a Ni catalyst was developed that could promote the homoallylation of 
benzaldehyde with a wide variety of 1,3-dienes in the presence of triethylborane to 
afford bis-homoallyl alcohols (Eq. 1)4.  For these processes, isoprene reacts at the C1 
position with an aromatic aldehyde to give 3-methyl-4-penten-1-ol with excellent 
1,3-anti stereoselectivity.  A similar homoallylation to produce aliphatic aldehydes 
and ketones was successful using diethylzinc instead of triethylborane5.  Results 
indicated that diethylzinc functions as a more effective promoter than triethylborane 
for the homoallylation of aliphatic aldehydes and ketones.  In contrast, triethylborane 
is compatible with water and alcohols, and even promotes homoallylation of aqueous 
aldehyde (e.g., glutaraldehyde) and ω-hydroxyaldehyde (lactol) with conjugated dienes 
to afford ω-hydroxyhomoallyl alcohols (Eq. 2)6.  Thus, triethylborane and diethylzinc 
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    In addition, Ni-catalyzed homoallylation of aldimines prepared from aldehydes 
and primary amines in situ with conjugated dienes provided bis-homoallylamines in 
high regio- and stereoselectivity (Eq. 3)7.  Thus, the C1 position of isoprene reacts 
with aldimines to afford 3-methyl-4-pentenylamines with excellent 1,3-syn 
stereoselectivity, compared to 1,3-anti stereoselectivity when using aldehydes. 
    This report describes a similar reaction system involving a Ni catalyst and 
cat. Ni(0)
Et3B




























triethylborane that was extended successfully to the homoallylation of N,O-acetals 
prepared from cyclic hemiacetals and primary amines to provide ω-hydroxy- 
bishomoallylamines in high regio- and stereoselectivity (Eq. 4).  In similar catalytic 
reaction systems, N,O-acetals from carbohydrates with primary amines gave the 

















Results and Discussion 
 
    Results of reactions of isoprene with N,O-acetals prepared from cyclic hemiacetals 
and p-methoxyaniline are summarized in Table 1.  Reactions were conducted at room 
temperature using isoprene, Ni(cod)2 catalyst, triethylborane, and N,O-acetals under 
nitrogen atmosphere.  Isoprene reacted at the C1 position with N,O-acetals and 
underwent homoallylation to provide hydroxybishomoallylamines.  2-Hydroxytetra- 
hydrofuran provided 1-(3-hydroxypropyl)-3-methyl-4-pentenylamine 4a in reasonable 
yield along with a mixture of diastereomers in a 5:1 ratio (entry 1, Table 1).  5-Naph- 
thyl-2-hydroxytetrahydrofuran provided the desired product 4b in 71% yield along with 
two diastereomers in a 2:1 ratio (entry 2, Table 1).  5-Methyl-5-n-hexyl-2-hydroxy- 
tetrahydrofuran participated in the homoallylation to afford hydroxylamine 4c, which 
possessed a tertiary alcohol moiety (entry 3, Table 1).  Six-membered cyclic hemia- 
cetals could be used for homoallylation to form amino alcohols 4d and 4e in 6:1 and 4:1 
ratios, respectively (entries 4-5, Table 1).  2-Hydroxychroman served as an N,O-acetal 
precursor by treatment with a primary amine to provide o-aminoalkyl phenol 4f, (entry 
6, Table 1).  N-Boc-2-hydroxypiperidine acted as an aldimine in the presence of 
p-methoxyaniline to participate in the coupling reaction with isoprene to provide 
2-butenylaminobishomoallylamine 4g (entry 7, Table 1).  Seven-membered cyclic 
hemiacetal underwent a similar homoallylation to provide 1-(5-hydroxypentyl)-3- 
methyl-4-pentenylamine 4h in reasonable yield (entry 8, Table 1).  
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entry hemiacetal product 
yield of 4 (%) 
[ratio] 
1 
3a:   








4c: 59 [3:1] 
4 
3d:   
4d: 91 [6:1] 
5 
3e:   









































(Table 1, continued)   
    
7 
3g:   
4g: 41 [3:1] 
8 
3h:   
4h: 58 [4:1] 
 
a N,O-Acetals were prepared from cyclic hemiacetals (1 mmol) and amines (2 mmol) stirring in THF (2 
mL).  A solution of isoprene (4 mmol), Ni(cod)2 (0.1 mmol) in THF (2 mL) and Et3B (3.6 mmol) were 
introduced to the N,O-acetals, and the reaction mixture was stirred at room temperature for 24 h under 
nitrogen atmosphere. 
 
   Glycolaldehyde dimer is a two-carbon monosaccharide (diose) that is an important 
component of biologically active molecules8.  The reaction of glycol- aldehyde dimer 
as an N,O-acetal precursor with conjugated dienes to furnish 1-hydroxymethyl- 
4-pentenylamines also was examined.  Results using various conjugated dienes and 
N,O-acetals prepared from primary amines and glycolaldehyde dimer are summarized 
in Table 2.  1,3-Butadiene reacted with N,O-acetal prepared from p-methoxyaniline to 
yield 47% of 1-hydroxymethyl-4-pentenylamine 6aa along with 23% of the internal 
olefin isomer 6’aa (entry 1, Table 2).  N,O-Acetal from aniline underwent homo- 
allylation with isoprene to provide 1-hydroxymethyl-3-methyl-4-pentenylamine 6bb in 
reasonable yield with a diastereomeric mixture in a 8:1 ratio (entry 2, Table 2).  
p-Methoxy and o-methoxyaniline participated in similar homoallylations to provide 











Table 2.  Scope of the Nickel-Catalyzed Homoallylation of N,O-Acetals,  
Prepared from Glycolaldehyde Dimer, with Isoprenea 
 
entry diene: R amine: R1 yield of 6 (%) [ratio] 
1 1a: H  2a 6aa: 47b 
2 1b: Me 2b: phenyl 6bb: 64 [8:1] 
3 1b: Me 2a 6ba: 59 [single] 
4 1b: Me 2c: o-methoxyphenyl 6bc: 64[8:1] 
5 1b: Me 2d: p-bromophenyl 6bd: 50 [single] 
6 1b: Me 2e: benzyl intractable mixture 
7 1c: -(CH2)2CH=CMe2 2a 6ca: 49 [single] 
 
aN,O-Acetals were prepared from glycolaldehyde dimer (1 mmol) and amines (4 mmol) stirring in THF 
(2 mL).  A solution of conjugated diene (8 mmol), Ni(cod)2 (0.1 mmol) in THF (2 mL) and Et3B (6 
mmol) were introduced to the N,O-acetals, and the reaction mixture was stirred at room temperature for 
48 h under N2.   




















and as a single isomer, respectively (entries 3-4, Table 2).  p-Bromoaniline underwent 
homoallylation effec- tively to afford the desired hydroxylamine 6bd as the sole 
product (entry 5, Table 2).  Benzylamine yielded an intractable mixture; the expected 
reaction was not observed (entry 6, Table 2).  Myrcene also participated in 
homoallylation with N,O-acetal to produce the corresponding hydroxylamine 6ca as a 
single product (entry 7, Table 2). 
 
    Glyceraldehyde is a triose monosaccharide generally used for the enzymatic 
synthesis of D-fructose and L-sorbose with aldolases9.  The glyceraldehyde can serve 
as an important electrophilic component for coupling reactions to form a physiologica- 
lly active molecules.  The Ni-catalyzed homoallylation of glyceraldehyde dimer was 
accomplished using primary amines and conjugated dienes in the presence of 
triethylborane (Table 3).  In this reaction, N,O-acetals prepared from glyceraldehyde 
dimer and primary amines in DMF via azeotropic distillation underwent homo- 
allylation with conjugated dienes to furnish dihydroxybishomoallylamines.  1,3-Buta- 
diene reacted with N,O-acetal from p-methoxyaniline to provide 1-(1,2-dihydroxy- 
ethyl)-4-pentenyl-amine 8aa in 56% yield along with the internal olefin isomer 8’aa in 
17% yield (entry 1, Table 3).  N,O-Acetal from aniline participated in homoallylation 
with isoprene to provide 1-(1,2-dihydroxyethyl)-3-methyl-4-pent-enylamine 8bb in 
62% yield in a 2:1 ratio of diastereomers (entry 2, Table 3).  p-Methoxyaniline gave a 
similar homoallylation product 8ba with a mixture of diastereoisomers in a 2:1 ratio 
(entry 3, Table 3).  Benzylamine provided an intractable mixture in the same way as 
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Table 3.  Scope of the Nickel-Catalyzed Homoallylation of N,O-Acetals,  
Prepared from Glyceraldehyde Dimer, with Isoprenea 
 
 
entry diene: R amine: R1 yield of 8 (%) [ratio] 
1 1a  2a 8aa: 56 [3:1] 
2 1b 2b 8bb: 62 [2:1] 
3 1b 2a 8ba: 69 [2:1] 
4 1b 2e intractable mixture  
5 1c 2a 8ca: 64 [2:1] 
 
a N,O-Acetals were prepared from glyceraldehyde dimer (1 mmol) and amines (4 mmol) in DMF (2 mL) 
via azeotropic distillation.  A solution of conjugated diene (8 mmol), Ni(cod)2 (0.1 mmol) in THF (2 
mL) and Et3B (6 mmol) were introduced to the residual oil of N,O-acetals, and then the reaction mixture 
was stirred at room temperature for 48 h under N2.   
b Internal olefin isomer 8’aa was obtained in 17% with 3:1 diastereoisomeric ratio. 
     























the result of glycolaldehyde with aliphatic amine (entry 4, Table 3).  Myrcene 
underwent homoallylation with N,O-acetal to produce the corresponding 
hydroxylamine 8ca in reasonable yield with diastereomers in a 2:1 ratio, as well as 
isoprene (entry 5, Table 3). 
 
    Next, homoallylation of N,O-acetals from carbohydrates, such as 2-deoxy- 
D-ribose, D-ribose, and 2-deoxy-D-glucose, was investigated.  Various N,O-acetals 
prepared from carbohydrates and aromatic amines underwent homoallylation with 
conjugated dienes in one pot to provide polyhydroxyamines (Table 4).  1,3-Butadiene 
reacted with N,O-acetal from 2-deoxy-D-ribose and p-methoxyaniline to afford the 
homoallylation product 9aa in moderate yield along with the allylation product as a 
diastereoisomeric mixture of internal olefin isomers 9’aa (entry 1, Table 4).  Isoprene 
reacted at the C1 position with N,O-acetals derived from 2-deoxy-D-ribose and various 
aromatic amines to provide the desired polyhydroxyamines 9ba-9bg as mixtures of 
two diastereomers in a nearly 2:1 ratio (entries 2-6, Table 4).  Myrcene also 
participated in homoallylation as a conjugated diene and afforded the desired product 
9ca in 56% in a 1:1 ratio (entry 7, Table 4).  Since D-ribose and 2-deoxy-D-glucose 
are insoluble in THF, a series of N,O-acetals with D-ribose and 2-deoxy-D-glucose 
were prepared from amines in DMF via azeotropic distillation, and were used for 
homoallylation with isoprene to produce the expected polyhydroxyamines 10ba and 




Table 4.  Scope of the Nickel-Catalyzed Homoallylation of N,O-Acetals,  
Prepared from Carbohydrate, with Isoprenea 
 
entry carbohydrate diene: R amine: R1 
yield of 9, 10 and 
11 (%) [ratio] 
1 2-deoxy-D-ribose 1a  2a 9aa: 27 [1:1]b 
2 2-deoxy-D-ribose 1b 2a 9ba: 74 [2:1] 
3 2-deoxy-D-ribose 1b 2c 9bc: 80 [2:1] 
4 2-deoxy-D-ribose 1b 2f: 3,4-dimethoxyphenyl 9bf: 58 [2:1] 
5 2-deoxy-D-ribose 1b 2b 9bb: 75 [2:1] 
6 2-deoxy-D-ribose 1b 2g: p-chlorophenyl 9bg: 30 [2:1] 
7 2-deoxy-D-ribose 1c 2a 9ca: 56 [1:1] 
8 D-ribose 1b 2a 10ba: 57 [2:1] 
9 2-deoxy-D-glucose 1b 2a 11ba: 64 [1:1] 
 
a N,O-Acetals were prepared from carbohydrate (1 mmol) and amines (2 mmol) in THF (5 mL, entries 
1-7) or DMF (5 mL, entries 8 and 9) via azeotropic distillation.  A solution of conjugated diene (8 
mmol), Ni(cod)2 (0.1 mmol) in THF (2 mL) and Et3B (6 mmol) were introduced to the N,O-acetals, and 
the reaction mixture was stirred at room temperature (entries 1-7) or 50 ˚C for 48 h (entries 8 and 9) under 
N2.    





























to serve as carbonyl electrophiles and chiral auxiliaries to induce stereoselectivity of 
the homoallylation, the consecutive homoally- lations of N,O-acetals did not proceed 
with high stereoselectivity.  
 
    Although all product absolute configurations have not yet been determined, a 
plausible reaction mechanism based on the homoallylation of aldimines prepared from 
aldehydes and primary amines with isoprene is illustrated in Scheme 17.  N,O-Acetals 
were readily prepared from cyclic hemiacetals with primary amines in situ, and the low 
concentration of ω-hydroxyimine tautomers in equilibrium with the N,O-acetals 
appeared to promote reaction with conjugated dienes (Scheme 2).  As triethylborane 
coordinates to the nitrogen atom of N,O-acetals as a Lewis acid, the formation of 
ω-hydroxyimine tautomers might predominate over N,O-acetals.  Formation of an 
azanickelacycle intermediate via oxidative cyclization with isoprene and ω-hydroxy- 
imine in the presence of Ni(0) catalyst results in a quasi-equatorial position of the 
nitrogen atom substituent to avoid the steric repulsion toward the ω-hydroxyalkyl main 
chain.  As a result, the aldimine moiety assumed a diaxial configuration resulting in 






























































    Reactions employed oven-dried glassware unless otherwise noted.  Thin layer 
chromatography (TLC) employed glass 0.25 mm silica gel plates with UV indicator 
(Merck, Silica gel 60F
254
).  Flash chromatography columns were packed with 230-400 
mesh silica gel as a slurry in hexane.  Gradient flash chromatography was conducted 
eluting with a continuous gradient from hexane to the indicated solvent.  Distillation 
were carried out in a Kugelrohr apparatus (SIBATA glass tube oven GTO-350RG).  
Boiling points are meant to refer to the oven temperature (± 1 °C).  Microanalyses 
were performed by the Instrumental Analysis Center of Nagasaki University.  Analysis 
agreed with the calculated values within ± 0.4%.  Proton and carbon NMR data were 
obtained with a JEOL-GX400 with tetramethylsilane as an internal standard.  
Chemical shift values were given in ppm downfield from the internal standard.  
Infrared spectra were recorded with a JASCO A-100 FT-IR or SHIMAZU FTIR-8700 
spectrophotometer.  High resolution mass spectra (HRMS) were measured with a 
JEOL JMS-DX303. 
Solvents and Reagents 
    Tetrahydrofuran, toluene, and diethyl ether were dried and distilled from 
benzophenone-sodium immediately prior to use under nitrogen atmosphere.  DMF was 
distilled over calcium chloride.  Triethylborane (1 M THF, Aldrich), Ni(cod)2 
(KANTO Kagaku) were used without further purification.  Isoprene, myrcene, 
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glycolaldehyde dimmer, glyceraldehyde dimer, 2-deoxy-D-ribose, D-ribose, 
2-deoxy-D-glucose, aniline, p-methoxyaniline, o-methoxyaniline, p-bromoaniline, 
benzylamine were purchased and used without purification.  1,3-Butadiene (Tokyo 
Kasei Kogyo Co., Ltd) was purchased, and was liquefied by cooling at -78 ˚C (dry 
ice/isopropanol) prior to use under argon atmosphere.  1,3-Butadiene could be 
measured by syringe kept cool in the freezer as well beforehand, and then was 
introduced into the reaction mixture at room temperature.  Tetrahydrofuran-2-ol, 
tetrahydro-2H-pyran-2-ol, oxepane-2-ol, 5-(naphthalen-2-yl)tetrahydrofuran-2-ol, and 






General procedure 1: for the Nickel-catalyzed homoallylation of N,O-acetals with 
isoprene (entry 4, Table 1)   
    An oven-dried, 25 mL, three-necked round-bottomed flask equipped with a dropp- 
ing funnel, a rubber septum cap, an air condenser (fitted with a three-way stopcock 
connected into nitrogen balloon), and a Teflon-coated magnetic stir bar was charged.  
A solution of tetrahydro-2H-pyran-2-ol (102 mg, 1 mmol) and p-anisidine (246 mg, 2 
mmol) in dry THF (2 mL) was stirred overnight under nitrogen.  A mixture of Ni(cod)2 
(27.5 mg, 0.1 mmol) and isoprene (400 µL, 4 mmol) dissolved in THF (2 mL) and 
triethylborane (3.6 mmol, 1.0 M THF solution) were successively added to the 
N,O-acetal solution via the dropping funnel over a period of 10 min.  The reaction 
mixture was stirred at room temperature for 24 h and monitored by TLC.  After the 
reaction was completed, the reaction mixture was cooled to 0 ˚C, and then poured into 
ice-water.  The resulting solution was diluted with 30 mL of EtOAc and carefully 
washed with 2 M HCl, with sat. NaHCO3, and brine.  The aqueous layer was extracted 
with 30 mL of EtOAc.  The combined organic phases were dried (MgSO4) and 
concentrated in vacuo, and the residual oil was subjected to column chromatography 
over silica gel (eluent; hexane/EtOAc = 2/1 v/v) to afford 4d (258 mg, 91%; Rf = 0.30; 






5-[(4-Methoxyphenyl)amino]-7-methylnon-8-en-1-ol (4d): (a mixture of major and 
minor isomers in a ratio of 6:1): IR (neat) 3368 (s), 2934 (s), 1514 (m), 1458 (s), 1236 
(s), 1040 (s), 820 (s) cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 1.00 (d, J = 6.6 
Hz, 3 H),  1.37 – 1.58, (m, 8 H), 2.33 – 2.38 (m, 1 H), 3.31 (m, 1 H), 3.62 (t, J = 6.3 
Hz, 2 H), 3.73 (s, 3 H), 4.92 (dd, J = 10.4, 1.1 Hz, 1 H), 4.93 (dd, J = 17.0, 1.1 Hz, 1 H), 
5.65 (ddd, J = 17.0, 10.4, 8.1 Hz, 1 H), 6.52 (d, J = 8.9 Hz, 2 H), 6.74 (d, J = 8.9 Hz, 2 
H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 21.1, 22.0, 32.8, 35.0, 35.2, 42.5, 
52.1, 55.8, 62.8, 113.2, 114.4, 114.9, 142.1, 144.3, 151.6; 1H NMR (400 MHz, CDCl3, 
minor-isomer) δ 0.98 (d, J = 6.8 Hz, 3 H),  1.37 – 1.58, (m, 8 H), 2.33 – 2.38 (m, 1 H), 
3.31 (m, 1 H), 3.61 (t, J = 6.5 Hz, 2 H), 3.74 (s, 3 H), 4.92 (dd, J = 10.4, 1.1 Hz, 1 H), 
4.93 (dd, J = 17.0, 1.1 Hz, 1 H), 5.65 (ddd, J = 17.0, 10.4, 8.1 Hz, 1 H), 6.52 (d, J = 8.9 
Hz, 2 H), 6.74 (d, J = 8.9 Hz, 2 H); 13C NMR (100 MHz, CDCl3, minor-isomer) δ 21.1, 
21.9, 32.8, 35.0, 35.2, 42.1, 52.1, 55.8, 62.8, 113.2, 114.2, 114.8, 142.1, 144.3, 151.6; 
HRMS, calcd for C17H27 NO2: 277.2018. Found m/z (relative intensity): 278.2001 







Following General Procedure 1, Purification by flash column chromatography. 
 
(4S,6S)-4-(4-methoxyphenylamino)-6-methyloct-7-en-1-ol (4a): (a mixture of major 
and minor isomers in a ratio of 5:1): IR (neat) 3310 (s) , 3071 (s), 2924 (s), 1643 (m), 
1458 (s), 1065 (s), 910 (s), 741 (s) cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 
0.99 (d, J = 6.7 Hz, 3 H), 1.60 – 1.69 (m, 6 H), 2.35 (qm, J = 6.7 Hz, 1 H), 2.52 (br, 
1H), 3.32 (m, 1 H), 3.60 (t, J = 6.1 Hz, 2 H), 3.73 (s, 3 H), 4.92 (dm, J = 10.7 Hz, 1 H), 
4.93 (dd, J = 16.9, 1.0 Hz, 1 H), 5.65 (ddd, J = 16.9, 10.7, 8.0 Hz, 1 H) , 6.54 (dd, J = 
6.6, 2.2 Hz, 2 H), 6.75 (m, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ  21.0, 
29.3, 32.0, 35.0, 42.5, 54.0, 55.8, 62.9, 63.0, 113.2, 114.9, 115.0, 115.4, 141.5, 141.8, 
144.3; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.99 (d, J = 6.7 Hz, 3 H), 1.60 – 
1.69 (m, 6 H), 2.35 (qm, J = 6.7 Hz, 1 H), 2.52 (br, 1H), 3.32 (m, 1 H), 3.60 (t, J = 6.1 
Hz, 2 H), 3.73 (s, 3 H), 4.93 (dd, J = 16.9, 1.0 Hz, 1 H), 4.98 (dm, J = 17.1 Hz, 1 H), 
5.65 (ddd, J = 16.9, 10.7, 8.0 Hz, 1 H) , 6.54 (dd, J = 6.6, 2.2 Hz, 2 H), 6.75 (m, 2 H); 
13C NMR (100 MHz, CDCl3, minor-isomer) δ 20.8, 29.2, 32.0, 35.0, 45.3, 54.0, 55.8, 
62.9, 63.0, 113.2, 114.8, 115.0, 115.4, 141.6, 141.8, 144.1; HRMS, calcd for 
C16H25NO2: 263.1885. Found m/z (relative intensity): 264.1882 (M++1, 18), 263.1850 
(M+, 97), 205.1411 (15), 204.1394 (100). 
 
(4S,6S)-4-(4-methoxyphenylamino)-6-methyl-1-(naphthalenyl) octen-7-ol: (4b) 






(4S,6S)-4-(4-methoxyphenylamino)-6-methyl-1-(naphthalenyl) octen-7-ol (4b): (a 
mixture of major and minor isomers in a ratio of 2:1): IR (neat) 3366 (s), 2930 (s), 
2359 (m), 1506 (s), 1238 (s), 1040 (s), 820 (s), 750 (s) cm-1; 1H NMR (400 MHz, 
CDCl3, major-isomer) δ 0.95 (d, J = 6.8 Hz, 3 H), 1.38 – 1.94 (m, 6 H), 2.29 (qm, J = 
6.8 Hz, 1 H), 3.11 (br, 1 H), 3.32 (br q, J = 5.9 Hz, 1 H), 3.71 (s, 3 H), 4.78 – 4.82 (m, 
1 H), 4.88 (dd, J = 18.3, 1.9 Hz, 1 H), 4.89 (dd, J = 10.8, 1.9 Hz, 1 H), 5.59 (ddd, J = 
18.3, 10.8, 8.3 Hz, 1 H), 6.53 (d, J = 8.9 Hz, 2 H), 6.70 (dd, J = 8.9, 1.0 Hz, 2 H), 7.39 
– 7.82 (m, 7 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 20.9, 31.7, 35.0, 35.5, 
42.3, 53.0, 55.7, 74.5, 113.2, 114.8, 115.3, 123.9, 124.4, 125.6, 125.7, 125.9, 126.0, 
127.5, 128.0, 132.8, 133.1, 141.9, 144.1, 152.2; 1H NMR (400 MHz, CDCl3, 
minor-isomer) δ 0.92 (d, J = 6.8 Hz, 3 H), 1.38 – 1.94 (m, 6 H), 2.29 (qm, J = 6.8 Hz, 1 
H), 3.11 (br, 1 H), 3.32 (br q, J = 5.9 Hz, 1 H), 3.72 (s, 3 H), 4.83 (dm, J = 18.3 Hz, 1 
H), 4.88 (dd, J = 18.3, 1.9 Hz, 1 H), 4.89 (dd, J = 10.8, 1.9 Hz, 1 H), 5.58 – 5.66 (m, 1 
H), 6.53 (d, J = 8.9 Hz, 2 H), 6.70 (dd, J = 8.9, 1.0 Hz, 2 H), 7.39 – 7.82 (m, 7 H); 13C 
NMR (100 MHz, CDCl3, minor-isomer) δ 20.9, 31.2, 34.9, 35.7, 42.3, 52.7, 55.7, 74.4, 
113.2, 114.8, 115.2, 124.0, 124.4, 125.6, 125.7, 125.9, 126.0, 127.5, 128.1, 132.6, 
133.1, 141.3, 144.1, 152.1; HRMS, calcd for C26H31NO2: 389.2355. Found m/z 








Following General Procedure 1, Purification by flash column chromatography. 
 
10-(4-methoxyphenylamino)-7,12-dimethyl-13-tetradecen-7-ol (4c): (a mixture of 
major and minor isomers in a ratio of 3:1): IR (neat) 3379 (s), 2932 (s), 2359 (m), 1639 
(s), 1514 (s), 1238 (s), 1043 (s), 912 (s), 818 (s) cm-1; 1H NMR (400 MHz, CDCl3, 
major-isomer) δ 0.88 (t, J = 6.4 Hz, 3 H), 0.96 (d, J = 6.8 Hz, 3 H), 1.12 –1.26 (m, 8 H), 
1.42 (br, 3 H), 1.49 – 1.69 (m, 8 H), 2.29 (qm, J = 6.8 Hz, 1 H), 3.25 – 3.33 (m, 1 H), 
3.74 (s, 3 H), 4.91 (dd, J = 10.7, 1.5 Hz, 1 H), 4.92 (dd, J = 17.5, 1.5 Hz, 1 H), 5.63 
(ddd, J = 17.5, 10.7, 8.0 Hz, 1 H) , 6.69 – 6.72 (m, 2 H), 6.75 (d, J = 9.3 Hz, 2 H); 13C 
NMR (100 MHz, CDCl3, major-isomer) δ 14.1, 20.7, 20.9, 22.6, 26.9, 27.6, 29.8, 31.8, 
35.0, 37.4, 37.6, 41.9, 55.6, 55.7, 72.6, 113.3, 114.0, 116.8, 143.4, 143.9, 144.0; 1H 
NMR (400 MHz, CDCl3, minor-isomer) δ 0.88 (t, J = 6.4 Hz, 3 H), 0.97 (d, J = 6.8 Hz, 
3 H), 1.12 –1.26 (m, 8 H), 1.42 (br, 3 H), 1.49 – 1.69 (m, 8 H), 2.29 (qm, J = 6.8 Hz, 1 
H), 3.25 – 3.33 (m, 1 H), 3.74 (s, 3 H), 4.91 (dd, J = 10.7, 1.5 Hz, 1 H), 4.92 (dd, J = 
17.5, 1.5 Hz, 1 H), 5.63 (ddd, J = 17.5, 10.7, 8.0 Hz, 1 H) , 6.69 – 6.72 (m, 2 H), 6.75 
(d, J = 9.0 Hz, 2 H); 13C NMR (100 MHz, CDCl3, minor-isomer) δ 14.1, 20.8, 20.9, 
22.6, 26.8, 27.6, 29.8, 31.8, 35.0, 37.4, 37.6, 41.9, 55.6, 55.7, 72.7, 113.4, 114.0, 116.7, 
143.5, 143.9, 144.0; HRMS, calcd for C23H39NO2: 361.2981. Found m/z (relative 








Following General Procedure 1, Purification by flash column chromatography.  
 
(5S,7S)-5-(4-methoxyphenylamino)-3,3,7-trimethylnonen-8-ol (4e): (a mixture of 
major and minor isomers in a ratio of 4:1): IR (neat) 3373 (s), 2932 (s), 2359 (m), 1732 
(s), 1514 (s), 1234 (s), 1042 (s), 818 (s) cm-1; 1H NMR (400 MHz, CDCl3, 
major-isomer) δ 0.94 (s, 6 H), 0.97 (d, J = 6.8 Hz, 3 H), 1.21 – 1.70(m, 6 H), 2.28 (qm, 
J = 6.8 Hz, 1 H), 3.02 (br, 1 H),3.34 (m, 1 H), 3.69 (s, 3 H), 3.66 – 3.76 (m, 2 H), 4.98 
(dd, J = 17.7, 1.8 Hz, 1 H), 4.99 (dd, J = 10.0, 1.8 Hz, 1 H), 5.67 (ddd, J = 17.7, 10.0, 
8.3 Hz, 1 H), 6.55 (br, 2 H), 6.75 (br d, J = 8.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3, 
major-isomer) δ 20.1, 21.6, 28.4, 28.5, 32.7, 44.5, 47.5, 47.9, 49.3, 55.0, 59.6, 113.6, 
114.9, 115.0, 144.1, 144.7, 152.0; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.95 (s, 
6 H), 0.99 (d, J = 6.6 Hz, 3 H), 1.21 – 1.70(m, 6 H), 2.28 (qm, J = 6.8 Hz, 1 H), 3.02 
(br, 1 H),3.34 (m, 1 H), 3.67 (s, 3 H), 3.66 – 3.76 (m, 2 H), 4.92 (dd, J = 10.2, 0.8 Hz, 
1 H), 4.95 (dd, J = 16.9, 0.8 Hz, 1 H), 5.67 (ddd, J = 17.7, 10.0, 8.3 Hz, 1 H), 6.55 (br, 
2 H), 6.75 (br d, J = 8.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3, minor-isomer) δ 20.1, 
21.6, 28.4, 28.5, 32.6, 44.3, 47.5, 47.9, 49.3, 55.0, 59.6, 113.6, 114.8, 115.0, 144.1, 
144.7, 152.0; HRMS, calcd for C19H31NO2: 305.2355. Found m/z (relative intensity): 








Following General Procedure 1, Purification by flash column chromatography. 
 
2-((3S,5S)-3-(4-methoxyphenylamino)-5-methyl-6-heptenyl)phenol (4f): (a mixture 
of major and minor isomers in a ratio of 7:1): IR (neat) 3308 (s), 2930 (s), 1583 (m), 
1506 (s), 1236 (s), 1040 (s), 822 (s), 754 (s) cm-1; 1H NMR (400 MHz, CDCl3, 
major-isomer) δ 0.84 (d, J = 6.8 Hz, 3 H), 1.11 – 1.68 (m, 4 H), 2.20 (qm, J = 6.8 Hz, 1 
H), 2.65 – 2.71 (m, 2 H), 2.88 – 2.95 (m, 1 H), 3.13-3.29 (m, 1 H), 3.75 (s, 3 H),  4.86 
(dd, J = 10.8, 0.8 Hz, 1 H), 4.87 (dd, J = 16.7, 0.8 Hz, 1 H), 5.57 (ddd, J = 16.7, 10.8, 
7.8 Hz, 1 H) , 6.78 (d, J = 8.6 Hz, 2 H), 6.84 (d, J = 8.6 Hz, 2 H), 6.73 – 6.92 (m, 2 H), 
7.06 – 7.12 (m, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 20.2, 26.2, 34.8, 
35.3, 40.0, 53.3 , 55.6, 55.7, 112.9, 114.8, 116.3, 120.3, 127.2, 127.3, 127.4, 129.9, 
130.0, 144.3, 154.8; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.89 (d, J = 6.3 Hz, 
3 H), 1.11 – 1.68 (m, 4 H), 2.20 (qm, J = 6.8 Hz, 1 H), 2.65 – 2.71 (m, 2 H), 2.88 – 
2.95 (m, 1 H), 3.13-3.29 (m, 1 H), 3.75 (s, 3 H),  4.86 (dd, J = 10.8, 0.8 Hz, 1 H), 
4.87 (dd, J = 16.7, 0.8 Hz, 1 H), 5.57 (ddd, J = 16.7, 10.8, 7.8 Hz, 1 H) , 6.78 (d, J = 
8.6 Hz, 2 H), 6.84 (d, J = 8.6 Hz, 2 H), 6.73 – 6.92 (m, 2 H), 7.06 – 7.12 (m, 2 H); 13C 
NMR (100 MHz, CDCl3, minor-isomer) δ 20.2, 26.2, 34.8, 35.3, 40.0, 53.3 , 55.6, 55.7, 
112.9, 114.6, 116.3, 120.6, 127.2, 127.3, 127.4, 129.9, 130.1, 144.3, 154.8; HRMS, 




325.2045 (M+, 78), 257.1349 (18), 256.1329 (100). 
 
tert-butyl(5S,7S)-5-(4-methoxyphenylamino)-7-methylnon-8-enylcarbamate (4g) 
Following General Procedure 1, Purification by flash column chromatography.  
 
tert-butyl(5S,7S)-5-(4-methoxyphenylamino)-7-methylnon-8-enylcarbamate (4g): 
(a mixture of major and minor isomers in a ratio of 3:1):IR (neat) 2864 (s), 2359 (m), 
1682 (s), 1539 (s), 1251 (s), 1173 (s), 910 (s), 750 (s) cm-1; 1H NMR (400 MHz, 
CDCl3, major-isomer) δ 1.01 (d, J = 6.8 Hz, 3 H),  1.34 – 1.51 (m, 8 H), 1.44 (s, 9 H), 
2.32 (dm, J = 7.4 Hz, 1 H), 3.11 (br, 2 H), 3.67 (br, 1 H), 4.93 (dd, J = 10.2, 1.1 Hz, 1 
H), 5.01 (dd, J = 17.4, 1.1 Hz, 1 H), 5.77 (ddd, J = 17.4, 10.2, 7.4 Hz, 1 H); 13C NMR 
(100 MHz, CDCl3, major-isomer) δ 20.2, 22.6, 28.4, 30.1, 35.4, 37.2, 40.4, 44.5, 70.1, 
79.0, 112.6, 114.9, 155.9; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.98 (d, J = 6.6 
Hz, 3 H),  1.34 – 1.51 (m, 8 H), 1.44 (s, 9 H), 2.32 (dm, J = 7.4 Hz, 1 H), 3.11 (br, 2 
H), 3.67 (br, 1 H), 4.88 (dm, J = 11.2 Hz, 1 H), 5.01 (dd, J = 17.4, 1.1 Hz, 1 H), 5.77 
(ddd, J = 17.4, 10.2, 7.4 Hz, 1 H), ,; 13C NMR (100 MHz, CDCl3, minor-isomer) δ 19.8, 
22.6, 28.4, 30.0, 35.4, 37.2, 40.4, 44.3, 69.8, 79.0, 112.0, 114.6, 155.9; HRMS, calcd 
for C15H29NO3: 271.2147. Found m/z (relative intensity): 376.2731 (M+, 100). 
 
(6S,8S)-6-(4-methoxyphenylamino)-8-methyldec-9-en-1-ol (4h) 







(6S,8S)-6-(4-methoxyphenylamino)-8-methyldec-9-en-1-ol (4h): (a mixture of major 
and minor isomers in a ratio of 4:1): IR (neat) 3364 (s), 2934 (s), 1614 (m), 1514 (s), 
1238 (s), 1038 (s), 822 (s) cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 1.00 (d, 
J = 6.8 Hz, 3 H), 1.21 – 1.58, (m, 10 H), 2.34 – 2.38 (m, 1 H), 3.27 – 3.32 (m, 1 H), 
3.61 (t, J = 6.6 Hz, 2 H), 3.74 (s, 3 H), 4.92 (dd, J = 10.2, 0.9 Hz, 1 H), 4.93 (dd, J = 
17.0, 0.9 Hz, 1 H), 5.65 (ddd, J = 17.0, 10.2, 8.1 Hz, 1 H), 6.63 (d, J = 9.1 Hz, 2 H), 
6.74 (d, J = 9.1 Hz, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 21.2, 25.6, 
25.9, 32.8, 35.1, 35.3, 42.4, 55.8, 55.9, 62.9, 113.3, 114.9, 116.4, 139.8, 144.3, 152.8; 
1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.97 (d, J = 6.8 Hz, 3 H), 1.21 – 1.58, (m, 
10 H), 2.34 – 2.38 (m, 1 H), 3.27 – 3.32 (m, 1 H), 3.61 (t, J = 6.4 Hz, 2 H), 3.74 (s, 3 
H), 4.92 (dd, J = 10.2, 0.9 Hz, 1 H), 4.93 (dd, J = 17.0, 0.9 Hz, 1 H), 5.65 (ddd, J = 
17.0, 10.2, 8.1 Hz, 1 H), 6.63 (d, J = 9.1 Hz, 2 H), 6.74 (d, J = 9.1 Hz, 2 H), ,; 13C 
NMR (100 MHz, CDCl3, minor-isomer) δ 21.2, 25.6, 25.9, 32.8, 35.1, 35.3, 42.4, 55.8, 
55.9, 63.1, 113.3, 114.8, 116.4, 139.8, 144.3, 152.8; HRMS, calcd for C18H29NO2: 
291.2196. Found m/z (relative intensity): 292.2236 (M++1, 15), 291.2196 (M+, 65), 
223.1501 (13), 222.1497 (100). 
 
2-(4-methoxyphenylamino)-5-hexenol (6aa) 






2-(4-methoxyphenylamino)-5-hexenol (6aa): IR (neat) 3375 (s), 3076 (m), 2936 (s), 
1639 (s), 1514 (s), 1464 (s), 1238 (s), 1038 (s), 822 (s) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 1.42 (quin, J = 7.5 Hz, 2 H), 2.14 (br q, J = 6.8 Hz, 1 H), 2.25 (br q, J = 6.4 
Hz, 1 H), 2.69 (br, 1 H), 3.40 (m, 2 H), 3.49 (dd, J = 10.9, 6.1 Hz, 1 H), 3.51 (dd, J = 
10.9, 6.1 Hz, 1 H), 3.74 (s, 3 H), 4.94 (dm, J = 9.7 Hz, 1 H), 5.00 (dt, J = 16.1,1.9 Hz, 
1 H), 5.78 (ddt, J = 16.1, 9.7, 6.4 Hz, 1 H), 6.64 (dd, J = 6.6, 2.4 Hz, 2 H), 6.74 (dd, J 
= 6.6, 2.4 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 28.7, 30.4, 55.8, 56.3, 64.1, 114.8, 
115.7, 116.4, 137.8, 139.8, 152.7; HRMS, calcd for C13H19NO2: 221.1416. Found m/z 




Following General Procedure 1, Purification by flash column chromatography. 
 
(E)-2-(4-methoxyphenylamino)-4-hexenol (6’aa): (a mixture of E- and Z- isomers in 
a ratio of 1 : 2): IR (neat) 3375 (s), 3076 (m), 2936 (s), 1639 (s), 1514 (s), 1464 (s), 
1238 (s), 1038 (s), 822 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 1.64 (dm, J = 7.6 Hz, 
3 H), 2.02 (m, 2 H), 3.40 (m, 2 H), 3.49 (dd, J = 10.9, 6.1 Hz, 1 H), 3.51 (dd, J = 10.9, 







6.74 (dd, J = 6.6, 2.4 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 18.0, 33.3, 55.8, 56.5, 
64.4, 114.9, 116.1, 125.7, 133.8, 139.8, 152.8; HRMS, calcd for C13H19NO2: 221.1416. 




Following General Procedure 1, Purification by flash column chromatography. 
 
(2R,4S)-4-methyl-2-(phenylamino)-5-hexenol (6bb): (a mixture of major and minor 
isomers in a ratio of 8:1): IR (neat) 3393 (s), 3078 (m), 2926 (s), 1601 (s), 1506 (s), 
1317 (s), 1030 (s), 914 (m), 748 (s), 692 (s) cm-1; 1H NMR (400 MHz, CDCl3, 
major-isomer) δ 1.03 (d, J = 6.8 Hz, 3 H), 1.52 (t, J = 5.7 Hz, 2 H), 2.32 (ddm, J = 7.7, 
6.8 Hz, 1 H), 3.49 (dd, J = 10.5, 5.4 Hz, 1 H), 3.55 (tdm, J = 5.4, 4.1 Hz, 2 H), 3.71 (dd, 
J = 10.5, 4.1 Hz, 1 H), 4.89 (dd, J = 17.2, 0.9 Hz, 1 H), 4.92 (dd, J = 10.4, 0.9 Hz, 1 H), 
5.64 (ddd, J = 17.2, 10.4, 7.7 Hz, 1 H), 6.64 (dd, J = 8.6, 1.2 Hz, 2 H), 6.70 (t, J = 7.3 
Hz, 1 H), 7.15 (dd, J = 8.6, 7.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 
21.1, 35.0, 39.8, 53.5, 65.0, 113.7, 113.8, 117.8, 129.3, 143.7, 147.7; 1H NMR (400 
MHz, CDCl3, minor-isomer) δ 1.00 (d, J = 6.8 Hz, 3 H), 1.50 (t, J = 5.1 Hz, 2 H), 2.32 
(ddm, J = 7.7, 6.8 Hz, 1 H), 3.49 (dd, J = 10.5, 5.4 Hz, 1 H), 3.55 (tdm, J = 5.4, 4.1 Hz, 
2 H), 3.71 (dd, J = 10.5, 4.1 Hz, 1 H), 4.89 (dd, J = 17.2, 0.9 Hz, 1 H), 4.92 (dd, J = 





H), 6.70 (t, J = 7.3 Hz, 1 H), 7.14 (dd, J = 8.5, 7.3 Hz, 2 H); 13C NMR (100 MHz, 
CDCl3, minor-isomer) δ 21.1, 35.0, 39.8, 53.5, 65.0, 113.7, 113.8, 117.8, 129.3, 143.7, 
147.7; HRMS, calcd for C13H19NO: 205.1467. Found m/z (relative intensity): 206.1505 
(M++1, 4), 205.1463 (M+, 20), 175.1278 (16), 174.1268 (100). 
 
(2R,4S)-2-(4-methoxyphenylamino)-4-methyl-5-hexenol (6ba) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(2R,4S)-2-(4-methoxyphenylamino)-4-methyl-5-hexenol (6ba): IR (neat) 3383 (s), 
3078 (m), 2932 (s), 1618 (s), 1418 (s), 1238 (s), 1040 (s), 914 (m), 820 (s), 667 (m) 
cm-1; 1H NMR (400 MHz, CDCl3) δ 1.01 (d, J = 6.6 Hz, 3 H), 1.49 (t, J = 6.8 Hz, 2 H), 
2.31 (qtm, J = 6.8, 6.6 Hz, 1 H), 3.45 (dd, J = 8.4, 3.2 Hz, 1 H), 3.46 (dd, J = 8.4, 5.5 
Hz, 1 H), 3.71 (dm, J = 6.6 Hz, 1 H), 3.74 (s, 3 H), 4.89 (dd, J = 17.1, 1.2 Hz, 1 H), 
4.92 (dd, J = 10.2, 1.2 Hz, 1 H), 5.63 (ddd, J = 17.1, 10.2, 8.1 Hz, 1 H), 6.64 (dd, J = 
6.6, 2.2 Hz, 2 H),	 6.76 (dd, J = 6.6, 2.2 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 
21.0, 34.9, 39.6, 55.0, 55.7, 64.8, 113.6, 114.8, 115.4, 141.7, 143.7, 152.3; HRMS, 
calcd for C14H21NO2: 235.1572. Found m/z (relative intensity): 236.1583 (M++1, 5), 
235.1562 (M+, 28), 204.1378 (100). 
 
(2R,4S)-2-(2-methoxyphenylamino)-4-methyl-5-hexenol (6bc) 






(2R,4S)-2-(2-methoxyphenylamino)-4-methyl-5-hexenol (6bc): (a mixture of major 
and minor isomers in a ratio of 8:1): IR (neat) 3414 (s), 3070 (m), 2932 (s), 2359 (s), 
1601 (s), 1516 (s), 1456 (s), 1223 (s), 1030 (s), 914 (s), 737 (s) cm-1; 1H NMR (400 
MHz, CDCl3, major-isomer) δ 1.03 (d, J = 6.8 Hz, 3 H), 1.54 (t, J = 6.6 Hz, 2 H), 2.31 
(qm, J = 6.8 Hz, 1 H), 3.50 (dd, J = 10.4, 5.8 Hz, 1 H), 3.55 (tdm, J = 6.6, 3.9 Hz, 1 H), 
3.72 (dd, J = 10.4, 3.9 Hz, 1 H), 3.85 (s, 3 H), 4.87 (dd, J = 17.8, 1.7 Hz, 1 H), 4.90 (dd, 
J = 10.1, 1.7 Hz, 1 H), 5.64 (ddd, J = 17.8, 10.1, 8.0 Hz, 1 H), 6.68 (d, J = 7.6 Hz, 1 H), 
6.69 (dd, J = 7.6, 1.6 Hz, 1 H), 6.77 (dd, J = 7.6, 1.2 Hz, 1 H), 6.83 (dm, J = 7.6 Hz, 1 
H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 21.1, 34.9, 39.8, 53.4, 55.5, 65.1, 
109.8, 111.2, 113.7, 116.9, 121.3, 137.4, 143.7, 147.0; 1H NMR (400 MHz, CDCl3, 
minor-isomer) δ 0.99 (d, J = 6.8 Hz, 3 H), 1.54 (t, J = 6.6 Hz, 2 H), 2.31 (qm, J = 6.8 
Hz, 1 H), 3.50 (dd, J = 10.4, 5.8 Hz, 1 H), 3.55 (tdm, J = 6.6, 3.9 Hz, 1 H), 3.72 (dd, J 
= 10.4, 3.9 Hz, 1 H), 3.85 (s, 3 H), 4.87 (dd, J = 17.8, 1.7 Hz, 1 H), 4.90 (dd, J = 10.1, 
1.7 Hz, 1 H), 5.64 (ddd, J = 17.8, 10.1, 8.0 Hz, 1 H), 6.68 (d, J = 7.6 Hz, 1 H), 6.69 (dd, 
J = 7.6, 1.6 Hz, 1 H), 6.77 (dd, J = 7.6, 1.2 Hz, 1 H), 6.83 (dm, J = 7.6 Hz, 1 H); 13C 
NMR (100 MHz, CDCl3, minor-isomer) δ 21.1, 35.0, 39.8, 53.4, 55.6, 65.1, 109.8, 
111.2, 113.7, 116.9, 121.3, 137.4, 143.8, 147.0; HRMS, calcd for C14H21NO2: 








Following General Procedure 1, Purification by flash column chromatography. 
 
(2R,4S)-2-(4-bromophenylamino)-4-methyl-5-hexenol (6bd): IR (neat) 3400 (s), 
2927 (s), 2868 (s), 2362 (m), 2345 (s), 1593 (s), 1496 (s), 1317 (s), 1074 (s), 916 (m), 
812 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 1.01 (d, J = 6.6 Hz, 3 H), 1.50 (m, 2 H), 
2.02 (br, 1 H), 2.30 (m, 1 H), 3.48 (m, 2 H), 3.71 (dd, J = 13 6.2 Hz, 1 H), 4.88 (dd, J = 
23, 1.2 Hz, 1 H), 4.92 (dd, J = 16, 1.2 Hz, 1 H), 5.62 (ddd, J = 17.0, 10.2, 8.1 Hz, 1 H), 
6.49 (d, J = 9.0 Hz, 2 H),	 7.21 (d, J = 9.0 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 
21.0, 34.9, 38.5, 53.4, 64.8, 109.0, 113.9, 115.0, 131.8, 143.5, 146.7; HRMS, calcd for 




Following General Procedure 1, Purification by flash column chromatography. 
 
(2R,4S)-2-(4-methoxyphenylamino)-8-methyl-4-vinylnon-7-enol (6ca): IR (neat) 
3368 (s), 3078 (m), 2916 (s), 1607 (m), 1514 (s), 1375 (s), 1240 (s), 1042 (s), 914 (s), 








2 H), 1.56 (s, 3 H), 1.67 (s, 3 H), 1.94 (m, 2 H), 2.15 (dm, J = 4.4 Hz, 1 H), 3.44 (dd, J 
= 10.0, 7.4 Hz, 1 H), 3.46 (dd, J = 10.0, 5.8 Hz, 1 H), 3.69 (m, 2 H), 3.74 (s, 3 H), 4.84 
(dd, J = 17.0, 2.0 Hz, 1 H), 4.99 (dd, J = 10.2, 2.0 Hz, 1 H), 5.05 (tt, J = 5.6, 1.4 Hz, 1 
H), 5.49 (ddd, J = 17.0, 10.2, 9.0 Hz, 1 H), 6.65 (dd, J = 6.6, 2.3 Hz, 2 H), 6.75 (dd, J 
= 6.6, 2.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 17.7, 25.6, 25.7, 35.5, 38.1, 40.5, 
55.7, 65.0, 114.8, 115.5, 115.8, 124.1, 131.4, 141.2, 142.2, 152.7; HRMS, calcd for 
C19H29NO2: 303.2198. Found m/z (relative intensity): 304.2201 (M+ +1, 11), 303.2183 
(M+, 48), 273.2022 (19), 272.2000 (100). 
 
3-(4-methoxyphenylamino)-6-hexene-1,2-diol (8aa) 
Following General Procedure 1, Purification by flash column chromatography. 
 
3-(4-methoxyphenylamino)-6-hexene-1,2-diol (8aa): (a mixture of major and minor 
isomers in a ratio of 3:1): IR (neat) 3356 (s), 3074 (m), 2934 (s), 1666 (s), 1441 (s), 
1236 (s), 1038 (s), 822 (s) cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 1.62 (td, 
J = 8.7, 5.9 Hz, 2 H), 2.00 – 2.33 (m, 2 H), 2.60 – 3.00 (m, 1 H), 3.35 – 3.47 (m, 1 H), 
3.68 – 3.80 (m, 2 H), 3.74 (s, 3 H), 4.95 (dd, J = 9.9, 1.5 Hz, 1 H), 4.96 (dd, J = 17.8, 
1.5 Hz, 1 H), 5.76 (ddt, J = 17.8, 9.9, 6.7 Hz, 1 H), 6.65 (dt, J = 9.3, 2.5 Hz, 2 H), 6.76 
(dt, J = 9.3, 2.5 Hz, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 30.3, 30.8, 






CDCl3, minor-isomer) δ 1.62 (td, J = 8.7, 5.9 Hz, 2 H), 2.00 – 2.33 (m, 2 H), 2.60 – 
3.00 (m, 1 H), 3.35 – 3.47 (m, 1 H), 3.68 – 3.80 (m, 2 H), 3.74 (s, 3 H), 4.95 (dd, J = 
9.9, 1.5 Hz, 1 H), 4.96 (dd, J = 17.8, 1.5 Hz, 1 H), 5.76 (ddt, J = 17.8, 9.9, 6.7 Hz, 1 H), 
6.65 (dt, J = 9.3, 2.5 Hz, 2 H), 6.76 (dt, J = 9.3, 2.5 Hz, 2 H); 13C NMR (100 MHz, 
CDCl3, minor-isomer) δ 30.2, 30.8, 55.7, 57.8, 64.2, 72.6, 114.8, 115.2, 115.6, 137.7, 
141.2, 152.6; HRMS, calcd for C14H21NO3: 251.1521. Found m/z (relative intensity): 
252.1614 (M++1, 4), 251.1512 (M+, 30), 220.1334 (6), 191.1258 (14), 190.1187 (100). 
 
(E)-3-(4-methoxyphenylamino)-5-hexene-1,2-diol (8’aa) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(E)-3-(4-methoxyphenylamino)-5-hexene-1,2-diol (8’aa): (a mixture of major and 
minor isomers in a ratio of 3:1): IR (neat) 3356 (s), 3074 (m), 2934 (s), 1666 (s), 1441 
(s), 1236 (s), 1038 (s), 822 (s) cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 1.72 
(d, J = 6.8 Hz, 3 H), 2.00 – 2.33 (m, 2 H), 2.60 – 3.00 (m, 1 H), 3.35 – 3.47 (m, 1 H), 
3.68 – 3.80 (m, 2 H), 3.74 (s, 3 H), 5.36 – 5.43 (m, 1 H), 5.48 – 5.55, (m, 1 H), 6.65 (dt, 
J = 9.3, 2.5 Hz, 2 H), 6.76 (dt, J = 9.3, 2.5 Hz, 2 H); 13C NMR (100 MHz, CDCl3, 
major-isomer) δ 18.0, 33.8, 55.7, 57.4, 64.8, 72.2, 114.9, 115.2, 126.5, 128.8, 141.5, 
152.8; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 1.72 (d, J = 6.8 Hz, 3 H), 2.00 – 






3 H), 5.36 – 5.43 (m, 1 H), 5.48 – 5.55, (m, 1 H), 6.65 (dt, J = 9.3, 2.5 Hz, 2 H), 6.76 
(dt, J = 9.3, 2.5 Hz, 2 H); 13C NMR (100 MHz, CDCl3, minor-isomer) δ 18.0, 33.8, 
55.7, 57.4, 64.7, 72.2, 114.8, 115.2, 126.5, 128.8, 141.5, 152.8; HRMS, calcd for 
C14H21NO3: 251.1521. Found m/z (relative intensity): 252.1614 (M++1, 4), 251.1512 
(M+, 30), 220.1334 (6), 191.1258 (14), 190.1187 (100). 
 
(3R,5S)-5-methyl-3-(phenylamino)-6-heptene-1,2-diol (8bb) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(3R,5S)-5-methyl-3-(phenylamino)-6-heptene-1,2-diol (8bb): (a mixture of major 
and minor isomers in a ratio of 2:1): IR (neat) 3281 (s), 2961 (s), 1603 (s), 1512 (s), 
1325 (s), 1024 (s), 748 (s), 692 (s) cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 
1.01 (d, J = 6.8 Hz, 3 H), 1.54 – 1.63 (m, 2 H), 2.23 – 2.33 (qm, J = 6.8 Hz, 1 H), 3.54 
– 3.77 (m, 4 H), 4.94 (dd, J = 10.3, 1.5 Hz, 1 H), 4.98 (dd, J = 17.1, 1.5 Hz, 1 H), 5.59 
(ddd, J = 17.1, 10.3, 8.3 Hz, 1 H), 6.65 (td, j = 8.5, 1.0 Hz, 2 H), 6.70 – 6.74 (m, 1 H), 
7.15 (dt, J = 8.5, 7.6 Hz, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 21.4, 34.9, 
39.0, 54.3, 64.0, 73.5, 113.7, 117.8, 118.1, 129.2, 143.4, 147.6; 1H NMR (400 MHz, 
CDCl3, minor-isomer) δ 0.97 (d, J = 6.6 Hz, 3 H), 1.47 (ddd, J = 14.0, 9.8, 4.2 Hz, 2 
H), 2.23 – 2.33 (qm, J = 6.8 Hz, 1 H), 3.54 – 3.77 (m, 4 H), 4.82 (dd, J = 17.3, 1.7 Hz, 






8.5, 1.0 Hz, 2 H), 6.70 – 6.74 (m, 1 H), 7.15 (dt, J = 8.5, 7.6 Hz, 2 H); 13C NMR (100 
MHz, CDCl3, minor-isomer) δ 21.2, 34.5, 38.2, 54.6, 63.8, 72.7, 113.8, 117.8, 118.0, 
129.3, 143.9, 147.4; HRMS, calcd for C14H21NO2: 235.1572. Found m/z (relative 
intensity): 236.1596 (M++1, 3), 235.1554 (M+, 12), 175.1262 (13), 174.1240 (100). 
 
(3R,5S)-3-(4-methoxyphenylamino)-5-methyl-6-heptene-1,2-diol (8ba)  
Following General Procedure 1, Purification by flash column chromatography. 
 
(3R,5S)-3-(4-methoxyphenylamino)-5-methyl-6-heptene-1,2-diol (8ba) : (a mixture 
of major and minor isomers in a ratio of 2:1): IR (neat) 3366 (s), 3078 (m), 2932 (m), 
2835 (m), 1655 (s), 1238 (s), 1036 (s), 822 (s) cm-1; 1H NMR (400 MHz, CDCl3, 
major-isomer) δ 1.00 (d, J = 6.6 Hz, 3 H), 1.48 (ddd, J = 14.0, 9.7, 4.2 Hz, 1 H), 1.55 
(ddd, J = 14.0, 9.7, 4.2 Hz, 1 H), 2.03 (br, 2 H) 2.25 (m, 1 H), 3.44 – 3.54 (m, 1 H), 
3.74 (s, 3 H), 3.66 – 3.8 (m, 4 H), 4.80 (dd, J = 17.1, 1.3 Hz, 1 H), 4.91 (dd, J = 10.5, 
1.3 Hz, 1 H), 5.57 (ddd, J = 17.1, 10.5, 8.3 Hz, 1 H), 6.68 (dd, j = 6.8, 2.3 Hz, 2 H), 
6.76 (dd, J = 6.8, 2.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 21.4, 
35.0, 39.0, 55.8, 56.3, 64.1, 73.1, 114.2, 114.9, 115.9, 143.5, 143.7, 152.8; 1H NMR 
(400 MHz, CDCl3, minor-isomer) δ 0.96 (d, J = 6.6 Hz, 3 H), 1.48 (ddd, J = 14.0, 9.7, 
4.2 Hz, 1 H), 1.55 (ddd, J = 14.0, 9.7, 4.2 Hz, 1 H), 2.03 (br, 2 H) 2.25 (m, 1 H), 3.44 – 






(dd, J = 17.4, 1.3 Hz, 1 H), 5.67 (ddd, J = 17.4, 10.2, 7.6 Hz, 1 H), 6.68 (dd, j = 6.8, 
2.3 Hz, 2 H), 6.76 (dd, J = 6.8, 2.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3, 
minor-isomer) δ 20.4, 34.7, 39.0, 55.8, 56.3, 63.8, 73.1, 115.0, 114.9, 116.1, 143.5, 
143.7, 152.8; HRMS, calcd for C15H23NO3: 265.1678. Found m/z (relative intensity): 
266.1678 (M++1, 3), 265.1659 (M+, 18), 205.1406 (15), 204.1406 (100). 
 
(3R,5S)-3-(4-methoxyphenylamino)-9-methyl-5-vinyl-8-decene-1,2-diol (8ca) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(3R,5S)-3-(4-methoxyphenylamino)-9-methyl-5-vinyl-8-decene-1,2-diol (8ca): (a 
mixture of major and minor isomers in a ratio of 2:1): IR (neat) 3358 (s), 3074 (s), 2916 
(s), 2343 (m), 1666 (s), 1514 (s), 1238 (s), 1040 (s), 822 (s) cm-1; 1H NMR (400 MHz, 
CDCl3, major-isomer) δ 1.19 – 1.38 (m, 4 H), 1.55 (s, 3 H), 1.67 (s, 3 H), 1.79 – 1.98 
(dm, J = 7.5 Hz, 1 H), 2.00 – 2.17 (m, 2 H), 3.47 (dd, J = 12.0, 5.9 Hz, 1 H), 3.54 (dd, J 
= 12.0, 6.9 Hz, 1 H), 3.69 – 3.80 (m, 3 H), 3.74 (s, 3 H), 4.74 (dd, J = 18.6, 2.0 Hz, 1 H), 
4.94 – 5.05 (m, 1 H), 4.98 (dd, J = 10.0, 2.0 Hz, 1 H), 5.46 (ddd, J = 18.6, 10.0, 7.5 Hz, 
1 H), 6.69 (d, J = 6.6 Hz, 2 H), 6.75 – 6.78 (m, 2 H); 13C NMR (100 MHz, CDCl3, 
major-isomer) δ 17.7, 25.4, 25.6, 35.2, 35.4, 40.5, 55.6, 55.7, 64.0, 73.1, 114.9, 115.3, 
116.2, 124.1, 124.3, 131.5, 131.6, 141.9; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 






– 2.17 (m, 2 H), 3.47 (dd, J = 12.0, 5.9 Hz, 1 H), 3.54 (dd, J = 12.0, 6.9 Hz, 1 H), 3.69 – 
3.80 (m, 3 H), 3.75 (s, 3 H), 4.74 (dd, J = 18.6, 2.0 Hz, 1 H), 4.94 – 5.05 (m, 1 H), 4.98 
(dd, J = 10.0, 2.0 Hz, 1 H), 5.46 (ddd, J = 18.6, 10.0, 7.5 Hz, 1 H), 6.69 (d, J = 6.6 Hz, 2 
H), 6.75 – 6.78 (m, 2 H); 13C NMR (100 MHz, CDCl3, minor-isomer) δ 17.7, 25.4, 25.6, 
35.2, 35.4, 40.4, 55.6, 55.7, 64.0, 73.1, 114.8, 115.3, 116.3, 124.1, 124.3, 131.4, 131.6, 
141.8; HRMS, calcd for C20H31NO3: 333.2304. Found m/z (relative intensity): 334.2348 
(M++1, 7), 333.2312 (M+, 33), 302.2102 (4), 273.2012 (20), 272.2004 (100). 
 
(2S, 3S, 5S)- 5-(4-methoxyphenylamino)-8-nonen-1,2,3-triol (9aa) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(2S, 3S, 5S)- 5-(4-methoxyphenylamino)-8-nonen-1,2,3-triol (9aa): (a mixture of 
major and minor isomers in a ratio of 1:1): IR (neat) 3277 (m), 2932 (s), 2839 (s), 1732 
(s), 1514 (s), 1456 (s), 1441 (s), 1238 (s), 1040 (s), 970 (s), 912 (m), 824 (s) cm-1; 1H 
NMR (400 MHz, CDCl3, major-isomer) δ 1.43 (m, 2 H), 1.87 (dt, J = 11.5, 3.2 Hz, 2 
H), 2.15- 2.30 (br d, J = 6.8 Hz, 2 H), 3.51- 3.62 (m, 4 H), 3.61 (br t, J = 3.2 Hz, 1 H), 
3.74 (s, 3 H), 3.93- 4.01 (m, 1 H), 4.95 (dd, J = 11.2, 1.6 Hz, 1 H), 4.98 (dd, J = 18.1, 
1.6 Hz, 1 H), 5.78 (ddd, J = 18.1, 11.2, 6.8 Hz, 1 H), 6.70 (d, J = 8.8 Hz, 2 H), 6.77 (d, 








56.8, 63.7, 71.3, 74.6, 114.5, 114.8, 118.3, 138.5, 141.1, 153.2; 1H NMR (400 MHz, 
CDCl3, minor-isomer) δ 1.43 (m, 2 H), 1.87 (dt, J = 11.5, 3.2 Hz, 2 H), 2.15- 2.30 (br d, 
J = 6.8 Hz, 2 H), 3.51- 3.62 (m, 4 H), 3.61 (br t, J = 3.2 Hz, 1 H), 3.74 (s, 3 H), 3.93- 
4.01 (m, 1 H), 4.95 (dd, J = 11.2, 1.6 Hz, 1 H), 4.98 (dd, J = 18.1, 1.6 Hz, 1 H), 5.78 
(ddd, J = 18.1, 11.2, 6.8 Hz, 1 H), 6.70 (d, J = 8.8 Hz, 2 H), 6.77 (d, J = 8.8 Hz, 2 H); 
13C NMR (100 MHz, CDCl3, minor-isomer) δ 28.7, 32.7, 36.1, 55.7, 56.8, 63.7, 71.3, 
74.7, 114.6, 114.8, 118.5, 138.5, 141.1, 153.3; HRMS, calcd for C16H25NO4: 295.1783. 
Found m/z (relative intensity): 296.1817 (M++1, 21), 295.1776 (M+, 100), 294.1700 
(5). 
 
(2S, 3S, 5S)- 5-(4-methoxyphenylamino)-7-nonen-1,2,3-triol (9’aa) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(2S, 3S, 5S)- 5-(4-methoxyphenylamino)-7-nonen-1,2,3-triol (9’aa): (a mixture of 
major and minor isomers in a ratio of 3:1): IR (neat) 3277 (m), 2932 (s), 2839 (s), 1732 
(s), 1514 (s), 1456 (s), 1441 (s), 1238 (s), 1040 (s), 970 (s), 912 (m), 824 (s) cm-1; 1H 
NMR (400 MHz, CDCl3, major-isomer) δ 1.43 (m, 2 H), 1.87 (dt, J = 11.5, 3.2 Hz, 2 
H), 2.15- 2.30 (m, 2 H), 2.03 (d, J = 7.3 Hz, 3 H), 3.51- 3.62 (m, 4 H), 3.61 (br t, J = 
3.2 Hz, 1 H), 3.74 (s, 3 H), 3.93- 4.01 (m, 1 H), 5.32 (dq, J = 14.6, 7.3 Hz, 1 H), 5.46 








NMR (100 MHz, CDCl3, major-isomer) δ 18.0, 32.5, 37.7, 52.7, 55.7, 63.9, 71.1, 74.1, 
114.9, 116.9, 125.5, 130.6, 140.8, 154.0; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 
1.43 (m, 2 H), 1.87 (dt, J = 11.5, 3.2 Hz, 2 H), 2.15- 2.30 (m, 2 H), 2.03 (d, J = 7.3 Hz, 
3 H), 3.51- 3.62 (m, 4 H), 3.61 (br t, J = 3.2 Hz, 1 H), 3.74 (s, 3 H), 3.93- 4.01 (m, 1 H), 
5.32 (dq, J = 14.6, 7.3 Hz, 1 H), 5.46 (dt, J = 14.6, 6.6 Hz, 1 H), 6.70 (d, J = 8.8 Hz, 2 
H), 6.77 (d, J = 8.8 Hz, 2 H); 13C NMR (100 MHz, CDCl3, minor-isomer) δ 18.0, 32.5, 
37.4, 52.7, 55.7, 63.9, 71.1, 74.3, 114.9, 117.0, 125.2, 130.7, 140.8, 154.0; HRMS, 
calcd for C16H25NO4: 295.1783. Found m/z (relative intensity): 296.1817 (M++1, 21), 
295.1776 (M+, 100), 294.1700 (5). 
 
(2S, 3S, 5S, 7S)- 5-(4-methoxyphenylamino)-7-methyl-8-nonen-1,2,3-triol (9ba) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(2S, 3S, 5S, 7S)- 5-(4-methoxyphenylamino)-7-methyl-8-nonen-1,2,3-triol (9ba): (a 
mixture of major and minor isomers in a ratio of 2:1): IR (neat) 3267 (s), 2835 (s), 
1639 (m), 1616 (m), 1417 (s), 1238 (s), 1180 (s), 1038 (s), 914 (s), 824 (s), 606 (s) 
cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 1.00 (d, J = 6.6 Hz, 3 H), 1.46- 
1.64 (m, 4 H), 1.88 (ddd, J = 14.4, 8.5, 3.4 Hz, 1 H), 2.26- 2.33 (br-d, J = 7.3 Hz, 1 H), 
3.48- 3.80 (m, 3 H), 3.75 (s, 3 H), 3.97 (ddd, J = 11.5, 5.6, 2.9 Hz, 1 H), 4.89 (dd, J = 








H), 6.66 (d, J = 9.0 Hz, 2 H), 6.77 (d, J = 9.0 Hz, 2 H); 13C NMR (100 MHz, CDCl3, 
major-isomer) δ 20.7, 35.1, 37.4, 42.6, 51.2, 55.8, 63.9, 71.3, 74.0, 113.5, 114.9, 116.2, 
141.0, 144.0, 153.0; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.94 (d, J = 6.8 Hz, 
3 H), 1.46- 1.64 (m, 4 H), 1.91 (ddd, J = 14.4, 8.5, 3.4 Hz, 1 H), 2.26- 2.33 (br-d, J = 
7.3 Hz, 1 H), 3.48- 3.80 (m, 3 H), 3.75 (s, 3 H), 3.97 (ddd, J = 11.5, 5.6, 2.9 Hz, 1 H), 
4.89 (dd, J = 17.2, 1.0 Hz, 1 H), 4.91 (dd, J = 9.7, 1.7 Hz, 1 H), 5.65 (ddd, J = 17.2, 9.7, 
7.3 Hz, 1 H), 6.67 (d, J = 10.5 Hz, 2 H), 6.69 (d, J = 10.2 Hz, 2 H); 13C NMR (100 
MHz, CDCl3, minor-isomer) δ 20.7, 34.9, 37.2, 43.2, 51.6, 55.7, 63.8, 71.3, 74.2, 113.5, 
114.9, 116.2, 141.0, 144.2, 153.0; HRMS, calcd for C17H27NO4: 309.1940. Found m/z 
(relative intensity): 310.1951 (M++1, 19), 309.1932 (M+, 100), 248.1652 (12), 
247.1566 (5). 
 
(2S, 3S, 5S, 7S)- 5-(2-methoxyphenylamino)-7-methyl-8-nonen-1,2,3-triol (9bc) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(2S, 3S, 5S, 7S)- 5-(2-methoxyphenylamino)-7-methyl-8-nonen-1,2,3-triol (9bc): (a 
mixture of major and minor isomers in a ratio of 2:1): IR (neat) 3379 (s), 3071 (s), 
2932 (s), 2360 (s), 1596 (s), 1512 (s), 1458 (s), 1227 (s), 1026 (s), 910 (s), 733 (s), 679 
(s) cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 0.99 (d, J = 6.6 Hz, 3 H), 1.42- 








3.57- 3.58 (m, 2 H), 3.76- 3.78 (m, 3 H), 3.77 (s, 3 H), 4.01 (br, 3 H), 4.83 (d, J = 17.3 
Hz, 1 H), 4.86 (d, J = 10.0 Hz, 1 H), 5.62 (ddd, J = 17.3, 10.0, 7.5 Hz, 1 H), 6.56- 6.64 
(m, 1 H), 6.70- 6.72 (m, 2 H), 6.78 (t, J = 7.6 Hz, 1 H); 13C NMR (100 MHz, CDCl3, 
major-isomer) δ 20.5, 34.7, 38.4, 43.3, 48.4, 55.3, 63.1, 70.1, 74.5, 109.7, 110.8, 113.1, 
116.2, 121.2, 137.6, 143.9, 146.6; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.95 (d, 
J = 6.3 Hz, 3 H), 1.65- 1.78 (m, 4 H), 2.22- 2.27 (br d, J = 6.6 Hz, 1 H), 3.42- 3.43 (m, 
1 H), 3.57- 3.58 (m, 2 H), 3.76- 3.78 (m, 3 H), 3.77 (s, 3 H), 4.01 (br, 3 H), 4.83 (d, J = 
17.3 Hz, 1 H), 4.86 (d, J = 10.0 Hz, 1 H), 5.62 (ddd, J = 17.3, 10.0, 7.5 Hz, 1 H), 6.56- 
6.64 (m, 1 H), 6.70- 6.72 (m, 2 H), 6.78 (t, J = 7.6 Hz, 1 H); 13C NMR (100 MHz, 
CDCl3, minor-isomer) δ 20.7, 34.6, 38.4, 43.3, 48.2, 55.3, 63.1, 70.1, 74.5, 109.7, 
110.8, 113.2, 116.4, 121.2, 137.5, 143.9, 146.6; HRMS, calcd for C17H27NO4: 
309.1940. Found m/z (relative intensity): 309.1922 (M+, 100). 
 
(2S, 3S, 5S, 7S)- 5-(3,4-dimethoxyphenylamino)-7-methyl-8-nonen-1,2,3-triol (9bf) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(2S, 3S, 5S, 7S)- 5-(3,4-dimethoxyphenylamino)-7-methyl-8-nonen-1,2,3-triol 
(9bf): (a mixture of major and minor isomers in a ratio of 2:1):IR (neat) 3379 (s), 3078 







1H NMR (400 MHz, CDCl3, major-isomer) δ 1.00 (d, J = 6.6 Hz, 3 H), 1.45- 1.63 (m, 
4 H), 1.86 (ddd, J = 14.2, 9.3, 3.2 Hz, 1 H), 2.20- 2.40 (m, 1 H), 3.12 (br, 1 H), 3.56 (br 
dd, J = 9.5, 5.4 Hz, 1 H), 3.75 (m, 2 H), 3.80 (s, 3 H), 3.82 (s, 3 H), 3.95 (ddd, J = 8.8, 
5.4, 3.1 Hz, 1 H), 4.90 (d, J = 17.1 Hz, 1 H), 4.92 (d, J = 10.5 Hz, 1 H), 5.65 (ddd, J = 
17.1, 10.5, 7.9 Hz, 1 H), 6.23 (dd, J = 8.5, 2.4 Hz, 1 H), 6.32 (d, J = 2.4 Hz, 1 H), 6.72 
(d, J = 8.5 Hz, 1 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 20.7, 35.0, 37.7, 
42.7, 50.8, 55.8, 56.6, 56.8, 63.6, 70.9, 100.5, 105.7, 113.4, 122.3, 132.3, 141.7, 144.0, 
149.9; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.96 (d, J = 6.8 Hz, 3 H), 1.45- 
1.63 (m, 4 H), 1.95 (ddd, J = 14.4, 8.8, 3.2 Hz, 1 H), 2.20- 2.40 (m, 1 H), 3.12 (br, 1 H), 
3.56 (br dd, J = 9.5, 5.4 Hz, 1 H), 3.75 (m, 2 H), 3.80 (s, 3 H), 3.82 (s, 3 H), 4.00 (m, 1 
H), 4.88 (d, J = 18.8 Hz, 1 H), 4.98 (br d, J = 10.8 Hz, 1 H), 5.58 (ddd, J = 18.8, 10.8, 
8.0 Hz, 1 H), 6.29 (dt, J = 8.5, 2.4 Hz, 1 H), 6.34 (d, J = 2.4 Hz, 1 H), 6.74 (d, J = 8.5 
Hz, 1 H); 13C NMR (100 MHz, CDCl3, minor-isomer) δ 20.7, 35.0, 37.7, 42.7, 50.8, 
55.8, 56.6, 56.8, 63.6, 70.9, 100.5, 105.7, 113.4, 122.3, 132.3, 141.7, 144.0, 149.9; 
HRMS, calcd for C18H29NO5: 339.2046. Found m/z (relative intensity): 340 (M++1, 24), 
339.2039 (M+, 100), 324 (7), 321 (3). 
 
(2S, 3S, 5S, 7S)- 5-phenylamino-7-methyl-8-nonen-1,2,3-triol (9bb) 







(2S, 3S, 5S, 7S)- 5-phenylamino-7-methyl-8-nonen-1,2,3-triol (9bb): (a mixture of 
major and minor isomers in a ratio of 2:1): IR (neat) 3400 (s), 2870 (s), 1639 (s), 1602 
(s), 1502 (s), 1259 (s), 1180 (s), 993 (s), 873 (s), 754 (s), 667 (s) cm-1; 1H NMR (400 
MHz, CDCl3, major-isomer) δ 1.01 (d, J = 6.8 Hz, 3 H), 1.52- 1.58 (m, 4 H), 1.85 (ddd, 
J = 14.4, 9.3, 3.4 Hz, 2 H), 2.28- 2.35 (br d, J = 7.2 Hz, 1 H), 3.55 (br d, J = 9.3 Hz, 1 
H), 3.77 (m, 3 H), 3.95 (ddd, J = 9.3, 5.4, 2.7 Hz, 1 H), 4.88 (dt, J = 17.4, 1.0 Hz, 1 H), 
4.92 (dt, J = 9.9, 0.9 Hz, 1 H), 5.65 (ddd, J = 17.4, 9.9, 7.5 Hz, 1 H), 6.65 (dd, J = 8.5, 
1.0 Hz, 2 H), 6.70 (dd, J = 8.5, 7.3 Hz, 1 H), 7.16 (dd, J = 8.5, 7.3 Hz, 2 H); 13C NMR 
(100 MHz, CDCl3, major-isomer) δ 20.9, 35.1, 38.1, 43.1, 49.5, 63.7, 71.0, 74.1, 113.9, 
114.5, 129.3, 144.0, 147.5; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.97 (d, J = 
6.8 Hz, 3 H), 1.52- 1.58 (m, 4 H), 1.85 (ddd, J = 14.4, 9.3, 3.4 Hz, 2 H), 2.28- 2.35 (br 
d, J = 7.2 Hz, 1 H), 3.55 (br d, J = 9.3 Hz, 1 H), 3.77 (m, 3 H), 3.95 (ddd, J = 9.3, 5.4, 
2.7 Hz, 1 H), 4.88 (dt, J = 17.4, 1.0 Hz, 1 H), 4.92 (dt, J = 9.9, 0.9 Hz, 1 H), 5.59 (br 
dd, J = 9.6, 7.5 Hz, 1 H), 6.65 (dd, J = 8.5, 1.0 Hz, 2 H), 6.70 (dd, J = 7.6, 6.8 Hz, 1 H), 
7.16 (dd, J = 8.5, 7.3 Hz, 2 H); 13C NMR (100 MHz, CDCl3, minor-isomer) δ 20.9, 
35.0, 38.1, 43.1, 49.5, 63.7, 71.0, 74.1, 113.6, 115.5, 129.3, 144.0, 147.5; HRMS, calcd 
for C16H25NO3: 279.1834. Found m/z (relative intensity): 280.1877 (M++1, 19), 
279.1831 (M+, 100), 278.1753 (4), 248.1628 (6), 217.1507 (3). 
 
(2S, 3S, 5S, 7S)- 4-(4-chlorophenylamino)-7-methyl-8-nonen-1,2,3-triol (9bg) 




(2S, 3S, 5S, 7S)- 4-(4-chlorophenylamino)-7-methyl-8-nonen-1,2,3-triol (9bg): (a 
mixture of major and minor isomers in a ratio of 2:1): IR (neat) 3364 (s), 3078 (s), 
2924 (s), 2361 (s), 1705 (s), 1597 (s), 1504 (s), 1319 (s), 1258 (s), 1180 (s), 918 (s), 
818 (s), 671 (s) cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 0.91 (d, J = 6.6 Hz, 
3 H), 1.38 (t, J = 6.6 Hz, 2 H), 1.18- 1.60 (m, 2 H), 2.18 (br quint, d, J = 6.6 Hz, 1 H), 
3.34- 3.39 (m, 1 H), 3.49- 3.57 (m, 3 H), 3.70- 3.72 (m, 2 H), 3.78 (br, 3 H), 4.76 (d, J 
= 17.2 Hz, 1 H), 4.83 (d, J = 10.2 Hz, 1 H), 5.52 (ddd, J = 17.2, 10.2, 7.9 Hz, 1 H), 
6.46 (d, J = 8.8 Hz, 2 H), 6.97 (d, J = 8.8 Hz, 2 H); 13C NMR (100 MHz, CDCl3, 
major-isomer) δ 20.0, 34.9, 38.4, 43.1, 49.2, 63.1, 70.2, 74.5, 113.6, 114.5, 121.6, 
129.0, 143.9, 146.5; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.88 (d, J = 6.8 Hz, 
3 H), 1.38 (t, J = 6.6 Hz, 2 H), 1.18- 1.60 (m, 2 H), 2.18 (br quint, d, J = 6.6 Hz, 1 H), 
3.34- 3.39 (m, 1 H), 3.49- 3.57 (m, 3 H), 3.70- 3.72 (m, 2 H), 3.78 (br, 3 H), 4.76 (d, J 
= 17.2 Hz, 1 H), 4.83 (d, J = 10.2 Hz, 1 H), 5.52 (ddd, J = 17.2, 10.2, 7.9 Hz, 1 H), 
6.51 (d, J = 8.8 Hz, 2 H), 7.02 (d, J = 8.8 Hz, 2 H); 13C NMR (100 MHz, CDCl3, 
minor-isomer) δ 21.0, 34.8, 38.4, 42.7, 49.2, 63.1, 70.2, 74.4, 113.7, 114.5, 121.6, 
129.1, 143.8, 146.5; HRMS, calcd for C16H24ClNO3: 313.1445. Found m/z (relative 








(2S, 3S, 5S, 7S)- 5-(4-methoxyphenylamino)-7-vinyl-11-dodecen-1,2,3-triol (9ca) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(2S, 3S, 5S, 7S)- 5-(4-methoxyphenylamino)-7-vinyl-11-dodecen-1,2,3-triol (9ca): 
(a mixture of major and minor isomers in a ratio of 1:1): IR (neat) 3300 (m), 2912 (s), 
2835 (s), 1639 (s), 1618 (s), 1500 (s), 1456 (s), 1294 (s), 1238 (s), 1180 (s), 1039 (s), 
916 (s), 821 (s), 748 (s) cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 1.18- 1.36 
(m, 2 H), 1.46- 1.71 (m, 2 H), 1.56 (s, 3 H), 1.67 (s, 3 H), 1.82- 2.00 (m, 2 H), 1.91 
(ddd, J = 14.1, 9.2, 3.7 Hz, 2 H), 2.04- 2.16 (m, 1 H), 3.53- 3.59 (br dd, J = 9.2, 5.3 Hz, 
1 H), 3.62- 3.65 (br d, J = 3.7 Hz, 1 H), 3.71- 3.85 (m, 2 H), 3.75 (s, 3 H), 3.95- 4.00 
(m, 1 H), 4.86 (dd, J = 17.1, 1.7 Hz, 1 H), 4.99 (dd, J = 10.1, 1.7 Hz, 1 H), 5.02- 5.06 (t 
m, J = 7.1 Hz, 1 H), 5.49 (ddd, J = 17.1, 10.1, 7.1 Hz, 1 H), 6.67 (d, J = 8.9 Hz, 2 H), 
6.76 (d, J = 8.9 Hz, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 17.8, 25.6, 
25.8, 35.4, 37.6, 40.7, 41.1, 51.6, 55.8, 63.8, 71.4, 74.1, 114.9, 115.5, 116.5, 124.2, 
131.5, 142.6, 142.8, 153.2; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 1.18- 1.36 (m, 
2 H), 1.46- 1.71 (m, 2 H), 1.56 (s, 3 H), 1.67 (s, 3 H), 1.82- 2.00 (m, 2 H), 1.91 (ddd, J 
= 14.1, 9.2, 3.7 Hz, 2 H), 2.04- 2.16 (m, 1 H), 3.53- 3.59 (br dd, J = 9.2, 5.3 Hz, 1 H), 
3.62- 3.65 (br d, J = 3.7 Hz, 1 H), 3.71- 3.85 (m, 2 H), 3.75 (s, 3 H), 3.95- 4.00 (m, 1 








= 7.1 Hz, 1 H), 5.49 (ddd, J = 17.1, 10.1, 7.1 Hz, 1 H), 6.67 (d, J = 8.9 Hz, 2 H), 6.78 
(d, J = 9.0 Hz, 2 H); 13C NMR (100 MHz, CDCl3, minor-isomer) δ 17.8, 25.4, 25.7, 
35.4, 37.6, 40.7, 41.1, 51.6, 55.7, 63.8, 71.4, 74.2, 114.8, 115.5, 116.5, 124.2, 131.5, 
142.6, 142.8, 153.8; HRMS, calcd for C22H35NO4: 377.2566. Found m/z (relative 
intensity): 377.2561 (M+, 100). 
 
General procedure 2: for the Nickel-catalyzed homoallylation of N,O-acetals 
prepared from carbohydrate and primary amines with dienes (entry 8, Table 4)   
    An oven-dried, 25 mL, three-necked round-bottomed flask equipped with a 
dropp- ing funnel, a rubber septum cap, an air condenser (fitted with a three-way 
stopcock connected into nitrogen balloon), and a Teflon-coated magnetic stir bar was 
charged.  A solution of D-ribose (150 mg, 1 mmol) and p-anisidine (246 mg, 2 mmol) 
in dry DMF (5 mL) was refluxed for 120 min under nitrogen.  The solvent was 
removed by distillation under reduced pressure (azeotropic removal of water).  A 
mixture of Ni(cod)2 (27.5 mg, 0.1 mmol) and isoprene (800 µL, 8 mmol) dissolved in 
THF (2 mL) and triethylborane (6.0 mmol, 1.0 M THF solution) were successively 
added to the N,O-acetal solution via the dropping funnel over a period of 10 min.  The 
reaction mixture was stirred at 50 ˚C for 48 h and monitored by TLC.  After the 
reaction was completed, the reaction mixture was cooled to 0 ˚C, and then poured into 
ice-water.  The resulting solution was diluted with 30 mL of EtOAc and carefully 
washed with 2 M HCl, with sat. NaHCO3, and brine.  The aqueous layer was 
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extracted with 30 mL of EtOAc.  The combined organic phases were dried (MgSO4) 
and concentrated in vacuo, and the residual oil was subjected to column 
chromatography over silica gel (eluent; hexane/EtOAc = 0/100 v/v) to afford 10ba 
(192 mg, 57%; Rf = 0.30; hexane/EtOAc = 0/100 v/v) in a 2:1 ratio. 
 
5-[(4-Methoxyphenyl)amino]-7-methylnon-8-ene-1,2,3,4-tetraol (10ba) 
Following General Procedure 2, Purification by flash column chromatography. 
 
5-[(4-Methoxyphenyl)amino]-7-methylnon-8-ene-1,2,3,4-tetraol (10ba): (a mixture 
of major and minor isomers in a ratio of 2:1): IR (neat) 3400 (m), 2930 (m), 1653 (s), 
1539 (s), 1456 (s), 1231 (s), 1180 (s), 1038 (s), 916 (s), 829 (s), 735 (s), 667 (s) cm-1; 
1H NMR (400 MHz, CDCl3, major-isomer) δ 0.98 (d, J = 6.6 Hz, 3 H), 1.48- 1.57 (br d, 
J = 13.8 Hz, 2 H), 1.74 (ddd, J = 13.8, 10.4, 2.9 Hz, 1 H), 2.27- 2.29 (br d, J = 7.7 Hz, 
1 H), 3.61- 3.69 (m, 2 H), 3.74 (s, 3 H), 3.76- 3.90 (m, 3 H), 4.82 (d, J = 17.1 Hz, 1 H), 
4.92 (dd, J = 10.2, 1.7 Hz, 1 H), 5.60 (ddd, J = 17.1, 10.2, 7.7 Hz, 1 H), 6.78 (d, J = 
10.6 Hz, 2 H), 6.79 (d, J = 10.6 Hz, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) 
δ 21.7, 35.2, 37.0, 55.9, 57.5, 63.6, 73.0, 73.4, 73.9, 114.4, 115.0, 117.4, 143.9, 153.9, 
162.5; 1H NMR (400 MHz, CDCl3, minor-isomer) δ 0.96 (d, J = 6.8 Hz, 3 H), 1.48- 
1.57 (br d, J = 13.8 Hz, 2 H), 1.74 (ddd, J = 13.8, 10.4, 2.9 Hz, 1 H), 2.27- 2.29 (br d, J 









Hz, 1 H), 4.91 (d, J = 11.2 Hz, 1 H), 5.60 (ddd, J = 17.1, 10.2, 7.7 Hz, 1 H), 6.78 (d, J 
= 10.6 Hz, 2 H), 6.79 (d, J = 10.6 Hz, 2 H); 13C NMR (100 MHz, CDCl3, 
minor-isomer) δ 21.7, 34.9, 36.6, 55.9, 57.5, 63.6, 73.2, 73.7, 73.9, 114.4, 115.1, 117.8, 
144.2, 153.9, 162.5; HRMS, calcd for C17H27NO5: 325.1889. Found m/z (relative 
intensity): 326.1940 (M++1, 20), 325.1873 (M+, 100). 
 
(2R, 3S, 4R, 6S, 8S)-6-(4-methoxyphenylamino)-8-methyl-9-decen-1,2,3,4-tetraol 
(11ba) 
Following General Procedure 2, Purification by flash column chromatography. 
 
(2R, 3S, 4R, 6S, 8S)-6-(4-methoxyphenylamino)-8-methyl-9-decen-1,2,3,4-tetraol 
(11ba): (a mixture of major and minor isomers in a ratio of 1:1): IR (KBr) 3285 (s), 
2937 (m), 2924 (m), 1514 (s), 1412 (m), 1240 (s), 1074 (s), 1040 (s), 822 (w), 640 (w) 
cm-1; 1H NMR (400 MHz, CDCl3, major-isomer) δ 1.00 (d, J = 6.8 Hz, 3 H), 1.44- 1.62 
(m, 4 H), 2.04- 2.11 (ddd, J = 5.1, 9.3, 12.7, 1 H), 2.26 (br d, J = 7.5 Hz, 1 H), 3.51- 
3.83 (m, 5 H), 3.74 (s, 3 H), 4.16- 4.20 (m, 1 H), 4.89 (d, J = 18.0 Hz, 1 H), 4.92 (d, J = 
10.5 Hz, 1 H), 5.63 (ddd, J = 17.1, 10.2, 7.8 Hz, 1 H), 6.73 (d, J = 9.0 Hz, 2 H), 6.77 (d, 
J = 9.0 Hz, 2 H); 13C NMR (100 MHz, CDCl3, major-isomer) δ 20.8, 35.2, 37.9, 42.5, 
51.7, 55.9, 64.0, 68.9, 72.9, 74.7, 113.7, 115.0, 116.7, 140.8, 144.1, 153.3; 1H NMR 
(400 MHz, CDCl3, minor-isomer) δ 0.93 (d, J = 6.8 Hz, 3 H), 1.44- 1.62 (m, 4 H), 2.04- 









(s, 3 H), 4.16- 4.20 (m, 1 H), 4.88 (d, J = 17.3 Hz, 1 H), 4.97 (d, J = 9.3 Hz, 1 H), 5.63 
(ddd, J = 17.1, 10.2, 7.8 Hz, 1 H), 6.72 (d, J = 10.7 Hz, 2 H), 6.79 (d, J = 9.0 Hz, 2 H); 
13C NMR (100 MHz, CDCl3, minor-isomer) δ 20.6, 35.0, 37.6, 42.9, 51.7, 55.5, 64.2, 
68.9, 73.0, 74.3, 113.5, 115.0, 116.7, 140.8, 144.3, 153.3; HRMS, calcd for C18H29NO5: 








(1) Tamaru, Y. Modern Organonickel Chemistry; Wiley-VCH: Weinheim, 2005. 
 
(2) Behr, A.; Neubert, P. Piperylene - A versatile basic chemical in catalysis. Chem 
Cat Chem 2014, 6, 412-428. 
 
(3) (a) Bertelo, C.; Schwartz, J. Hydrozirconation V. g,d-Unsaturated aldehydes and 
halides from 1,3-dienes via organozirconium(IV) intermediates. J. Am. Chem. 
Soc. 1976, 98, 262-264. 
(b) Yasuda, H.; Tatsumi, K.; Nakamura, A. Unique chemical behavior and 
bonding of early-transition-metal-diene complexes. Acc. Chem. Res. 1985, 18, 
120-126. 
 
(4) (a) Kimura, M.; Ezoe, A.; Shibata, K.; Tamaru, Y. Novel and highly regio- and 
stereoselective nickel-catalyzed homoallylation of benzaldehyde with 1,3-dienes. 
J. Am. Chem. Soc. 1998, 120, 4033-4034. 
(b) Kimura, M.; Ezoe, A.; Mori, M.; Iwata, K.; Tamaru, Y. Regio- and 
stereoselective nickel-catalyzed homoallylation of aldehydes with 1,3-dienes. J. 




(5) Kimura, M.; Fujimatsu, H.; Ezoe, A.; Shibata, K.; Shimizu, M.; Matsumoto, S.; 
Tamaru, Y. Nickel-catalyzed homoallylation of aldehydes and ketones with 
1,3-dienes and complementary promotion by diethylzinc or triethylborane. 
Angew. Chem. Int. Ed. 1999, 38, 397-400. 
 
(6) Kimura, M.; Ezoe, A.; Tanaka, S.; Tamaru, Y. Nickel-catalyzed homoallylation 
of aldehydes in the presence of water and alcohols. Angew. Chem. Int. Ed. 2001, 
40, 3600-3602. 
 
(7) Kimura, M.; Miyachi, A.; Kojima, K.; Tanaka, S.; Tamaru, Y. Highly stereo- and 
regioselective Ni-catalyzed homoallylation of aldimines with conjugated dienes 
promoted by diethylzinc. J. Am. Chem. Soc. 2004, 126, 14360-14361. 
 
(8) (a) Kim, H.-J.; Ricardo, A.; Illangkoon, H.-I.; Kim, M. J.; Carrigan, M. A.; Frye, 
F.; Benner. S. A. Synthesis of carbohydrates in mineral-guided prebiotic cycles. 
J. Am. Chem. Soc. 2011, 133, 9457-9468. 
(b) Archer, R.M.; Royer, S. F.; Mahy, W.; Winn, C.L.; Danson, M.J.; Bull, S. D.  
Syntheses of 2-keto-3-deoxy-D-xylonate and 2-keto-3-deoxy-L-arabinonate as 
stereochemical probes for demonstrating the metabolic promiscuity of sulfolobus 




(9) Li, Z.; Cai, L.; Wei, M.; Wang, P. G. One-pot four-enzyme synthesis of ketones 
with fructose 1,6-bisphosphate aldolases from staphylococcus carnosus and rabit 
muscle. Carbohydrate Res. 2012, 357, 143-146. 
(10) (a) Kodato, S.; Nakagawa, M.; Nakayama, K.; Hino, T. Synthesis of cerebroside 
B1b with antiulcerogenic activity I. Synthesis of ceramides with optically active 
α-hydroxypalmitic acids. Tetrahedron 1989, 45, 7247-7262. 
(b) Mukai, R.; Horino, Y.; Tanaka, S.; Tamaru, Y.; Kimura, M. Pd(0)-catalyzed 
amphiphilic activation of bis-allyl alcohol and ether. J. Am. Chem. Soc. 2004, 
126, 11138-11139. 
(c) Kimura, M.; Shimizu, M.; Tanaka, S.; Tamaru, Y. Pd-catalyzed nucleophilic 
allylic alkylation of aliphatic aldehydes by the use of allyl alcohols.  
Tetrahedron 2005, 61, 3709-3718. 
(d) Yamaguchi, Y.; Hasimoto, M.; Tohyama, K.; Kimura, M. Nucleophilic 
allylation of N,O-acetals with allylic alcohols promoted by Pd/Et3B and Pd/Et2Zn 











Multicomponent Coupling Reaction via Nickelacycle:  
Efficient and Selective Formation of Unsaturated Carboxylic Acids and 







Summary: Ni-catalyzed multicomponent coupling reaction of alkyne, dimethylzinc, 
and diketene (as butenoic acid equivalent) to provide 3-methylene-4-hexenoic acids in a 
single manipulation is described.  Under similar catalytic conditions, Et2Al(OEt) 
accelerates a formal [2+2+2] cycloaddition reaction with diketene and two equivalents 
of alkynes to produce phenylacetic acid derivatives.  Furthermore, in the presence of 
ligand, such as PPh3, symmetrical substituted phenylacetic acids are produced with 
accompanying cleavage reaction of the C–C double bond of diketene via 























































     Diketene is a unique and important key intermediate formed by dimerization of 
ketene1, and is often used as an acetoacetylation reagent for versatile nucleophiles, 
such as alcohols, amines, thiols and carbanions, in organic synthesis (Scheme 1, path 
a)2.  In the presence of transition metal catalysts, diketene smoothly reacts with 
organometallic compounds, such as Grignard reagents and organozinc reagents, to 
cleave the vinyl-oxygen bond to construct 3-substituted 3-butenoic acids (Scheme 1, 
path b)3.  The 3-butenoic acid skeleton serves as a synthon for the preparation of 
physiologically active molecules and the fine chemicals4. 
 
 
Scheme 1. Reactivity of Diketene with Nucleophiles 
 
    Phenylacetic acid (α-toluic acid) acts as an active auxin and is a critical 
constituent of many physiologically active molecules, such as tetraline-based natural 
products, analgesics, and non-steroidal anti-inflammatory drugs (NSAIDs)5.  

















demanded for use in medicinal chemistry, most involve some limitations of handling 
and harsh reaction conditions6.  Therefore, straightforward and selective formations 
of unsaturated carboxylic acids and phenylacetic acids from commercially available 
diketene promoted by transition metal catalysts with organometallic reagents will be 
beneficial. 
    Nickel-catalyzed coupling reactions are an attractive synthetic method for the 
construction of useful and complicated molecules in modern organic chemistry7.  We 
have previously demonstrated the Ni(0)-catalyzed multicomponent coupling reaction 
of alkyne, dimethylzinc, and unsaturated hydrocarbons (such as conjugated dienes and 
vinylcyclopropanes) to accomplish C–C bond formations with high regio- and 
stereoselectivities8.  All of these coupling reactions proceeded via nickelacyle 
intermediates by oxidative cyclization of unsaturated hydrocarbons and Ni(0) catalyst. 
    Herein, we would like to disclose the Ni-catalyzed multicomponent coupling 
reaction of alkyne, dimethylzinc, and diketene (as butenoic acid equivalent) to provide 
3-methylene-4-hexenoic acids in a single manipulation (Scheme 2).  Under similar 
catalytic conditions, Et2Al(OEt) accelerates a formal [2+2+2] cycloaddition reaction 
with diketene and two equivalents of alkynes to produce phenylacetic acid derivatives.  
Furthermore, in the presence of ligand, symmetrically substituted phenylacetic acids 
are produced with accompanying cleavage of the C–C double bond of diketene.  
Although Ni-catalyzed cycloaddition reactions with alkynes have been well developed9, 
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efficient syntheses of phenylacetic acids via cycloaddition reaction with alkyne and 





































Results and Discussion 
 
    The three-component coupling reaction with alkyne, diketene, and dimethylzinc 
was conducted in the presence of Ni(acac)2 catalyst (1 mol%) in THF under nitrogen 
atmosphere.  Table 1 summarizes the results obtained from using a wide variety of 
alkynes, including symmetrical and unsymmetrical substituted alkynes.  Symmetrical 
substituted alkynes, such as 2-butyne, 3-hexyne, and 4-octyne reacted with diketene and 
dimethylzinc smoothly to give the three-component coupling products 3 in excellent 
yields as a single isomer (entries 1-3, Table 1).  
    Bis(trimethylsilyl)acetylene also participated in a similar coupling reaction to 
afford 3d in reasonable yield (entry 4, Table 1).  Diphenylacetylene provided the 
expected coupling product 3e in modest yield  (entry 5, Table 1).  An electron- 
deficient alkyne such as dimethyl acetylenedicarboxylate did not take part in the 
reaction.  The regioselectivity of the unsymmetrical alkynes depended on the type of 
substituents.  1-Trimethylsilyl-1-propyne coupled with dimethylzinc at the trimethyl- 
silyl-substituted carbon atom and diketene at the methyl-substituted carbon atom to 
provide 3f in syn addition manner as a single stereoisomer (entry 6, Table 1).  
1-Trimethylsilyl-2-phenylethyne and 1-phenyl-1-butyne provided the expected 
unsaturated carboxylic acids as a mixture of regioisomers of 3g and 3h, respectively 
(entries 7 and 8, Table 1).   
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Table 1.  Scope of the Nickel-Catalyzed Three-Component Coupling Reaction 





entry alkyne R1 R2 time (h) yield of 3 (%) [ratio] 
1 Me Me  (2a) 1 3a: 91 
2 Et Et  (2b) 3 3b: 95 
3 n-Pr n-Pr  (2c) 3 3c: 90 
4 TMS TMS  (2d) 6 3d: 81 
5 Ph Ph  (2e) 24 3e: 29 
6 TMS Me  (2f) 3 3f: 91 [single] 
7 TMS Ph  (2g) 24 3g: 87 [3:1]b 
8 Ph Et  (2h) 24 3h: 87 [10:1]c 
 
a The reaction was undertaken in the presence of Ni(acac)2 (0.01 mmol), alkyne (1 mmol), diketene (1.5 
mmol), and Me2Zn (1.2 mmol) in THF at 50 ˚C under nitrogen atmosphere.  Yields were calculated 
based on alkyne.  
b The ratio shows the regioisomeric ratio with respect to olefin geometry.  Major isomer is depicted as 
the structure of compound 3.   
c The substituents of R1 and R2 on major isomer are opposite each other on minor isomer.     
 















    A plausible mechanism for the coupling reaction with alkyne, diketene, and 
dimethylzinc is illustrated in Scheme 3.  Ni-catalyzed oxidative cyclization of alkyne 
and diketene in the presence of dimethylzinc proceeds to form nickelacyclopentene 
intermediate I, which is followed by C–O bond cleavage to provide 7-membered oxa- 
nickelacycles II.  The methyl group transfer from dimethylzinc to Ni metal provides 




Scheme 3.  Plausible Reaction Mechanism for Ni-Catalyzed Multicomponent 













































    The features of the coupling reaction with diketene and alkyne promoted by Ni 
catalyst changed dramatically when organoaluminum reagents were used in place of 
dimethylzinc (Table 2).  For example, in the presence of Ni(cod)2 catalyst in THF 
solvent, Me3Al, diketene, and 3-hexyne combined in a 1:1:1 ratio to form the 
three-component coupling product 3b as well as the products shown in Table 1 (entry 1, 
Table 2).  Under similar conditions, complex mixtures were produced using Et3Al, 
Et2AlCl, and Et2Al(OEt) (entries 2-4, Table 2).  Among these investigations using 
various kinds of solvents, toluene was most effective for the cycloaddition reaction, 
providing ethyl-substituted phenylacetic acids. 
    In the presence of Ni catalyst and Me3Al, diketene underwent [2+2+2] cyclo- 
addition with two equivalents of 3-hexyne to afford phenylacetic acid 5b in 34% yield, 
along with the linear coupling product, trienyl carboxylic acid 4ba, in 24% yield as a 
byproduct (entry 5, Table 2).  Use of Et3Al also produced a similar result to give a 
mixture of 4bb and 5b in modest yields (entry 6, Table 2).  Although Et2AlCl resulted 
in the formation of a complex mixture, Et2Al(OEt) effectively promoted the [2+2+2] 






Table 2.  Scope of the Nickel-Catalyzed Three-Component Coupling Reaction 
of Diketene, Alkyne 2b, and Organoaluminuma 
 
 
entry organoaluminum solvent yield of 3b, 4 and 5b (%) 
1 Me3Al THF 3b: 50 
2 Et3Al THF complex mixture 
3 Et2AlCl THF complex mixture 
4 Et2Al(OEt) THF complex mixture 
5 Me3Al toluene 4ba: 24(R = Me), 5b: 34 
6 Et3Al toluene 4bb: 34(R = Et), 5b: 10 
7 Et2AlCl toluene complex mixture 
8 Et2Al(OEt) toluene 5b: 98 
 
a The reaction was undertaken in the presence of Ni(cod)2 (0.1 mmol), alkyne (1 mmol), diketene (3 




























    As shown in Table 3, the cycloaddition reaction of diketene with alkynes in the 
presence of Ni catalyst and Et2Al(OEt) was applied to a wide variety of alkynes.  
Surprisingly, use of phosphine ligands under similar catalytic conditions changed the 
outcome to provide the regioisomeric phenylacetic acid 6 exclusively.  Among the 
results of utilizing monodentate and bidentate phosphine ligands, PPh3 was the most 
efficient ligand to furnish phenylacetic acids 6 as the sole products (entries 9-12, Table 
3).  Symmetrical dialkyl-substituted alkynes underwent the cycloaddition reaction with 
diketene to provide unsymmetrical phenylacetic acids 5 by means of the Ni catalyst and 
Et2Al(OEt) system in the absence of PPh3 (entries 1-4, Table 3), diphenylacetylene 
provided the expected coupling product 5e in modest yield (entry 5, Table 3), whereas 
the formal [2+2+1+1] cycloaddition reaction product, symmetrically substituted 
phenylacetic acids 6, were selectively produced in the presence of PPh3 ligand (entries 9, 
and 13-16, Table 3).  The structures of both the unsymmetrical and symmetrical 
phenylacetic acids 5b and 6b were determined unequivocally by X-ray crystallographic 
analysis, as shown in Figure 1 and 210.  Although cycloaddition reactions involving 
unsymmetrical disubstituted alkynes often exhibit complicated regioselectivities11, the 
desired coupling products 5f and 6f were produced as a single isomer in the case of 
using of 1-trimethylsilyl-1-propyn regardless of the presence or absence of phosphine 
ligand (entries 6 and 17, Table 3).  Terminal alkynes possessing t-Bu and TMS groups 
could participate in the coupling reaction and the distinctive regioselective formations 













    The cycloaddition reaction was applied to the construction of a benzobicyclic ring 
via coupling reaction of a diyne moiety with diketene.  3,9-Dodecadiyne underwent 
the cycloaddition reaction with diketene and provided tetrahydronaphthylacetic acid 5i 
using the Ni-catalyst and Et2Al(OEt) system (eq 1).  Unfortunately, in the presence of 

























Table 3.  Scope of the Nickel-Catalyzed Three-Component Coupling Reaction 
of Diketene, Alkyne 2, and Organoaluminuma 
 
entry alkyne R1 R2 ligand yield of 5 and 6 (%) 
1 Me Me  (2a) none 5a: 80 
2 Et Et  (2b) none 5b: 98 
3 n-Pr n-Pr  (2c) none 5c: 76 
4 n-Bu n-Bu  (2j) none 5j: 65 
5 Ph Ph  (2e) none 5e: 24 
6 TMS Me  (2f) none 5f: 77b 
7 t-Bu H  (2k) none 5k: 65 
8 TMS H  (2l) none 5l: 40 
9 Et Et  (2b) PPh3 6b: 73 
10 Et Et  (2b) P(c-Hex)3 6b: 20 




























(Table 3, continued)    
     
12 Et Et  (2b) Xantphos 6b: 22 
13 Me Me  (2a) PPh3 6a: 60 
14 n-Pr n-Pr  (2c) PPh3 6c: 80 
15 n-Bu n-Bu  (2j) PPh3 6j: 71 
16 Ph Ph  (2e) PPh3 6e: 50 
17 TMS Me  (2f) PPh3 6f: 45 
18 t-Bu H  (2k) PPh3 6k: 34 
19 TMS H  (2l) PPh3 6l: 60 
 
a The reaction was undertaken in the presence of Ni(cod)2 (0.1 mmol), ligand (0.2 mmol), alkyne (1 
mmol), diketene (3 mmol), and Et2Al(OEt) (1.2 mmol) in toluene (5 mL) at r.t. under nitrogen 
atmosphere for 72 h.  
b In entry 6, 5f was obtained as a desilylation product 5f’ (R1 = H) in 77%. 
 
 
    The reactions of stoichiometric amount of Ni(cod)2, alkyne, and diketene without 
Et2Al(OEt) were conducted (Scheme 4).  In the absence of phosphine ligand, a 
mixture of Ni(cod)2 (0.5 mmol), 3-hexyne (1 mmol), and diketene (0.5 mmol) did not 
provide the expected phenylacetic acid 5b, and instead the intractable mixture was 
obtained.  On the other hand, in the presence of two equivalents of PPh3 based on 
Ni(0) complex, the reaction mixture of Ni(cod)2 (0.5 mmol), PPh3 (1.0 mmol), 
3-hexyne (1 mmol), and diketene (0.5 mmol) stirring for 72 hours followed by 
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hydrolysis with acidic water provided the symmetrical phenylacetic acid 6b in 54% as 
a sole product.  At the initial stage of the reaction for 1 hour, 
(3E)-4-ethyl-5-methylene-3-heptenoic acid 7b was obtained in 80% with high 
stereoselectivity.  Furthermore, we would like to argue the cross-coupling reaction of 
a mixture of stoichiometric amount of diketene, alkyne, PPh3, and Ni(cod)2 complex 
with phenylmagnesium bromide.  Addition of PhMgBr solution to the mixture of 
Ni(cod)2 (0.5 mmol), PPh3 (1 mmol), 3-hexyne (0.5 mmol), and diketene (0.5 mmol) 
provided (3Z)-4-ethyl-5-methylene-3-phenyl-3-heptenoic acid 8b in 26%, along with 
(3Z)-4-ethyl-5-methylene-3-[(3Z)-4-phenyl-3-hexenyl]-3-heptenoic acid 9b in 39% (eq 
2).  These results suggest the cleavage reaction of C–C double bond of diketene 
proceeds via a crucial key intermediate by the synergistic effect of Ni active species 










Scheme 4.  C–C Bond Cleavage Reaction of Diketene Promoted by 

































PPh3 (mmol) time (h) Product
0 72 complex mixture
1 72 6b (54%)



























8b: 26% 9b: 39%
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    Although it is premature to provide a complete explanation of the reactivities 
described here, a plausible mechanism for the cycloaddition reactions of diketene and 
alkyne promoted by Ni catalyst and Et2AlX are proposed in Scheme 5 and 6.  In the 
absence of phosphine ligand, oxidative cyclization of alkyne and diketene with Ni(0) 
catalyst provides nickelacycle I, which undergoes the ring expansion reaction to form 
oxanickelacycle intermediate II (Scheme 5).  Further insertion of an additional alkyne 
promoted by Et2AlX to afford vinylnickel intermediate III via transmetalation with 
Et2AlX.  Intramolecular carbonickelation via 6-endo cyclization of III (X = OEt), and 
the subsequent β-hydride elimination occurs to afford phenylacetic acid salt 5 with 
liberation of Ni(0) species12.  For Me3Al and Et3Al, reductive elimination might 
proceed through the intermediate III (X = Me or Et) rather than carbonickelation to 




Scheme 5.  Plausible Reaction Mechanism for the Formation of Phenylacetic 
Acids in the Absence of PPh3 
 
 
    The similar catalytic system, in the presence of PPh3 ligand, might promote 
diketene to undergo the oxidative cyclization with alkyne to form the nickelacyclo- 
pentene intermediate I (Scheme 6).  On the contrary to the mechanism demonstrated 
in Scheme 5, the active metallacycle I having PPh3 ligand invokes C–C bond cleavage 
reaction via nickel carbene cyclopropane rearrangement to form the nickelacyclo- 
pentene IV14.  [1,2]-Shift of the Ni atom proceeds to avoid the distortion of the spiro- 

































































undergoes cycloaddition reaction with alkyne to form vinylnickel intermediate VI15.  
Intramolecular carbonickelation followed by aromatization (VII, VIII) provides the 
alternative regioisomer 6 by transmetalation with Et2Al(OEt) accompanying the libera- 
tion of catalytically active Ni(0) species16. 
    Sterically controlled oxanickelacycle V would afford (3E)-4-ethyl-5-methylene- 
3-heptenoic acid 7b with high stereoselectivity by hydrolysis with acid aqueous media.  
Instead, the addition of PhMgBr to the reaction mixture would provide (3Z)-4-ethyl- 
5-methylene-3-phenyl-3-heptenoic acid 8b via transmetallation with oxanickelacycle 
V and (3Z)-4-ethyl-5-methylene-3-[(3Z)-4-phenyl-3-hexenyl]-3-heptenoic acid 9b 
from trienylnickel intermediate VI.  Although intermediates V and VI could not be 
verified by X-ray crystallographic analysis or NMR spectra, highly stereoselective 
formations of 7b, 8b, and 9b might prove the formation of nickel intermediates V and 
VI in situ.  Thus, a mechanism for the formation of 6 involving the stereodefined 







Scheme 6. Mechanism for the Formation of Phenylacetic Acids via 
Ni-Catalyzed Coupling of Diketene, Alkyne, and Organoaluminum in the 







































































    In conclusion, the multicomponent coupling reaction of diketene, alkyne, and 
Me2Zn has been demonstrated to give 3-methylene-4-hexenoic acids in excellent yields.  
Under similar conditions, the combination of Ni catalyst and Et2Al(OEt) accelerates 
the dimerization of alkyne followed by a [2+2+2] cycloaddition reaction to furnish 
phenyl- acetic acid derivatives.  In the presence of PPh3, a formal [2+2+1+1] 
cycloaddition reaction proceeds to afford the alternative regioisomer of phenylacetic 
acid derivatives accompanying the C–C double bond cleavage reaction of diketene.  
Synthetic applications involving the cleavage reaction of various C–C double bonds 








    Reactions employed oven-dried glassware unless otherwise noted.  Thin layer 
chromatography (TLC) employed glass 0.25 mm silica gel plates with UV indicator 
(Merck, Silica gel 60F
254
).  Flash chromatography columns were packed with 230-400 
mesh silica gel as a slurry in hexane.  Gradient flash chromatography was conducted 
eluting with a continuous gradient from hexane to the indicated solvent.  Distillation 
were carried out in a Kugelrohr apparatus (SIBATA glass tube oven GTO-350RG).  
Boiling points are meant to refer to the oven temperature (± 1 °C).  Microanalyses 
were performed by the Instrumental Analysis Center of Nagasaki University.  Analysis 
agreed with the calculated values within ± 0.4%.  Proton and carbon NMR data were 
obtained with a JEOL-GX400 with tetramethylsilane as an internal standard.  
Chemical shift values were given in ppm downfield from the internal standard.  
Infrared spectra were recorded with a JASCO A-100 FT-IR or SHIMAZU FTIR-8700 
spectrophotometer.  High resolution mass spectra (HRMS) were measured with a 
JEOL JMS-DX303. 
Solvents and Reagents 
    Tetrahydrofuran was dried and distilled from benzophenone and sodium 
immediately prior to use under nitrogen atmosphere.  Anhydrous toluene was 
purchased (Aldrich) and used without further purification.  Ni(acac)2, Ni(cod)2, PPh3, 
c-Hex3P, n-Bu3P, Xantphos [4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene], 
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Me2Zn (1.0 M hexane solution), Me3Al (1.0 M hexane solution), Et3Al (1.0 M hexane 
solution), Et2AlCl (1.0 M hexane solution), Et2Al(OEt) (1.0 M hexane solution), 
PhMgBr (1.0 M THF solution) (Kanto Kagaku) were purchased and used without 
further purification.  2-Butyne, 3-hexyne, 4-octyne, 5-decyne, bis(trimethylsilyl)acety- 
lene, diphenylacetylene, 1-phenyl-2-(trimethylsilyl)acetylene, 1-trimethylsilyl-1-prop- 
yne, 3,3-dimethyl-1-butyne, trimethylsilylacetylene, and 1-phenyl-1-butyne (Tokyo 
Kasei Kogyo Co., Ltd) were purchased and distilled prior to use.  Diketene (Tokyo 






General procedure 1: Formation of Unsaturated Carboxylic Acids from Diketene 
Promoted by Ni Catalyst (entry 2, Table 1)   
    An oven-dried, 25 mL, three-necked round-bottomed flask equipped with a dropp- 
ing funnel, a rubber septum cap, an air condenser (fitted with a three-way stopcock 
connected into nitrogen balloon), and a Teflon-coated magnetic stir bar was charged 
with Ni(acac)2 (2.6 mg, 0.01 mmol).  The apparatus was purged with nitrogen and the 
flask was charged successively via syringe with freshly dry THF (5 mL), diketene 
(126.1 mg, 1.5 mmol), and 3-hexyne (82.1 mg, 1 mmol). Dimethylzinc (1.2 mmol, 1.0 
M hexane solution) was added slowly at room temperature via the dropping funnel over 
a period of 10 min.  The mixture was stirred at 50 ℃ for 24 h and monitored by TLC.  
After the reaction was completed, the reaction mixture was cooled to 0 ˚C, and then 
poured into ice-water.  The resulting solution was diluted with 30 mL of EtOAc and 
carefully washed with 2 M HCl, with sat. NaHCO3, and brine.  The aqueous layer was 
extracted with 30 mL of EtOAc.  The combined organic phases were dried (MgSO4) 
and concentrated in vacuo, and the residual oil was subjected to column 
chromatography over silica gel (eluent; hexane/EtOAc = 4/1 v/v) to afford 3b as a 




(E)-4-Ethyl-5-methyl-3-methylenehept-4-enoic acid: (3b) 
 
(E)-4-Ethyl-5-methyl-3-methylenehept-4-enoic acid (3b): IR (neat) 2964 (s), 2934 
(s), 2874 (s), 2584 (brs), 1711 (s), 1630 (m), 1406 (m), 1375 (m), 907 (s) cm-1; 1H 
NMR (400 MHz, CDCl3) δ 0.92 (t, J = 7.6 Hz, 3 H), 0.98 (t, J = 7.6 Hz, 3 H), 1.67 (s, 
3 H), 2.06 (q, J = 7.6 Hz, 2 H), 2.10 (q, J = 7.6 Hz, 2 H), 3.10 (s, 2 H), 4.84 (d, J = 1.9 
Hz, 1 H), 5.18 (d, J = 1.9 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 13.0, 13.4, 19.0, 
23.1, 26.5, 41.4, 116.9, 133.0, 135.6, 141.7, 175.7; High-resolution MS, calcd for 
C11H18O2: 182.1307. Found m/z (relative intensity): 183 (M++1, 14), 182.1312 (M+, 
100), 137 (26). 
 
4,5-Dimethyl-3-methylenehex-4-enoic acid: (3a) 
Following General Procedure 1, Purification by flash column chromatography. 
 
4,5-Dimethyl-3-methylenehex-4-enoic acid (3a): IR (neat) 3085 (br), 2976 (s), 2920 
(s), 2862 (s), 2679 (m), 2573 (m), 1713 (s), 1636 (m), 1412 (m), 1294 (s), 907 (s) cm-1; 
1H NMR (CDCl3, 400 MHz) δ 1.68 (s, 3 H), 1.70 (s, 3 H), 1.73 (s, 3 H), 3.14 (s, 2 H), 
4.78 (d, J = 1.7 Hz, 1 H), 5.12 (d, J = 1.7 Hz, 1 H); 13C NMR (CDCl3, 100 MHz) δ 











C9H14O2: 154.0994. Found m/z (relative intensity): 155 (M++1, 45), 154.0989 (M+, 
100), 140 (68), 139 (100), 137 (24), 125 (32). 
 
(E)-5-Methyl-3-methylene-4-propyloct-4-enoic acid: (3c) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(E)-5-Methyl-3-methylene-4-propyloct-4-enoic acid (3c): IR (neat) 3074 (br), 2931 
(s), 2872 (s), 2682 (br), 2598 (br), 1713 (s), 1632 (m), 1410 (m), 1302 (s), 1223 (m), 
905 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.87 (t, J = 7.6 Hz, 3 H), 0.89 (t, J = 7.6 
Hz, 3 H), 1.32 (sext, J = 7.6 Hz, 2 H), 1.40 (sext, J = 7.6 Hz, 2 H), 1.67 (s, 3 H), 2.03 (t, 
J = 7.6 Hz, 2 H), 2.07 (t, J = 7.6 Hz, 2 H), 3.10 (s, 2 H), 4.83 (d, J = 2.0 Hz, 1 H), 5.17 
(d, J = 2.0 Hz, 1 H); 13C NMR (CDCl3, 100 MHz) δ 13.9, 14.0, 19.5, 21.4, 21.7, 32.2, 
35.6, 41.4, 116.8, 132.0, 134.8, 141.9, 177.3; High-resolution MS, calcd for C13H22O2: 
210.1620. Found m/z (relative intensity): 211 (M++1, 2), 210.1612 (M+, 10), 167 (9), 
135 (22), 121 (100). 
 
(Z)-3-Methylene-4,5-bis(trimethylsilyl)hex-4-enoic acid: (3d) 












(Z)-3-Methylene-4,5-bis(trimethylsilyl)hex-4-enoic acid (3d): IR (neat) 2952 (s), 
2900 (s), 2580 (brs), 2343 (s), 1712 (s), 1624 (m), 1406 (m), 1249 (s), 893 (m), 839 (s), 
756 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.18 (s, 9 H), 0.19 (s, 9 H), 1.84 (s, 3 H), 
2.99 (s, 2 H), 4.58 (d, J = 3.1 Hz, 1 H), 5.09 (d, J = 3.1 Hz, 1 H); 13C NMR (CDCl3, 
100 MHz) δ 1.25, 1.85, 22.0, 42.3, 111.4, 145.4, 150.0, 155.6, 175.6; High-resolution 
MS, calcd for C13H26O2Si2: 270.1471. Found m/z (relative intensity): 271 (M++1, 13), 
270.1477 (M+, 58), 255 (100), 241 (2). 
 
(Z)-3-methylene-4,5-diphenylhex-4-enoic acid: (3e) 
Following General Procedure 1, Purification by flash column chromatography.  
 
(Z)-3-methylene-4,5-diphenylhex-4-enoic acid (3e): IR (neat) 3020 (br), 2914 (m), 
2856 (w), 1709 (s), 1599 (m), 1489 (m), 1443 (s), 1265 (m), 762 (s), 698 (s) cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 2.28 (s, 3 H), 3.00 (s, 2H), 5,36 (d, J = 1.7 Hz, 1 H), 5,44 
(d, J = 1.7 Hz, 1 H), 6.94-7.19 (m, 10 H); 13C NMR (CDCl3, 100 MHz) δ 23.1, 40.9, 
118.9, 126.0, 126.2, 127.5, 127.5, 129.0, 130.2, 136.3, 138.7, 139.5, 141.8, 143.4, 
176.8; High-resolution MS, calcd for C19H18O2: 278.1307 Found m/z (relative 
intensity): 279 (M++1, 8), 278.1312 (M+, 33.7), 219 (100), 204 (26). 
 
(E)-4-Methyl-3-methylene-5-(trimethylsilyl)hex-4-enoic acid: (3f) 








(E)-4-Methyl-3-methylene-5-(trimethylsilyl)hex-4-enoic acid (3f): IR (neat) 3091 
(br), 2957 (br), 2916 (br), 2862 (m), 1713 (s), 1638 (m), 1603 (s), 1408 (s), 1250 (s), 
907 (m), 837 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.15 (s, 9 H), 1.68 (s, 3 H), 1.89 
(s, 3 H), 3.14 (s, 2 H), 4.86 (d, J = 1.5 Hz, 1 H), 5.14 (d, J = 1.5 Hz, 1 H); 13C NMR 
(CDCl3, 100 MHz) δ 0.26, 19.7, 22.8, 41.3, 115.4, 130.6, 144.2, 145.8, 177.3; 
High-resolution MS, calcd for C11H20O2Si: 212.1233. Found m/z (relative intensity): 
212.1215 (M+, 14), 198 (16), 197 (100). 
 
(Z)-3-Methylene-5-(trimethylsilyl)-4-phenylhex-4-enoic acid: (3g) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(Z)-3-Methylene-5-(trimethylsilyl)-4-phenylhex-4-enoic acid (3g): (a mixture of 
regioisomers in a 3 : 1 ratio): IR (neat) 3061 (br), 2960 (br), 2899 (br), 2862 (br), 2677 
(m), 1638 (m), 1711 (s), 1408 (m), 1248 (s), 908 (m), 837 (s), 762 (m), 702 (s), 633 
(m) cm-1; 1H NMR (CDCl3, 400 MHz, major isomer) δ -0.21 (s, 9 H), 1.92 (s, 3 H), 
2.93 (s, 2 H), 5.12 (d, J = 1.7 Hz, 1 H), 5.26 (d, J = 1.7 Hz, 1 H), 7.12-7.16 (m, 2 H), 
7.22-7.26 (m, 2 H), 7.26 (m, 1 H); 13C NMR (CDCl3, 100 MHz, major isomer) δ 0.77, 
20.6, 41.2, 117.6, 127.8, 128.5, 129.5, 136.5, 142.0, 149.9, 151.4, 177.0; 1H NMR 











J = 1.5 Hz, 1 H), 5.21 (d, J = 1.5 Hz, 1 H), 7.12-7.16 (m, 2 H), 7.26-7.31 (m, 2 H), 
7.26 (m, 1 H); 13C NMR (CDCl3, 100 MHz, minor isomer) δ 0.77, 24.4, 43.3, 113.9, 
127.8, 128.1, 128.5, 129.5, 135.1, 145.5, 149.9, 177.0; High-resolution MS, calcd for 
C16H22O2Si: 274.1389. Found m/z (relative intensity): 275 (M++1, 9), 274.1377 (M+, 
37), 260 (21), 259 (100), 241 (10). 
 
(E)-4-Ethyl-3-methylene-5-phenylhex-4-enoic acid: (3h) 
Following General Procedure 1, Purification by flash column chromatography. 
 
(E)-4-Ethyl-3-methylene-5-phenylhex-4-enoic acid (3h): (a mixture of regioisomers 
in a 10 : 1 ratio): IR (neat) 2968 (s), 2931 (s), 2594 (brs), 1708 (s), 1629 (m), 1598 (m), 
1490 (m), 1438 (m), 1407 (m), 1296 (s), 910 (s), 765 (s), 702 (s) cm-1; 1H NMR 
(CDCl3, 400 MHz, major isomer) δ 0.84 (t, J = 7.3 Hz, 3 H), 1.98 (q, J = 7.3 Hz, 2 H), 
1.98 (s, 3 H), 3.21 (s, 2 H), 5.05 (d, J = 1.6 Hz, 1 H), 5.34 (d, J = 1.6 Hz, 1 H), 7.12 
(dd, J = 7.4, 1.4 Hz, 2 H), 7.23 (td, J = 7.4, 1.4 Hz, 1 H), 7.32 (t, J = 7.4 Hz, 2 H); 13C 
NMR (CDCl3, 100 MHz, major isomer) δ 13.2, 22.5, 24.4, 40.9, 117.9, 126.1, 127.7, 
128.0, 129.2, 133.4, 138.4, 140.5, 144.0, 175.7; 1H NMR (CDCl3, 400 MHz, minor 
isomer) δ 0.94 (t, J = 7.3 Hz, 3 H), 1.98 (q, J = 7.3 Hz, 2 H), 2.17 (s, 3 H), 2.92 (s, 2 H), 
5.15 (d, J = 1.6 Hz, 1 H), 5.27 (d, J = 1.6 Hz, 1 H), 7.10-7.32 (m, 5 H); 13C NMR 
(CDCl3, 100 MHz, minor somer) δ 13.0, 18.8, 28.0, 30.9, 117.9, 126.4, 127.7, 127.9, 







230.1307. Found m/z (relative intensity): 231 (M++1, 10), 230.1304 (M+, 61), 215 (8), 
201 (100). 
 
General procedure 2: Formation of Unsaturated Carboxylic Acids from Diketene 
with Organoaluminum Promoted by Ni Catalyst (entry 5, Table 2)   
    An oven-dried, 25 mL, three-necked round-bottomed flask equipped with a dropp- 
ing funnel, a rubber septum cap, an air condenser (fitted with a three-way stopcock 
connected into nitrogen balloon), and a Teflon-coated magnetic stir bar was charged 
with Ni(cod)2 (27.5 mg, 0.1 mmol).  The apparatus was purged with nitrogen and the 
flask was charged successively via syringe with freshly dry toluene (3 mL), diketene 
(252.2 mg, 3.0 mmol), and 3-hexyne (82.1 mg, 1 mmol). Oganoaluminum (1.2 mmol, 
1.0 M hexane solution) was added slowly at room temperature via the dropping funnel 
over a period of 10 min (the reaction temperature should not be exceeded 50 ˚C).  The 
mixture was stirred at room temperature for 72 h and monitored by TLC.  After the 
reaction was completed, the reaction mixture was cooled to 0 ˚C, and then poured into 
ice-water.  The resulting solution was diluted with 30 mL of EtOAc and carefully 
washed with 2 M HCl, and brine.  The aqueous layer was extracted with 30 mL of 
EtOAc.  The combined organic phases were dried (MgSO4) and concentrated in vacuo, 
and the residual oil was subjected to column chromatography over silica gel (eluent; 
hexane/EtOAc = 10/1 v/v) to afford 4ba as a colorless oil (63.5 mg, 24%; Rf = 0.40; 




 (4Z,6E)-4,5,6-Triethyl-7-methyl-3-methylenenona-4,6-dienoic acid: (4ba) 
 
(4Z,6E)-4,5,6-Triethyl-7-methyl-3-methylenenona-4,6-dienoic acid (4ba) : IR 
(neat) 2966 (s), 2933 (s), 2874 (s), 2675 (br), 1711 (s), 1410 (m), 1296 (m), 905 (m) 
cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.91 (t, J = 7.3 Hz, 6 H), 0.97 (t, J = 7.3 Hz, 6 H), 
1.67 (s, 3 H), 2.05 (q, J = 7.3 Hz, 4 H), 2.10 (q, J = 7.3 Hz, 4 H), 3.10 (s, 2 H), 4.85 (d, 
J = 1.9 Hz, 1 H), 5.18 (d, J = 1.9 Hz, 1 H); 13C NMR (CDCl3, 100 MHz) δ 13.0, 13.4, 
19.0, 23.1, 26.5, 41.2, 116.9, 130.1, 132.0, 133.0, 135.6, 141.7, 176.4; High-resolution 
MS, calcd for C17H28O2: 264.2089. Found m/z (relative intensity): 265 (M++1, 9), 
264.2076 (M+, 58), 249 (21), 235 (100), 221 (30). 
 
(Z)-4,5,6,7-Tetraethyl-3-methylenenona-4,6-dienoic acid: (4bb) 
Following General Procedure 2, Purification by flash column chromatography. 
 
(Z)-4,5,6,7-Tetraethyl-3-methylenenona-4,6-dienoic acid (4bb) : IR (neat) 2964 (s), 















(m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.83-1.10 (m, 15 H), 1.99-2.14 (m, 10 H), 
3.09 (dd, J = 1.2, 0.7 Hz, 2 H), 4.85 (dt, J = 2.0, 0.7 Hz, 1 H), 5.14 (dt, J = 2.0, 1.2 Hz, 
1 H); 13C NMR (CDCl3, 100 MHz) δ 13.2, 13.5, 14.0, 20.0, 22.8, 23.0, 25.3, 41.6, 
116.2, 135.7, 138.2, 138.8, 141.4, 176.6; High-resolution MS, calcd for C18H30O2: 
278.2246. Found m/z (relative intensity): 279 (M++1, 11), 278.2220 (M+, 56), 250 (53), 
249 (100), 235 (44). 
 
General procedure 3: Formation of Phenylacetic acids from Diketene with 
Promoted by Ni Catalyst (entry 8, Table 2)   
    An oven-dried, 25 mL, three-necked round-bottomed flask equipped with a 
dropp- ing funnel, a rubber septum cap, an air condenser (fitted with a three-way 
stopcock connected into nitrogen balloon), and a Teflon-coated magnetic stir bar was 
charged with Ni(cod)2 (27.5 mg, 0.1 mmol).  The apparatus was purged with nitrogen 
and the flask was charged successively via syringe with freshly dry toluene (3 mL), 
diketene (252.2 mg, 3.0 mmol), and 3-hexyne (82.1 mg, 1 mmol). Oganoaluminum 
(1.2 mmol, 1.0 M hexane solution) was added slowly at room temperature via the 
dropping funnel over a period of 10 min (the reaction temperature should not be 
exceeded 50 ˚C).  The mixture was stirred at room temperature for 72 h and 
monitored by TLC.  After the reaction was completed, the reaction mixture was 
cooled to 0 ˚C, and then poured into ice-water.  The resulting solution was diluted 
with 30 mL of EtOAc and carefully washed with 2 M HCl, and brine.  The aqueous 
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layer was extracted with 30 mL of EtOAc.  The combined organic phases were dried 
(MgSO4) and concentrated in vacuo, and the residual oil was subjected to column 
chromatography over silica gel (eluent; hexane/EtOAc = 4/1 v/v) to afford 5b as a 
colorless oil (121.8 mg, 98%; Rf = 0.67; hexane/EtOAc = 4/1 v/v). 
 
2-(2,3,4,5-Tetraethylphenyl)acetic acid: (5b) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(2,3,4,5-Tetraethylphenyl)acetic acid (5b) : IR (KBr) 3086 (br), 2970 (s), 2933 (s), 
2862 (s), 2674 (s), 2675 (m), 1709 (s), 1628 (m), 1377 (m), 1034 (m), 874 (m), 835 
(m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.12-1.28 (m, 12 H), 2.59-2.70 (m, 8 H), 3.65 
(s, 2 H), 6.92 (s, 1 H); 13C NMR (CDCl3, 100 MHz) δ 15.2, 15.39, 15.42, 15.8, 21.8, 
22.1, 22.3, 25.5, 38.3, 128.6, 129.1, 138.1, 139.4, 139.7, 140.2, 175.6; High-resolution 
MS, calcd for C16H24O2: 248.1776. Found m/z (relative intensity): 249 (M++1, 17), 
248.1770 (M+, 100), 233 (43). 
 
2-(2,3,4,5-Tetramethylphenyl)acetic acid: (5a) 










2-(2,3,4,5-Tetramethylphenyl)acetic acid (5a) : IR (KBr) 3086 (s), 2931 (s), 2871 (s), 
2725 (br), 2534 (m), 1717 (s), 1693 (s), 1628 (m), 1460 (m), 1408 (s), 935 (s), 814 (m), 
750 (m), 679 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 2.18 (s, 3 H), 2.20 (s, 3 H), 2.21 
(s, 3 H), 2.25 (s, 3 H), 3.64 (s, 2H), 6.86 (s, 1 H); 13C NMR (CDCl3, 100 MHz) δ 16.1, 
16.2, 16.4, 20.6, 39.3, 128.8, 129.4, 132.6, 133.7, 134.4, 135.5, 175.7; High-resolution 
MS, calcd for C12H16O2: 192.1150. Found m/z (relative intensity): 193 (M++1, 3), 
192.1147 (M+, 22), 147 (100), 132 (16). 
 
2-(2,3,4,5-Tetrapropylphenyl)acetic acid: (5c) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(2,3,4,5-Tetrapropylphenyl)acetic acid (5c) : IR (KBr) 3086 (br), 2959 (s), 2930 
(s), 2872 (s), 2662 (br), 2561 (m), 1713 (s), 1651 (m), 1456 (s), 883 (m), 739 (m), 610 
(m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.96-1.06 (m, 12 H), 1.39-1.65 (m, 8 H), 2.53 
(m, 8 H), 3.61 (s, 2H), 6.88 (s, 1 H); 13C NMR (CDCl3, 100 MHz) δ 14.8, 14.9, 15.0, 















177.0; High-resolution MS, calcd for C20H32O2: 304.2402. Found m/z (relative 
intensity): 305 (M++1, 22), 304.2409 (M+, 100), 275 (40), 259 (3). 
 
2-(2,3,4,5-tetrabutylphenyl)acetic acid: (5j) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(2,3,4,5-tetrabutylphenyl)acetic acid (5j) : IR (KBr) 2953 (s), 2858 (d), 2667 (brs), 
2341 (d), 1712 (s), 1651 (s), 1463 (s), 1409 (s), 1377 (s), 1240 (s), 1103 (s), 1047 (s), 
948 (brs), 846 (s), 802 (s), 729 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.96 (m, 12 H), 
1.45 (m, 16 H), 2.55 (m, 8 H), 3.61 (s, 2 H), 6.87 (s, 1 H); 13C NMR (CDCl3, 100 
MHz) δ 13.8, 14.0, 23.0, 23.4, 23.5, 23.6, 28.9, 29.2, 29.3, 32.6, 33.2, 33.5, 33.7, 33.8, 
38.5, 128.9, 129.2, 137.0, 138.3, 138.5, 139.3, 176.4; High-resolution MS, calcd for 
C24H40O2: 360.3028 Found m/z (relative intensity): 361 (M++1, 26), 360.3014 (M+, 
100), 275 (11). 
 
2-{(2,3,4,5-tetrahenyl)phenyl}acetic acid: (5e) 










2-{(2,3,4,5-tetrahenyl)phenyl}acetic acid (5e): IR (neat) 3051 (br), 2932 (m), 2874 
(m), 2500 (m), 1709 (s), 1601 (m), 1560 (m), 1493 (m), 1443 (m), 1265 (s), 1157 (m), 
739 (s), 770 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 3.60 (s, 2 H), 6.74-7.14 (m, 20 H), 
7.46 (s, 1H) ; 13C NMR (CDCl3, 100 MHz) δ 39.1, 125.2, 125.4, 126.0, 126.1, 126.4, 
126.4, 126.7, 127.4, 127.4, 129.8, 130.2, 131.0, 131.0, 131.3, 139.2, 139.3, 139.6, 
140.0, 140.4, 141.1, 141.4, 141.8, 176.7; High-resolution MS, calcd for C32H24O2: 
440.1776. Found m/z (relative intensity): 441 (M++1, 61), 440.1779 (M+, 66.7), 395 
(100). 
 
2-(2,4-dimethyl-5-(trimethylsilyl)phenyl)acetic acid: (5f’) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(2,4-dimethyl-5-(trimethylsilyl)phenyl)acetic acid (5f’) : IR (neat) 3415 (br), 2932 
(s), 2873 (s), 2578 (brs), 2363 (s), 1712 (s), 1635 (d), 1448 (s), 1409 (s), 1375 (s), 1249 
(s), 1209 (s), 1151 (s), 1031 (s), 839 (s), 758 (s), 690 (s) cm-1; 1H NMR (CDCl3, 400 















H); 13C NMR (CDCl3, 100 MHz) δ -0.1, 19.3, 22.5, 38.4, 128.4, 131.0, 135.8, 136.4, 
137.7, 142.9, 176.5; High-resolution MS, calcd for C13H20O2Si: 236.1233 Found m/z 
(relative intensity): 237 (M++1, 10), 236.1218 (M+, 65), 222 (19), 221 (100). 
 
2-(3,5-di-tert-butylphenyl)acetic acid: (5k) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(3,5-di-tert-butylphenyl)acetic acid (5k) : IR (neat) 3203 (br), 2964 (s), 2870 (s), 
2360 (s), 2341 (s), 1710 (s), 1599 (s), 1409 (s), 1363 (s), 1265 (s), 894 (s), 738 (s) 
cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.32 (s, 18 H), 3.64 (s, 2 H), 7.12 (d, J = 1.71 Hz, 
2 H), 7.34 (t, J = 1.71 Hz, 1 H); 13C NMR (CDCl3, 100 MHz) δ 31.4, 34.8, 41.3, 121.2, 
123.4, 132.2, 150.9, 176.2; High-resolution MS, calcd for C16H24O2: 248.1776 Found 
m/z (relative intensity): 249 (M++1, 4), 248.1776 (M+, 23), 234 (29), 233 (100). 
 
2-(3,5-bis(trimethylsilyl)phenyl)acetic acid: (5l) 
















2-(3,5-bis(trimethylsilyl)phenyl)acetic acid (5l) : IR (neat) 2956 (s), 2570 (brs), 1712 
(s), 1645 (d), 1408 (s), 1377 (s), 1303 (s), 1249 (s), 1209 (s), 1151 (s), 1032 (s), 860 (s), 
837 (s), 756 (s), 694 (s) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.27 (s, 18 H), 3.65 (s, 2 
H), 7.41 (d, J = 0.97 Hz, 2 H), 7.57 (d, J = 0.97 Hz, 1 H); 13C NMR (CDCl3, 100 MHz) 
δ -1.1, 41.1, 113.9, 134.7, 137.4, 139.9, 176.6; High-resolution MS, calcd for 
C14H24O2Si2: 280.1315 Found m/z (relative intensity): 281 (M++1, 8), 280.1313 (M+, 
33), 265 (100), 237 (55). 
 
2-(5,8-diethyl-1,2,3,4-tetrahydronaphthalen-6-yl)acetic acid: (5i) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(5,8-diethyl-1,2,3,4-tetrahydronaphthalen-6-yl)acetic acid (5i) : IR (KBr) 
3312-2542 (br), 1692 (s), 1454 (s), 1420 (s), 1227 (s), 939 (m), 912 (m), 877 (m) cm-1; 
1H NMR (CDCl3, 400 MHz) δ 1.03 (t, J = 7.56 Hz, 3 H), 1.19 (t, J = 7.56 Hz, 3 H), 
1.77-1.78 (m, 4 H), 2.54 (q, J = 7.56 Hz, 2 H), 2.62 (q, J = 7.56 Hz, 2 H), 2.68 (t, J = 
6.10 Hz, 2 H) , 2.75 (t, J = 6.10 Hz, 2 H) 3.65 (s, 2 H), 7.24 (s, 1 H); 13C NMR (CDCl3, 
100 MHz) δ 13.9, 14.1, 21.8, 22.7, 23.1, 25.4, 26.6, 26.9, 38.4, 127.5, 128.3, 134.7, 
135.4, 138.2, 139.7, 177.8; High-resolution MS, calcd for C16H22O2 : 246.1620. Found 









2-(2,3,5,6-Tetramethylphenyl)acetic acid: (6a) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(2,3,5,6-Tetramethylphenyl)acetic acid (6a) : IR (KBr) 3086 (br), 3002 (s), 2924 
(s), 2874 (s), 2732 (br), 2332 (m), 1695 (s), 1607 (m), 1408 (m), 1381 (m), 1213 (s), 
1010 (m), 935 (m), 868 (m), 681 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 2.20 (s, 6 H), 
2.23 (s, 3 H), 2.24 (s, 3 H), 3.79 (s, 2 H), 6.91 (s, 1 H); 13C NMR (CDCl3, 100 MHz) δ 
16.1, 20.6, 35.5, 128.8, 129.4, 132.9, 133.7, 175.7; High-resolution MS, calcd for 
C12H16O2: 192.1150. Found m/z (relative intensity): 193 (M++1, 13), 192.1144 (M+, 
76), 147 (100). 
 
2-(2,3,5,6-Tetraethylphenyl)acetic acid: (6b) 
Following General Procedure 3, Purification by flash column chromatography. 
 















2876 (s), 2719 (br), 2363 (m), 1699 (s), 1483 (m), 1416 (s), 1231 (s), 939 (m), 887 (s), 
802 (m), 656 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.12 (t, J = 7.6 Hz, 6 H), 1.23 (t, 
J = 7.6 Hz, 6 H), 2.63 (q, J = 7.6 Hz, 4 H), 2.64 (q, J = 7.6 Hz, 4 H), 3.79 (s, 2 H), 6.98 
(s, 1 H); 13C NMR (CDCl3, 100 MHz) δ 14.8, 15.5, 22.3, 25.7, 34.4, 128.1, 129.4, 
138.2, 139.3, 177.8; High-resolution MS, calcd for C16H24O2: 248.1776. Found m/z 
(relative intensity): 249 (M++1, 14), 248.1770 (M+, 77), 233 (16), 203 (17), 189 (100). 
 
2-(2,3,5,6-Tetrapropylphenyl)acetic acid: (6c) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(2,3,5,6-Tetrapropylphenyl)acetic acid (6c) : IR (KBr) 3103 (br), 2957 (s), 2932 
(s), 2870 (s), 2711 (br), 2354 (m), 1703 (s), 1562 (m), 1454 (s), 1414 (m), 1018 (m), 
912 (m), 791 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.99 (t, J = 7.6 Hz, 6 H), 1.01 (t, 
J = 7.6 Hz, 6 H), 1.45 (sext, J = 7.6 Hz, 4 H), 1.59 (sext, J = 7.6 Hz, 4 H), 2.50 (t, J = 
7.6 Hz, 4 H), 2.54 (t, J = 7.6 Hz, 4 H), 3.75 (s, 2H), 6.91 (s, 1 H); 13C NMR (CDCl3, 
100 MHz) δ 14.4, 14.8, 24.0, 24.5, 31.9, 34.8, 35.2, 129.7, 130.0, 137.3, 138.0, 177.7; 
High-resolution MS, calcd for C20H32O2: 304.2402. Found m/z (relative intensity): 










2-(2,3,5,6-tetrabutylphenyl)acetic acid: (6j) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(2,3,5,6-tetrabutylphenyl)acetic acid (6j) : IR (neat) 3075 (br), 2957(s), 2930 (s), 
2860 (s), 2669 (m), 2343 (m), 1709 (s), 1464 (m), 1410 (m), 1379 (m), 1292 (m), 1227 
(m), 930 (m), 899 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.95 (m, 12 H), 1.38-1.46 
(m, 16 H), 2.52-2.58 (m, 8 H), 3.75 (s, 1 H), 6.91. (s, 2 H) ; 13C NMR (CDCl3, 100 
MHz) δ 13.8, 13.9, 14.0, 23.0, 23.4, 29.4, 32.8, 32.9, 33.8, 34.9, 124.6, 129.7, 129.9, 
137.3, 138.2, 140.1, 178.6 ; High-resolution MS, calcd for C24H40O2: 360.3028. Found 
m/z (relative intensity): 361 (M++1, 26), 360.3055 (M+, 100), 316 (9). 
 
2-{(2,3,5,6-tetrahenyl)phenyl}acetic acid: (6e) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-{(2,3,5,6-tetrahenyl)phenyl}acetic acid (6e) : IR (neat) 3024 (br), 2866 (s), 2835 (s), 
2500 (m), 1717 (s), 1653 (s), 1578 (m), 1420 (s), 1232 (s), 918 (m), 692 (s) cm-1; 1H 















MHz) δ37.0, 127.4, 127.5, 128.3, 128.4, 128.5, 128.7, 131.9, 132.0, 171.1; 
High-resolution MS, calcd for C32H24O2: 440.1776. Found m/z (relative intensity): 441 
(M++1, 29), 440.1769 (M+, 43.8), 395 (100). 
 
2-(2,5-dimethyl-3,6-bis(trimethylsilyl)phenyl)acetic acid: (6f) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(2,5-dimethyl-3,6-bis(trimethylsilyl)phenyl)acetic acid (6f) : IR(neat) 2959 (s), 
2903 (s), 2667 (w), 1705 (s), 1636 (m), 1410 (m), 1252 (s), 1211 (m), 1150 (m), 1032 
(m), 837 (s), 760 (s), 691 (m), 635 (m) cm-1; 1H NMR (CDCl3, 400 MHz) δ 0.31 (s, 9 H), 
0.41 (s, 9 H), 2.32 (s, 3 H), 2.45 (s, 3 H), 3.93 (s, 2 H), 7.19 (s, 1 H); 13C NMR (CDCl3, 
100 MHz) δ 0.0, 0.8, 14.0, 20.1, 38.8, 136.2, 137.2, 139.3, 139.6, 140.0, 140.5, 176.4; 
High-resolution MS, calcd for C16H28O2Si2: 308.1628. Found m/z (relative intensity): 
308.1634 (M+, 11.1), 293 (100). 
 
2-(2,5-di-tert-butylphenyl)acetic acid: (6k) 










2-(2,5-di-tert-butylphenyl)acetic acid (6k) : IR(neat) 2868 (s), 2550 (s), 2341 (m), 
1699 (s), 1464 (s), 1416 (s), 1362 (s), 1231 (s), 1204 (s), 910 (s), 824 (s), 741 (s) cm-1; 
1H NMR (CDCl3, 400 MHz) δ 1.29 (s, 9 H), 1.39 (s, 9 H), 3.95 (s, 2 H), 7.21 (s, 1 H), 
7. 33 (d, J = 8.5 Hz, 1 H), 7.38 (d, J = 8.5 Hz, 1 H); 13C NMR (CDCl3, 100 MHz) δ 
31.2, 31.6, 34.0, 36.5, 40.2, 124.0, 126.0, 130.0, 130.8, 148.4, 149.6, 177.8; 
High-resolution MS, calcd for C16H24O2: 248.1776. Found m/z (relative intensity): 
248.1768 (M+, 49.5), 233 (100), 216 (2.5), 203 (1.6). 
 
2-(2,5-bis(trimethylsilyl)phenyl)acetic acid: (6l) 
Following General Procedure 3, Purification by flash column chromatography. 
 
2-(2,5-bis(trimethylsilyl)phenyl)acetic acid (6l) : IR(neat) 2955 (s), 2899 (s), 2856 
(m), 1713 (s), 1410 (m), 1373 (m), 1250 (s), 839 (s), 752 (s), 691 (m),637 (m) cm-1; 1H 
NMR (CDCl3, 400 MHz) δ 0.26 (s, 9 H), 0.33 (s, 9 H), 3.81 (s, 2 H), 7.40 (d, J = 1.0 Hz, 
1 H), 7.42 (dd, J = 7.8, 1.0 Hz, 1 H), 7.51 (d, J = 7.3 Hz, 1 H); 13C NMR (CDCl3, 100 















MS, calcd for C14H24O2Si2: 280.1315. Found m/z (relative intensity): 281 (M++1, 6), 
280.1320 (M+, 0.6), 265 (100). 
 
 General procedure for the C–C bond cleavage reaction of diketene promoted by 
stoichiometric amount of Ni(0) (Scheme 4) 
    To a solution of Ni(cod)2 (137.5 mg, 0.5 mmol), and PPh3 (262.3 mg, 1.0 mmol) 
in dry toluene (5 mL) were successively added diketene (42.0 mg, 0.5 mmol), 
3-hexyne (41.1 mg, 0.5 mmol) via syringe under nitrogen atmosphere.  The mixture 
was stirred at room temperature for 1 h.  After the reaction, added 2 N HCl and stirred 
for overnight at room temperature.  The mixture was diluted with 30 mL of EtOAc 
and washed with brine.  The extract was dried (MgSO4) and concentrated in vacuo 
and the residual oil was subjected to column chromatography over silica gel 
(hexane/EtOAc = 4/1 v/v) to give 7b (67.3 mg, 80%, Rf = 0.33; hexane/EtOAc = 4/1 
v/v). 
 
(3E)-4-ethyl-5-methylene-3-heptenoic acid: (7b) 
 
(3E)-4-ethyl-5-methylene-3-heptenoic acid (7b) : IR(neat) 2970 (s), 2936 (s), 2878 (s), 
1713 (s), 1607 (m), 1413 (s), 1288 (s), 1219 (s), 893 (s) cm-1; 1H NMR (CDCl3, 400 
MHz) δ 0.98 (t, J = 7.5 Hz, 3 H), 1.05 (t, J = 7.5 Hz, 3 H), 2.25 (qd, J = 7.5, 1.3 Hz, 2 






(s, 1 H), 5.64 (t, J = 7.1 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ 13.2, 13.4, 21.5, 26.9, 
33.5, 110.1, 116.1, 144.5, 149.2, 177.7; High-resolution MS, calcd for C10H16O2: 
168.1150. Found m/z (relative intensity): 169 (M++1, 83.7), 168.1143 (M+, 51.1), 153 
(100). 
 
General procedure for the C–C bond cleavage reaction of diketene promoted by 
stoichiometric amount of Ni(0) with PhMgBr (eq 2) 
    To a solution of Ni(cod)2 (137.5 mg, 0.5 mmol), and PPh3 (262.3 mg, 1.0 mmol) 
in dry toluene (5 mL) were successively added diketene (42.0 mg, 0.5 mmol), 
3-hexyne (41.1 mg, 0.5 mmol) via syringe under nitrogen atmosphere.  The mixture 
was stirred at room temperature for 1 h.  Then, added the PhMgBr (0.6 mmol, 1M 
THF solution) and stirred for overnight at room temperature. After the reaction, added 
2 N HCl and stirred for 24 h at room temperature.  The mixture was diluted with 30 
mL of EtOAc and washed with brine.  The extract was dried (MgSO4) and 
concentrated in vacuo and the residual oil was subjected to column chromatography 
over silica gel (hexane/EtOAc = 4/1 v/v) to give the mixture of 8b and 9b (8b: 63.5 mg, 
26%, 9b: 127.2 mg, 39%, Rf = 0.33; hexane/EtOAc = 4/1 v/v).   













    A mixture of (3Z)-4-ethyl-5-methylene-3-phenyl-3-heptenoic acid (8b) and 
(3Z)-4-ethyl-5-methylene-3-[(3Z)-4-phenyl-3-hexenyl]-3-heptenoic acid (9b) in a 1 : 2 
ratio : IR(neat) 3402 (br), 3084 (s), 3028 (s), 2966 (s), 2934 (s), 1705 (s), 1636 (s), 
1441 (m), 1410 (m), 1286 (m), 943 (s), 897 (s), 766 (s), 700 (s) cm-1; 1H NMR (CDCl3, 
400 MHz, (8)) δ 0.90 (t, J = 7.5 Hz, 3 H), 1.05 (t, J = 7.5 Hz, 3 H), 2.31 (q, J = 7.5 Hz, 
2 H), 2.33 (q, J = 7.5 Hz, 2 H), 2.78 (s, 2 H), 4.89 (s, 1 H), 5.01 (s, 1 H), 7.08-7.32 (m, 
5 H); 13C NMR (CDCl3, 100 MHz, (8b)) δ 11.9, 12.5, 26.0, 28.5, 41.7, 118.4, 126.0, 
127.6, 128.9, 139.1, 141.8, 143.0, 145.7, 176.2; High-resolution MS (8b), calcd for 
C16H20O2: 244.1463. Found m/z (relative intensity): 245 (M++1, 19.0), 244.1458 (M+, 
100), 242 (2.9). 
1H NMR (CDCl3, 400 MHz, (9b)) δ 0.86 (t, J = 7.5 Hz, 3 H), 0.87 (t, J = 7.5 Hz, 3 H), 
1.02 (t, J = 7.5 Hz, 3 H), 1.06 (t, J = 7.5 Hz, 3 H), 1.85 (q, J = 7.5 Hz, 2 H), 2.31 (q, J 
= 7.5 Hz, 2 H), 2.33 (q, J = 7.5 Hz, 2 H), 2.40 (q, J = 7.5 Hz, 2 H), 3.47 (s, 2 H), 4.65 
(d, J = 1.5 Hz, 1 H), 4.80 (d, J = 1.5 Hz, 1 H), 7.08-7.32 (m, 5 H); 13C NMR (CDCl3, 
100 MHz, (9)) δ 11.9, 12.5, 13.1, 13.2, 25.3, 25.9, 27.4, 28.4, 39.5, 113.2, 126.1, 126.3, 
127.0, 127.5, 127.9, 128.7, 138.4, 142.9, 150.2, 176.2; High-resolution MS (9b), calcd 
for C22H30O2: 326.2246. Found m/z (relative intensity): 327 (M++1, 42.6), 326.2242 




X-ray Crystal Structure Determinations.  X-ray quality single crystals were grown 
from solvent combinations of ethyl acetate/hexane for both of 5b and 6b.  All 
measurements were made on a Rigaku Saturn724 diffractometer using multi-layer 
mirror monochromated Mo-Ka radiation.  Data were collected and processed using 
CrystalClear (Rigaku) at a temperature of -179+1 ˚C to a maximum 2θ value of 55˚.  
The structures were solved by direct methods (SHELXL-97) and expanded using 
Fourier techniques.  The non-hydrogen atoms were refined anisotropically and 
hydrogen atoms were refined using the riding model.  All calculations were performed 
using the CrystalStructure 4.0 (Crystal Structure Analysis Package, Rigaku 
Corporation) except for refinement, which was performed using SHELXL-97.  Crystal 
data and refinement parameters for the structurally characterized compounds 5b and 6b 
are summarized in Tables 4 and 5, respectively.  An ORTEP drawing of 5b and 6b are 
shown in Figure 1 and 2, respectively.  CCDC 832667 contains the supplementary 
crystallographic data for 5b and CCDC 828924 for 6b.  These data can be obtained 










Table 4.  Crystallographic data for compound 5b 
 
Formula    C16H24O2 
formula weight   248.36 
cryst system   monoclinic 
space group   P21/c 
cryst color   colorless, prism 
cryst size (mm)  0.280 x 0.220 x 0.056 
a (Å)    16.802(5) 
b (Å)    8.257(2) 
c (Å)    10.389(3) 
α (deg)     
β (deg)    97.407(4) 
γ (deg)     
V (Å3)    1429.4(7) 
Z    4 
ρcalc (gcm-3)   1.154 
µ (cm-1)    0.738 
2θmax (deg)  55.0 
no. of unique reflns  3255  
Rint   0.0466 
no. of parameters   168 
R1 a[I>2σ(I)]  0.0557 
R b(all data)  0.0766 
Rw c   0.1186 
GOF d   1.091 
 
a R1 = Σ ||Fo| − |Fc||/Σ |Fo|.  b R = Σ |Fo2 − Fc2|/Σ Fo2.  c Rw = {Σw(Fo2 − Fc2)2/Σw 
(Fo2)2}1/2. 
d GOF = [{Σw(Fo2 − Fc2)2}/(No − Np)]1/2, where No and Np denote the number of 





Table 5.  Crystal data and data refinement for 6b 
 
Formula    C16H24O2 
formula weight   248.36 
cryst system   triclinic 
space group   P-1 
cryst color   colorless, platelet 
cryst size (mm)  0.155 x 0.083 x 0.027 
a (Å)    4.876(3) 
b (Å)    9.006(6) 
c (Å)    16.659(10) 
α (deg)    97.07(2) 
β (deg)    94.054(8) 
γ (deg)    94.82(2) 
V (Å3)    721.0(8) 
Z    2 
ρcalc (gcm-3)   1.144 
µ (cm-1)    0.731 
2θmax (deg)  54.9 
no. of unique reflns  3284  
Rint   0.0407 
no. of parameters   171 
R1 a[I>2σ(I)]  0.0494 
R b(all data)  0.0816 
Rw c   0.1160 
GOF d   1.087 
 
a R1 = Σ ||Fo| − |Fc||/Σ |Fo|.  b R = Σ |Fo2 − Fc2|/Σ Fo2.  c Rw = {Σw(Fo2 − Fc2)2/Σw 
(Fo2)2}1/2. 
d GOF = [{Σw(Fo2 − Fc2)2}/(No − Np)]1/2, where No and Np denote the number of 
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